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Genomic imprinting is a form of non-Mendelian inheritance in which epigenetic 
mechanisms regulate monoallelic gene expression in a parent-of-origin-dependent manner. 
Imprinted genes play a pivotal role in the development of the fetus and extra-embryonic tissues, 
such as the placenta. The placenta is a temporary organ that is critical for interpreting complex 
biological cues between the mother, her developing child, and the surrounding environment. 
Alterations to placental function can occur on an epigenomic level and are widely recognized as 
having both immediate perinatal consequences as well as influencing the life-long health of the 
offspring. As a result, the placenta is an organ of intense interest in the growing field of the 
developmental origins of health and disease (DOHaD).  
This goal of this research was to explore the role of genomic imprinting not only as it 
relates to placental and fetal development, but also as a link to later-in-life disease. Using 
placental samples collected from the Extremely Low Gestational Age Newborn (ELGAN) 
cohort, we assessed the relationship between CpG DNA methylation of imprinted genes and: (1) 
risk of being born intrauterine growth restricted, (2) disruptions in childhood growth trajectories 
associated with risk of childhood obesity, and (3) the association with maternal pre-pregnancy 
BMI.  Through these studies, we demonstrated that alterations in CpG methylation levels of 
imprinted genes within the placenta are associated with in utero and childhood health outcomes, 
and that maternal pre-pregnancy BMI may contribute to the observed perturbations in imprinting 
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within the placenta. Moreover, we found a strong sexually dimorphic response, with both 
specific imprinted genes as well as broad biological functions showing distinct patterns 
dependent on fetal sex. These studies highlight the complex biologic and external factors which 
contribute to aberrant imprinting, leading to disease, and taken together these findings elucidate a 
critical role for imprinted genes in DOHaD.  
 
v 




I would like to thank Dr. Rebecca C. Fry – “boss lady,” mentor, and friend. You managed 
to reignite a passion for science I never thought I’d find again. I am thankful beyond measure for 
that high-five in the MIT Biopolymers Lab so many years ago, and hope for another 20 like these 
but with more snow.  
I would also like to thank the Fry Lab Army, current and past - especially Lauren, 
Caroline, and Hudson - you’re the best lab-mates anyone could ask for. And to Cassie, my mini-
me, #ssdgm 
I would like to thank my committee members, Dr. Tracy Manuck, Dr. Leena Nylander-
French, Dr. T. Michael O’Shea, and Dr. Jill Stewart - you were my colleagues and collaborators 
before I started my doctoral journey and I could not think of a better group to help me grow as a 
scientist. I am so thankful you each agreed to serve on my committee and appreciate your 
expertise and thoughtful consideration of my research projects. 
My biggest thanks are to my favorite Lowell boys, Marcel Smeester and Mat Castine. 
The countless rescheduled birthdays, trips, holidays, and events are finally paying off. I am 
“wicked thankful” you understood that my free time (and sanity) would cease to exist during this 
seemingly unending part-time adventure and allowed everything to revolve around my academic 
deadlines. I couldn’t have done it without you. Na Zdrowie! 
It really does take a village. And I love my village. 
 
vii 
TABLE OF CONTENTS 
LIST OF TABLES ........................................................................................................................ xii 
LIST OF FIGURES ..................................................................................................................... xiii 
LIST OF ABBREVIATIONS ...................................................................................................... xiv 
CHAPTER 1: INTRODUCTION, PROJECT APPROACH, AND 
DISSERTATION ORGANIZATION ............................................................................................ 1 
1.1 Genomic Location of Imprinted Genes ........................................................................... 2 
1.2 The Role of Imprinted Genes in Regulating Placental Function and Fetal 
Growth ................................................................................................................................... 3 
1.3 An Evolutionary Basis for the Existence of Imprinted Genes ........................................ 5 
1.4 Imprinted Genes and the Developmental Origins of Health and Disease ....................... 6 
1.4.1 Clinical syndromes and phenotypic dimorphism ............................................... 7 
1.4.2 Perinatal outcomes that increase risk of later in life disorders ......................... 11 
1.4.3 Imprinted genes and cancer .............................................................................. 12 
1.5 When Imprinting Goes Awry: Biologic, Environmental, and Maternal 
Impacts on Imprinted Genes ............................................................................................... 14 
1.5.1 Errors arising from cell division ....................................................................... 14 
1.5.2 Disruption of imprinted gene methylation by environmental 
contaminants .............................................................................................................. 15 
1.5.3 The role of the maternal “environment” in relation to genomic 
imprinting .................................................................................................................. 17 
1.6 Project Approach ........................................................................................................... 21 
1.7 Dissertation Organization .............................................................................................. 22 
REFERENCES ............................................................................................................................. 23 
 
viii 
CHAPTER 2: ALTERED METHYLATION PATTERNS OF IMPRINTED 
GENES WITHIN THE PLACENTA AND RISK OF INTRAUTERINE 
GROWTH RESTRICTION .......................................................................................................... 28 
2.1 Introduction ................................................................................................................... 28 
2.2 Materials and Methods .................................................................................................. 30 
2.2.1 The Elgan Study ............................................................................................... 30 
2.2.2 Participant characteristics and sociodemographic data .................................... 30 
2.2.3 Placental processing .......................................................................................... 30 
2.2.4 DNA extraction ................................................................................................. 31 
2.2.5 CpG methylation assessment ............................................................................ 31 
2.2.6 Analytic and statistical approaches ................................................................... 32 
2.2.7 Functional analysis of biological networks ...................................................... 33 
2.3 Results ........................................................................................................................... 34 
2.3.1 Study demographics .......................................................................................... 34 
2.3.2 Altered methylation of imprinted genes is associated with IUGR 
risk ............................................................................................................................. 34 
2.3.3 Methylation patterns associated with IUGR risk are altered in a 
sexually-dimorphic manner ....................................................................................... 34 
2.3.4 Differentially methylated ICRs are associated with IUGR risk ....................... 37 
2.4 Discussion ..................................................................................................................... 38 
REFERENCES ............................................................................................................................. 43 
CHAPTER 3: ALTERED METHYLATION PATTERNS OF IMPRINTED 
GENES WITHIN THE PLACENTA AND CHILDHOOD GROWTH 
TRAJECTORIES .......................................................................................................................... 47 
3.1 Introduction ................................................................................................................... 47 
3.2 Materials and Methods .................................................................................................. 49 
3.2.1 The Elgan Study ............................................................................................... 49 
3.2.2 Participant characteristics & sociodemographic data ....................................... 49 
 
ix 
3.2.3 Placental processing .......................................................................................... 49 
3.2.4 DNA extraction ................................................................................................. 50 
3.2.5 CpG methylation assessment ............................................................................ 50 
3.2.6 Analytic and statistical approaches ................................................................... 51 
3.2.7 Functional analysis of biological networks ...................................................... 52 
3.3 Results ........................................................................................................................... 52 
3.3.1 Study demographics .......................................................................................... 52 
3.3.2 Altered methylation of imprinted genes is associated with 
childhood growth trajectories .................................................................................... 52 
3.3.3 Altered methylation of imprinted genes associated with 
childhood growth trajectories exhibits a strong sexually dimorphic 
response ..................................................................................................................... 53 
3.4 Discussion ..................................................................................................................... 55 
REFERENCES ............................................................................................................................. 59 
CHAPTER 4: THE EFFECT OF MATERNAL PRE-PREGNANCY BMI ON 
IMPRINTED GENES WITHIN THE PLACENTA..................................................................... 64 
4.1 Introduction ................................................................................................................... 64 
4.2 Materials and Methods .................................................................................................. 66 
4.2.1 The Elgan Study ............................................................................................... 66 
4.2.2 Participant characteristics & sociodemographic data ....................................... 66 
4.2.3 Placental processing .......................................................................................... 66 
4.2.4 DNA extraction ................................................................................................. 67 
4.2.5 CpG methylation assessment ............................................................................ 67 
4.2.6 Analytic and statistical approaches ................................................................... 68 
4.3 Results ........................................................................................................................... 70 
4.3.1 Study demographics .......................................................................................... 70 
 
x 
4.3.2 Maternal pre-pregnancy BMI is associated with altered 
methylation of imprinted genes ................................................................................. 70 
4.3.3 Maternal pre-pregnancy BMI is associated with altered 
methylation of imprinted genes in a sexually dimorphic manner .............................. 72 
4.4 Discussion ..................................................................................................................... 74 
REFERENCES ............................................................................................................................. 78 
CHAPTER 5: DISSERTATION DISCUSSION, FUTURE RESEARCH, AND 
CONCLUSION ............................................................................................................................. 83 
5.1 Imprinted Genes in the Placenta Play a Critical Role in Pre-/Perinatal, 
Childhood, and Lifelong Health Trajectories of Offspring ................................................. 83 
5.2 Imprinted Genes Within the Placenta are Susceptible to the Endogenous 
Maternal “Environment” ..................................................................................................... 85 
5.3 Perturbations in Placental Imprinting are Sexually Dimorphic..................................... 87 
5.4 Proposed Biological Functions and Underlying Mechanisms 
Contributing to Perturbed Methylation Patterns Differ among Studies .............................. 87 
5.4.1 The role of lipoproteins and altered lipid transfer in IUGR 
pathogenesis and risk of associated later-in-life diseases .......................................... 88 
5.4.2 Hormone signaling as modulators of childhood growth 
trajectory in females .................................................................................................. 89 
5.4.3 Oxidative stress and altered one carbon metabolism, driven by 
maternal pre-pregnancy BMI, disrupts proper placental imprinting ......................... 90 
5.5 Public Health Relevance ............................................................................................... 92 
5.6 Future Research ............................................................................................................. 93 
5.6.1 Do the methylation signatures identified in these studies result 
in functional (e.g. transcriptomic and proteomic) changes? Do these 
trends persist over time? ............................................................................................ 94 
5.6.2 How do other genetic, epigenetic, and environmental factors 
influence imprinting within the placenta? ................................................................. 95 
5.6.3 What is the paternal contribution to genomic imprinting and 
DOHaD? .................................................................................................................... 97 
5.7 Conclusion ..................................................................................................................... 97 
 
xi 
REFERENCES ............................................................................................................................. 99 
APPENDIX 1: REFERENCES FOR STUDIES CITED IN TABLE 2 ..................................... 106 
APPENDIX 2: LIST OF EXPERIMENTALLY VALIDATED AND 
PREDICTED IMPRINTED GENES USED FOR ALL ANAYSES ......................................... 110 
APPENDIX 3: ILLUMINA EPIC MANIFEST PROBE IDS AND 
ASSOCIATED GENOMIC INFORMATION COMPRISING THE CURRATED 
IMPRINTED GENE DATASET ................................................................................................ 121 
APPENDIX 4: DIRECTED ACYCLIC GRAPHS (DAGS) USED TO ASSIST IN 
SELECTING MODEL COVARIATES ..................................................................................... 153 
APPENDIX 5: SEX-STRATIFIED BIOLOGIC FUNCTIONS ASSOCIATED 
WITH ALTERED CPG METHYLATION INFLUENCED BY MATERNAL 
PRE-PREGNANCY BMI ........................................................................................................... 156 
APPENDIX 6: REFERENCES FOR STUDIES CITED IN FIGURE 7 .................................... 157 
APPENDIX 7: COMMON IMPRINTED GENES WITHIN THE PLACENTA 




LIST OF TABLES 
Table 1. Classical imprinting disorders .......................................................................................... 8 
Table 2. Human imprinting hotspot 11p15 ................................................................................... 20 
Table 3. Elgan cohort characteristics. ........................................................................................... 35 
Table 4. Imprinting control regions associated with relative risk of IUGR, 
including 95% CI. ......................................................................................................................... 38 
Table 5. Imprinted genes associated with childhood growth trajectories. .................................... 54 




LIST OF FIGURES 
Figure 1. Imprinted genes in parental resource allocation. ............................................................. 5 
Figure 2. Imprinting errors and tumorigenesis. ............................................................................ 13 
Figure 3. Overarching goal of dissertation. .................................................................................. 21 
Figure 4. CpG methylation of imprinted genes and relative risk of IUGR................................... 36 
Figure 5. Venn diagram of sex-dependent differentially methylated probes that 
were associated with relative risk of IUGR. ................................................................................. 37 
Figure 6. Interacting molecular network of imprinted genes associated with 
childhood growth trajectories. ...................................................................................................... 55 
Figure 7. Tissue specific functions of the sexually dimorphic imprinted genes 
associated with maternal pre-pregnancy BMI. ............................................................................. 73 
Figure 8. Venn diagram displaying shared and unique imprinted genes within the 
placenta across all aims. ................................................................................................................ 84 
Figure 9. CpG methylation of imprinted genes across various human tissues. 
Taken from Murphy et al., 2012. .................................................................................................. 86 
Figure 10. Biological underpinnings of associations between CpG methylation of 
imprinted genes within the placenta, peri-/post-natal outcomes (a, b), as well as 




LIST OF ABBREVIATIONS 
5-hmC 5-hydroxymethylcytosine 
5-mC 5-methylcytosine 
ATSDR Agency for Toxic Substances and Disease Registry 
BMI Body mass index 
BW Birth weight 
BWS Beckwith-Wiedemann syndrome 
CHEAR Children's Health Exposure Analysis Resource 
Chr Chromosome 
CpG Cytosine -phosphate - guanine 
CPM Confined placental mosaicism 
DAG Directed acyclic graph 
DALY Disability-adjusted life years 
DMR Differentially methylated region 
DNA Deoxyribonucleic acid 
DOHaD Developmental Origins of Health and Disease 
ECHO Environmental influences on Child Health Outcomes 
ELGAN Extremely Low Gestational Age Newborn 
FDR False discovery rate 
GA Gestational age 
ICR Imprinting control region 
IG Imprinted gene 
IUGR Intrauterine growth restriction 
 
xv 
KOS Kagami–Ogata syndrome 
LBW Low birth weight 
LGA Large for gestational age 
lncRNA Long non-coding ribonucleic acid 
LOI Loss of imprinting 
LOM Loss of methylation 
miRNA Micro-ribonucleic acid 
mTOR Mechanistic target of rapamycin 
OS Oxidative stress 
PBS Phosphate Buffered Saline 
PE Preeclampsia 
PTB Preterm Birth 
PW Prader-Willi syndrome 
ROS Reactive Oxygen Species 
RR Relative risk 
SAM S-Adenosyl methionine 
SGA Small for gestational age 
SNP Single nucleotide polymorphism 
SRS Silver-Russell syndrome 
TET Ten-eleven translocation 
UPD Uniparental disomy 
WT Wilms Tumor 
 
1 
CHAPTER 1: INTRODUCTION, PROJECT APPROACH, AND DISSERTATION 
ORGANIZATION 
 Mendelian genetics dictates that offspring inherit two copies of every autosomal gene, 
one from the mother and one from the father, and that both copies are expressed for most genes.  
Imprinted genes represent an exception to this rule as expression, regulated via epigenetics, is 
tied to the parent from whom each allele was inherited. Evidence that parental genomes are not 
equivalent was first identified in mouse models, when researchers failed to generate viable 
mouse embryos using only maternal or paternal chromosomes [1, 2]. The inability of embryos 
with uniparental genomes to undergo normal embryogenesis established that normal fetal and 
placental development required genetic material from both parents; maternal and paternal 
genomes are neither equivalent, nor interchangeable. These studies were the first to hint at an 
underlying, parent-of origin mechanism of inheritance that would come to be recognized as 
genomic imprinting.  
Currently, there are more than 200 known or putative imprinted genes in humans [3]. In 
the context of disease susceptibility, as imprinted genes are functionally haploid, they are 
especially susceptible to biologic, environmental, and nutritional influences, which may result in 
either complete epigenetic silencing or inappropriate expression due to “loss of imprinting” 
(LOI).  
Related to the impact on fetal growth and development, imprinted genes play a pivotal 
role in the development of the fetus and extra-embryonic tissues such as the placenta [3]. The 
placenta is a temporary organ critical for modulating biological cues between the mother, her 
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developing child, and the surrounding environment [4]. Many of the known imprinted genes are 
expressed within the placenta, and genomic imprinting has been confirmed in all placental 
mammals studied thus far [5]. Alterations to placental function can occur on an epigenomic level 
[6] and are widely recognized as having both immediate perinatal consequences as well as 
influencing the life-long health of the offspring, making the placenta a central focus in 
understanding health trajectories of offspring [7].   
1.1 Genomic Location of Imprinted Genes 
 About 1% of the mammalian genome is imprinted [8]. While imprinted genes are 
regulated through various epigenetic mechanisms (see section 5.7.2), the most well-known 
mechanism is the methylation of cytosines separated from guanines by one phosphate group 
(CpG). The process of methylation at imprinted loci differs from typical DNA methylation. 
During early embryogenesis, DNA methylation marks are globally wiped and subsequently re-
established in a lineage-specific manner in order to guide differentiation during critical periods 
of embryonic development, yet imprinted genes are protected from this reprogramming [6]. 
Imprinted genes are often clustered together within the genome and possess imprinting control 
regions (ICRs), which are acquired during germline development and maintained in somatic cells 
of the conceptus [9]. A single ICR may control both maternally and paternally-expressed genes, 
and their existence suggests that gene imprinting may be regulated at a chromosomal level, 
rather than at a gene-specific level [10]. In support of chromosomal-level regulation are certain 
genomic locations, such as 11p15, where several clusters of imprinted genes occur making this 
chromosome a “hotspot” of imprinted activity [11]. ICRs, as well as other regulatory regions 
associated with genomic imprinting, are referred to as differentially methylated regions (DMRs), 
representing discrete DNA elements that carry a heritable epigenetic mark that distinguishes the 
 
3 
parental alleles and are maintained throughout development. Imprinted gene DMRs display 
~50% methylation, where one allele is methylated and the other unmethylated in a parent-of-
origin dependent manner. Unlike other regions of the genome, methylation of DMRs exhibit 
little inter-individual variability, and methylation patterns displayed stability across prenatal, 
postnatal, and adult tissues [12].  
1.2 The Role of Imprinted Genes in Regulating Placental Function and Fetal Growth  
The placenta is the lifeline of the developing fetus: ensuring access to maternal nutrients 
and oxygen, removing metabolic waste from the fetal compartment, and regulating hormone 
levels and energy homeostasis [13].  Imprinting is particularly important and enriched in the 
placenta, playing a role in fetal growth and maturation [14]. The rate of nutrient transfer to the 
developing fetus is dependent upon the placenta; thus, unsurprisingly, imprinted genes play a 
unique role not only in proper placental morphology and function but also in influencing 
maternal resource allocation. Extra-embryonic tissues such as the placenta rely on activation of 
paternal genes to drive fetal demand for resources, and as such, many of placentally imprinted 
genes are predominantly growth-promoting [10]. Studies using mouse models support this, 
where knockout of several paternally-imprinted genes resulted in smaller placental size, 
compared to hyperplasia of the placenta when maternally imprinted genes were knocked out [as 
summarized in 10]. For example, the Insulin-Like Growth Factor (IGF) signaling pathway is a 
major growth-promoting axis that includes maternally imprinted Insulin Like Growth Factor II 
(IGF2).  IGF2 regulates the optimal placental morphology for nutrient transport –large surface 
area and reduced thickness of the exchange barrier [15]. 
Previous studies have identified several imprinted genes as drivers of placental 
morphology and physiology, with biological roles in the modulation of placental labyrinth size 
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and surface area, density of vascular branching during development, and trophoblast-
derived endocrine cell differentiation [as reviewed in 13]. Placental imprinting is not static, but 
rather a dynamic process throughout human gestation [16, 17]. Specifically, several imprinted 
genes assessed in 1st trimester placentas display significantly higher rates of LOI than that of 
term placentas, despite minimal differences in subsequent gene expression [17]. For example, 
prior to week 10 of pregnancy, researchers observed bi-allelic expression of H19 Imprinted 
Maternally Expressed Transcript (H19) in ~1/3 of placental tissues; however, when examined 
further in gestation, only monoallelic expression was observed [16], indicating that the imprinted 
parent-of-origin mark may not be fully established early in human pregnancy. In other instances, 
first trimester placental imprinting can be cell-type dependent. Expression of Catenin Alpha 3 
(CTNNA3) is biallelic in extra-villous trophoblast cells, maternal in villous cytotrophoblast cells, 
and expression is lost following epithelial–mesenchymal transition in order to assist in 
development of invasive properties, facilitating the invasion of endometrium [18].  
Fetal growth rate varies throughout gestation, the most rapid phase being between 16 to 
32 weeks and is dictated by a combination of placental sufficiency and intrinsic fetal factors [19]. 
By examining the correlation between imprinted and fetal growth measurements in both tissues 
obtained through chorionic villus sampling and term placenta in humans, one group has been 
able to tease apart drivers of early- and late-stage fetal growth. Their observations suggest that 
maternally imprinted IGF2 regulates fetal growth potential early in gestation, and that the 
paternally imprinted growth suppressing genes, Pleckstrin Homology Like Domain Family A 
Member 2 (PHLDA2) and Growth Factor Receptor-bound Protein 10 (GRB10), act to fine tune 
fetal growth during the later stages of pregnancy [20]. GRB10 is a particularly interesting 
imprinted gene. It is a growth suppressor with roles in cellular proliferation, apoptosis, and 
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metabolism, exhibiting an isoform and a tissue specific imprinting pattern. Specifically, in 
humans, GRB10 is biallelically expressed in most tissues, while it is maternally imprinted in the 
brain and paternally imprinted in the placenta [21]. This dichotomy may hint at the role 
imprinted genes have in postnatal growth and metabolism. Postnatally, imprinted genes such as 
GRB10 that are expressed in the brain may influence behavior, cognitive, and emotional 
characteristics [22]. 
1.3 An Evolutionary Basis for the Existence of Imprinted Genes 
Perhaps the most widely accepted hypothesis for the basis of the existence of imprinted 
genes is the so-called evolutionary conflict theory, or the “battle of the sexes,” (Figure 1). This 
theory describes the struggle between males passing on fitness enhancing, growth promoting 
genes, and females passing on growth restricting genes that could conserve maternal resources  
 
 
Figure 1. Imprinted genes in parental resource allocation. The evolutionary conflict theory, 
or “battle of the sexes,” describes the struggle for parental resource allocation.  Maternally-
expressed genes tend to be growth restricting, whereas paternally-expressed genes are growth 
promoting, and each play a distinct role in fetal and placental development.  
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during fetal development [23].  Still, because imprinted genes are functionally haploid, they are 
especially susceptible to epigenetic modification and LOI. Evolutionarily, this is 
counterintuitive:  Why would a mechanism arise that may put fetal growth and development at a 
disadvantage?  
During early mammalian evolution, when imprinting was thought to arise, females were 
able to simultaneously gestate offspring from multiple males. In this context, it is hypothesized 
the evolutionary basis for the conflict theory is that growth and resource extraction of 
offspring carrying the male’s DNA is the “paternal” attempt to out-compete offspring from other 
males. Conversely, suppression of fetal growth and limiting resources is in the “maternal” 
interest of increasing equal chance of survival among all her offspring. Despite low prevalence 
within the genome, the imprinting of these genes often has dramatic consequences for feto-
placental development [24]. While some genes are imprinted specifically in the placenta, there is 
a delicate synergy maintaining placental sufficiency and fetal growth; unsurprisingly, there is 
some overlap of imprinted genes responsible for both [5]. 
1.4 Imprinted Genes and the Developmental Origins of Health and Disease 
Observations from a series of epidemiological studies examining birth and death records 
of men and women in the United Kingdom first published over 30 years ago led to David J. 
Barker’s “fetal origins hypothesis”, a theory that gestational undernutrition is linked to certain 
birth phenotypes, such as intrauterine growth restriction (IUGR), low birth weight (LBW), and 
preterm birth (PTB), and is an important early genesis of later-in-life metabolic disorders [25]. 
While Barker suggested these observations were due to adaptive responses of the fetus 
specifically, this was the basis for the current DOHaD hypothesis. This hypothesis evolved 
beyond just fetal adaptive response to more broadly examine periconceptual, fetal, and early-life 
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conditions which pose a lifetime risk for development of chronic diseases, such as environmental 
insults and maternal wellbeing (nutrition, stress), with a particular interest in the underlying role 
epigenetics may play. One of the hallmarks of imprinting disorders is developmental 
abnormality, resulting in altered growth and nutrient acquisition early in life due to their critical 
role in regulating these physiological processes [13], thus making imprinting a model mechanism 
for DOHaD.  
1.4.1 Clinical syndromes and phenotypic dimorphism 
There are currently around a dozen recognized ‘classical’ imprinting disorders caused by 
aberrant expression of imprinted genes (Table 1). Given the role of imprinted genes in prenatal 
growth and development, it is unsurprising these clinical syndromes manifest in a range of 
growth, developmental, metabolic, and behavioral deficiencies, many of which are apparent at 
birth or manifest during early childhood. Among the most interesting, and well-studied, are the 
handful involving the same imprinted locus with vastly different outcomes. 
In the mid-1960s, English physician Harry Angelman encountered three children who 
presented with a similar grouping of phenotypic symptoms including a smiling, laughing 
demeanor despite developmental and speech disabilities, seizures, and motor coordination issues 
such as jerky gait [26]. While diagnoses of “Angelman syndrome” began to rise, approximately 
one in every 15,000 to 20,000 births currently, it would take over 20 years to uncover the genetic 
cause underlying this disease - a relatively small deletion in the maternally derived chromosome 
15, which included Ubiquitin Protein Ligase E3A (UBE3A). UBE3A plays a critical role in the 
normal development and function of the nervous system and is paternally silenced, and thus 
cannot compensate for the maternal loss.  
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Prader-Willi syndrome (PWS) involves imprinted genes from the same chromosome 15 
region (15q11-13) as Angelman’s but arises from loss of the paternally expressed gene, Small 
Nuclear Ribonucleoprotein Polypeptide N (SNRPN). Individuals with PWS have decreased  
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muscle tone, resulting in developmentally delayed motor skills, and also exhibit disordered 
eating habits (food obsessed with insatiable appetite) [27]. 
Beckwith–Wiedemann syndrome (BWS) and Silver–Russell syndrome (SRS) are both 
growth related imprinting disorders arising from imprinting errors in 11p15.5 but present with 
very different phenotypes. Individuals with BWS tend to be born above average birth weight and 
length (large for gestational age, LGA), with a large tongue that may interfere with breathing, 
swallowing, and speaking, with abdominal wall defects, and placental overgrowth [27], with the 
most common underlying cause being the loss of methylation at the ICR for KCNQ1 Opposite 
Strand/Antisense Transcript 1 (KCNQ1OT1) [28]. Conversely, SRS individuals are born small 
for their gestational age (SGA) and exhibit dwarfism later in life. This growth retardation is 
associated with loss of methylation at the ICR for H19/IGF2, which results in biallelic 
expression of H19 and complete loss of IGF2 expression [29]. 
Imprinting within the GNAS complex locus (GNAS, 20q13.11) is multifaceted, giving 
rise to maternally, paternally, and biallelically expressed transcripts driven in part by differential 
methylation of four alternative promoters, all encoding for distinct proteins [30]. Disruption in 
GNAS, a regulator of hormones, shows significant reduction of activity in tissues with 
monoallelic GNAS expression and results in end-organ resistance to several hormones, including 
thyroid stimulating hormone (TSH) and parathyroid hormone (PTH) among others [30]. 
Pseudohypoparathyroidism type 1a (PHP1a) arises from mutations in the GNAS locus resulting 
 
10 
in a 50% reduction in expression of the non-imprinted maternal gene and, in addition to 
resistance to PTH, is associated with features of Albright's hereditary osteodystrophy (AHO), 
such as short stature, obesity/round face, brachydactyly, cognitive impairment, and 
developmental delay [30]. Pseudohypoparathyroidism type 1b (PHP1b) is a true imprinting 
disorder resulting from loss of methylation (LoM) of DMRs in GNAS [30]. 
Parent-of-origin dependent uniparental disomies (UPDs) at imprinting locus 14q32.2 are 
the most prevalent underlying cause of both Temple syndrome (UPD(14)mat) and Kagami–
Ogata syndrome (KOS, UPD(14)pat). In Temple syndrome there is loss of paternally expressed 
Retrotransposon-like Protein 1 (RLT1) and Delta Like Non-Canonical Notch Ligand 1 (DLK1), 
involved in placental development and cell differentiation respectively, resulting in pre- and 
post-natal growth deficiencies, feeding difficulties, motor delay, early puberty, and obesity [31]. 
Duplicate paternal copies of RTL1 coupled with the loss of maternally expressed RTL1 antisense 
(RTL1as), a repressor for RTL1, results in ~2.5-fold increased expression of RTL1, which is 
thought to be the primary underlying factor for the unique physical phenotype of KOS [32]. KOS 
is characterized by in utero dysregulation leading to enlarged placenta and excessive amniotic 
fluid and postnatally with distinctive craniofacial characteristics, a small, bell-shaped thorax with 
coat-hanger angled ribs, and abdominal wall defects [32]. 
As many of the imprinted loci include both maternally and paternally imprinted genes, it 
is unsurprising that complementary syndromes result in reciprocal phenotypes, determined by 
which parental allele is affected. The disruption of the delicate balance between maternal and 
paternal contributions seen in these classical imprinting disorders results in considerable 
development defects, both to the fitness of the intrauterine environment as well as that of the 
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offspring, and further supports the theory that imprinting arose as a battle over distribution of 
parental resources.  
1.4.2 Perinatal outcomes that increase risk of later in life disorders 
While the exact underlying mechanisms of many adverse pregnancy outcomes such as 
IUGR, LBW, and preeclampsia (PE) have yet to be fully understood, a role for imprinted genes 
has emerged in these placental-related pathologies [10]. One proposed mechanism may be that 
imprinted genes control trophoblast invasion. The rapid growth and angiogenesis required for 
placental trophoblast cells to invade into the uterine wall is otherwise only seen in tumorigenesis, 
hence its moniker the “pseudo-malignant” placenta [33]. For example, increased expression of 
the imprinted gene RB Transcriptional Corepressor 1 (RB1), has been observed in IUGR 
placentas as compared to non-restricted placentas [34]. This suggests RB1, which is also a tumor 
suppressor, may be inversely associated with cell proliferation resulting in decrease in 
trophoblast migration.  
Differential expression of several fetal growth-related imprinted genes, specifically 
decreased expression of the maternally imprinted Mesoderm Specific Transcript (MEST) and 
Pleiomorphic Adenoma Gene-like 1 (PLAGL1) and increased expression of the paternally 
silenced PHLDA2, has been observed in IUGR placentas [35]. Altered regulation of PHLDA2 
has also been associated with birth weight. Specifically, increased expression of PHLDA2 in the 
placenta was associated with a decrease in birth weight [36]. PE is a pregnancy complication 
whose hallmark signs are high blood pressure and proteinuria, and delivery of fetus is the only 
treatment. LOI of H19 was observed in placental tissues from PE patients with severe 
hypertension, and its resulting increased expression may contribute to the pathogenesis of PE 
[16]. Moreover, these placental pathologies have been associated with later-in-life disease risk; 
specifically, being born IUGR increases later life risk of developing cardiovascular disease and 
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type 2 diabetes mellites [37], individuals born LBW were at higher risk of cardiometabolic 
disease [38], and PE is associated with growth retardation, which leads to similar later-in-life 
risks as seen in the case of IUGR.  
Given that a large number of imprinted genes are expressed in the brain, their role in 
cognition and neurobehavior is unsurprising. Both clinically diagnosed depression during 
pregnancy, as well as self-reported high pregnancy depression scores, were found to be associated 
with decreased placental Paternally Expressed 3 (PEG3) expression, and in the case of at least one 
cohort exhibits a sexually dimorphic response (observed only in placentas from pregnancies with 
a male fetus) [39]. Other studies have identified a subset of imprinted genes that are associated 
with movement deficits, asymmetrical or suboptimal reflexes, and an increased manifestation of 
physiologic stress [40]. 
1.4.3 Imprinted genes and cancer 
As previously mentioned, placentation and tumorigenesis share many of the same 
invasive properties such as rapid growth and angiogenesis; however, the first evidence of the link 
between imprinted genes and cancer was fortuitous. A predisposition for childhood solid tumors 
was observed in children with BWS, with the frequency of Wilms’ tumor (WT) increased by 
700-fold [41]. Later studies revealed that LOI of IGF2 was implicated in the increased risk of 
Wilms’ tumor observed in BWS [42], as well as other childhood cancers such as Ewing’s 
sarcoma, hepatoblastoma, and rhabdomyosarcoma [as reviewed in 43]. 
LOI of IGF2 is linked to various adult cancers as well, including those of the central 
nervous system, kidney, liver, and several female reproductive organs, among others [as 
reviewed in 43]. However, IGF2 is not the only imprinted gene linked to malignancy. The tumor 
suppressor DIRAS Family GTPase 3 (DIRAS3, also known as ARHI) [44], and PEG1/MEST [45] 
have been implicated in breast cancer. PEG1/MEST has also been implicated in lung cancer [46]. 
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Hypermethylation of DLK1/GTL2 DMRs has been observed in neuroblastomas and Wilms’ 
tumors [47], while PEG3 has been found to be downregulated in glioma cell lines [48]. 
There are various ways by which imprinted genes are thought to contribute to tumorigenesis 
(Figure 2). Because imprinted genes are functionally haploid, UPD or LOI at an imprinted region 
of either a growth promoting gene or an oncogene may lead to biallelic expression of the 
oncogene (Figure 2A), resulting in improper overexpression. Conversely, UPD or improper 
imprinting at an imprinted region may result in the loss or silencing of the single functional copy 
of a tumor suppressor gene (Figure 2B). Moreover, aberrant methylation of ICRs may lead to 
dysregulation of a cluster of imprinted genes, as is the case with WT, where inactivation of H19 
was seen in conjunction with LOI of IGF2 [43]. Studies have shown that restricted access to the  
 
 
Figure 2. Imprinting errors and tumorigenesis. There are various ways by which imprinted 
genes are thought to contribute to tumorigenesis. Because imprinted genes are functionally 
haploid, uniparental disomy (UPD) or loss of imprinting (LOI) at an imprinted region of either a 
growth promoting gene or an oncogene may lead to biallelic expression (A), resulting in 
improper overexpression. Conversely, UPD or improper imprinting may result in the loss or 




insulator protein CTCF of the maternal allele due to hypermethylation of an ICR upstream of 
H19 results in inactivation of H19 subsequently leading to the observed biallelic expression 
of IGF2 [49].  
1.5 When Imprinting Goes Awry: Biologic, Environmental, and Maternal Impacts on 
Imprinted Genes  
The mono-allelic, parent-of-origin dependent expression of imprinted genes makes them 
particularly vulnerable to genetic and epigenetic perturbation [50]. Mutations or epigenetic 
alterations that would normally have minimal impact for a biallelically expressed gene may lead 
to detrimental consequences for an imprinted gene as only one copy is functional. Such 
alterations in imprinted genes have been tied to both faulty feto-placental development, as well 
as perinatal and later-in-life adverse health outcomes.  
1.5.1 Errors arising from cell division  
There are multiple ways by which the expression of imprinted genes can be impacted; for 
example, through errors during meiosis or mitosis. One example of this is UPD, where offspring 
inherit two copies of a chromosome from one parent and no copy from the other parent. 
Inheritance of a pair of non-identical chromosomes from one parent is referred to as 
heterodisomy, whereas inheritance of a duplicated chromosome from one parent is isodisomy 
[51]. If either type of UPD involves a chromosome carrying an imprinted locus, it can result in 
unbalanced expression of imprinted genes. 
Other errors arising from cell division result in a divergence of the chromosomal makeup 
of the placenta and fetus. Confined Placental Mosaicism (CPM) is a tissue-specific chromosomal 
mosaicism occurring in extra-embryonic tissues that is not observed in the fetus itself. The 
incidence of the CPM is approximately 1-2% of viable pregnancies [52] and is categorized 
according to which tissues are affected: the cytotrophoblast cells, the mesodermal villous stroma 
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cells, or both (defined as types I, II, and III, respectively) [53]. CPM type I and type II are due to 
errors in mitotic duplication of a chromosome in progenitors of extra-embryonic tissue, whereas 
type III arises from a “trisomic rescue” where the loss of a trisomic chromosome from 
embryonic progenitors during meiotic division restores a normal diploid karyotype. However, if 
both of the retained chromosomes come from the same parent, this results in UPD [52]. While 
CPM does not directly influence the imprinting process, it may result in inheritance of both 
copies of a chromosome from the same parent, rather than one from each parent. This is 
particularly troublesome when the chromosomes involved carry imprinted genes, as depending 
on the parental origin of the lost chromosome CPM may negatively affect intrauterine growth of 
the fetus [52] and may also be linked to a range of adverse outcomes including spontaneous 
abortion, intrauterine death, and perinatal morbidity [54].  
1.5.2 Disruption of imprinted gene methylation by environmental contaminants  
Imprinted genes and their regulatory mechanisms are vulnerable to broad range of 
ubiquitous environmental contaminants, such as toxic metals and endocrine disrupting 
compounds (EDCs) [55].  The World Health Organization estimates that globally, 12.6 million 
deaths and approximately 56% of Disability-Adjusted Life Years (DALYs) can be attributed to 
environmental contaminants [56]. 
Toxic metals are consistently ranked near the top of the Agency for Toxic Substances and 
Disease Registry (ATSDR) priority list of environmental contaminants [57], and a number of 
studies have observed links between toxic metal exposure and dysregulation of imprinted genes. 
Tobacco is a common source of cadmium, a toxic metal that has been associated with altered 
DNA methylation [58]. Paternally imprinted gene Anoctamin-1 (ANO1) is differentially 
methylated in newborn leukocytes [59], whereas paternally expressed IGF2 showed 
hypermethylation in cord blood of male newborns born to smoking mothers while female 
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newborns did not [60], further illustrating the sexually dimorphic effects of aberrant imprinting. 
Inorganic arsenic is a metalloid that alters later-in-life methylation of ANO1, as well as the 
predicted imprinted gene Forkhead Box F1 (FOXF1), showing an increase promoter methylation 
in leukocytes for both genes [61]. Conversely, in a separate study, maternally imprinted Insulin 
(INS) exhibited decreased promoter methylation as a result of arsenic exposure [62].  
Epidemiologic findings from the Cincinnati Lead Study show that perinatal exposure to lead, a 
known neurodevelopmental toxicant, resulted in altered methylation of DMRs of several 
imprinted genes that persist into adulthood (average age of 27 years at follow-up) and in some 
cases, did so in a sex-dependent and gene-specific manner [63]. Specifically, childhood lead 
exposure resulted in decreased methylation of the DMR of PEG3, a growth promoting gene, with 
observations more striking in males as compared to females. Conversely, disruption in 
reciprocally imprinted IGF2 (paternally expressed)/H19 (maternally expressed) DMRs showed a 
stronger association in females than in males. Lastly, hypomethylation of the imprinted gene 
PLAGL1, a gene implicated in cell proliferation, postnatal growth, and reproductive traits, did 
not show a sexually dimorphic effect but methylation of DMRs was positively associated with 
neonatal lead levels [63].  
Various EDCs have been shown to alter the DNA methylation of imprinted genes related 
to behavioral and reproductive phenotypes. The presence of polybrominated diphenyl ethers 
(PBDEs), organobromine compounds used as flame retardants, in umbilical cord blood have 
been associated with imprinted gene methylation within the placenta [57]. Specifically, 
hypomethylation of IGF2 was associated with increased concentrations of BDE-153 and BDE-
209 and the authors speculated that PBDE induction of oxidative stress response may reduce 
efficiency of epigenetic machinery [57]. Additionally, endocrine-disrupting plasticizers such as 
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phthalates and bisphenol A (BPA) have been implicated in imprinted gene dysregulation. 
Elevated levels of phthalate metabolites as measured in maternal urine were associated with a 
significant decrease of placental IGF2/H19 methylation [58]. Mouse model studies have helped 
to define tissue and timing specific effects of in utero exposure to BPA. Researchers found both 
a lower dose threshold as well as a greater number of imprinting errors in the placenta when 
comparing extra-embryonic and fetal tissues [as summarized in 8], suggesting the placenta may 
be more sensitive to BPA exposure. Timing of exposure also plays a role: conflicting LOI results 
were seen in studies when exposures were set to days 5.5-12.5, yet when exposures were 
extended to two weeks peri-conception, LOI was observed in several genes, including Snrpn, 
Igf2, and Kcnq1ot1, in both embryonic and placental tissues [as summarized in 8].  
1.5.3 The role of the maternal “environment” in relation to genomic imprinting  
Strong epidemiological evidence regarding the impact maternal nutrition has on fetal 
growth and development comes from the Dutch Hunger Winter (or Dutch Famine) birth cohort 
studies. During the winter of 1944-1945, nearing the end of World War II, food supplies to many 
of the farm towns in German-occupied western Netherlands were cut off. Early association 
studies found that offspring of women who were subjected to peri-conceptional famine showed 
an increased incidence of cardiovascular disease, obesity, metabolic syndrome, and mental 
disorders later in life [as summarized in 55]. Potential underlying mechanisms of these trans-
generational, heritable effects would be uncovered 60 years later while looking at DNA CpG 
methylation patterns from whole blood of the famine offspring. Notably, there was a 
dysregulation of DMRs of several growth and metabolism related imprinted genes, such as 
IGF2, INS, GNAS, Maternally Expressed 3 (Non-protein Coding) (MEG3), Interleukin 10 (IL10), 
Leptin (LEP) and ATP-binding Cassette A1 (ABCA1) [as summarized in 55].  
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Poor maternal nutrition may negatively impact fetal growth and development through 
improper placental morphology and impaired nutrient transfer capabilities. Broadly, maternal 
nutrition may influence both the activation of the hypothalamo–pituitary–adrenal (HPA) stress 
axis as well as placental growth and function [59]. Perhaps more importantly, in terms of 
imprinting, is the role of micronutrients in maintaining methyl marks [60]. Methylation of both 
DNA and histones require methyl donors from dietary nutrients involved in one carbon 
metabolism, such as folate, B vitamins, S-adenosylmethionine (SAM), and methyltransferases, 
among others [8]. Poor diet can lead to vitamin deficiencies, chronic inflammation, and increased 
oxidative stress [60], which can in turn reduce the availability of SAM and folate [61]. As with 
environmental exposures, nutritional deficiencies are modifiable and allow for intervention 
strategies aimed at protecting in utero growth and development. 
Nutrition is not the only maternal factor influencing fetal growth and development. The 
maternal “environment” can broadly be thought of in terms of non-nutritional influences such as 
maternal stress, medication use, and alcohol consumption, all of which have been shown to 
impact genomic imprinting. Using cortisol measurements and mood/anxiety related 
questionnaires to assess maternal mental state, researchers have shown a correlation between 
maternal stress during pregnancy and altered DNA methylation of IGF2 and Guanine 
Nucleotide-binding Protein, Alpha Stimulating Extra-large (GNASXL) in newborn cord blood 
[62]. Moreover, a race-dependent response was observed where hypermethylation of H19 DMRs 
was seen in African American but not Caucasian mothers who reported using antidepressants 
during pregnancy [63]. Antibiotics, commonly used during pregnancy, have also been shown to  
alter DMRs of imprinted genes as well as being associated with adverse birth outcomes. After 
adjusting for potential confounders, researchers found that DMRs of IGF2, H19, PLAGL1, 
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MEG3, and PEG3 as assessed in newborn cord blood were associated with maternal antibiotic 
use during pregnancy and that in utero exposure to antibiotics was associated with 138 g 
reduction in birth weight [64]. 
In utero exposure to alcohol, a known teratogen, is linked to several behavioral deficits 
and neurodevelopmental phenotypes collectively referred to as fetal alcohol syndrome [65]. 
While far from definitive, some studies using mouse models have reported a potential role for 
imprinted genes. Alcohol-induced changes in embryonic DNA methylation patterns were 
observed genome-wide with the most striking differences seen in chromosomes known to be 
enriched for imprinted genes [65], the most interesting of which is chromosome 7, a region 
analogous to the human imprinting hotspot 11p15 know to be responsible for embryonic growth 
and development (Table 2) [66]. Moreover, significant changes in DNA methylation were seen 
in a handful of imprinted genes, including Ube3a, the human homolog of which has been 
implicated in Angelmann Syndrome [65]. Other studies have focused on specific imprinted gene 
hubs. For instance, a partial correlation was observed between alcohol exposure and 
demethylation of paternally imprinted H19, suggesting a possible underlying mechanism driving 
in utero growth retardation [67]. 
While the role of genomic imprinting in feto-placental growth and development is 
undisputed, a growing body of evidence suggests a broader role for imprinted genes in DOHaD. 
Early cues during developmental periods of vulnerability, whether maternal or environmental in 







Table 2. Human imprinting hotspot 11p15 
 
+coordinates based on GRCh38. Abbreviations: AFib = Atrial fibrillation; BW = Birth weight; BWS = Beckwith-Wiedemann syndrome; CVD = Cardiovascular 
disease; DM = Diabetes mellitus; GR = Growth restriction; ICR = Imprinting control region; IDDM2 = Insulin-dependent diabetes mellitus 2; IUGR = 
Intrauterine growth restriction; LBW = Low birth weight; LGA = Large for gestational age; M = maternally expressed allele; MI = Myocardial infarction; 
MODY = Maturity onset diabetes of the young (before 25 yrs age); NSCLC = Non-small cell lung cancer; P = Paternally expressed allele; PE = Preeclampsia; 
SA = spontaneous abortion; SRS = Silver–Russell syndrome; T2DM = Type 2 diabetes mellitus; TNDM1 = Transient neonatal diabetes type 1; WT = Wilms’ 
tumor. References can be found in Appendix 1. 
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have detrimental effects that not only reach throughout an individual’s lifetime, but may also 
have multi-generational effects. 
1.6 Project Approach 
 This research focuses on CpG methylation of imprinted genes within the placenta, 
disease risk throughout the life of the offspring, and the contribution of the maternal endogenous 
“environment” to these outcomes. The central hypothesis of this research is that variation in 
CpG methylation of imprinted genes within the placenta will be associated with risk of 
both IUGR and childhood/later-in-life disease, and that maternal pre-pregnancy BMI will 
contribute to altered methylation (Figure 3).  This project addresses critical research gaps 
related to the role of imprinted genes in the developmental origins of health and disease and is 
driven by the scientific premise that aberrant imprinting in the placenta during critical periods of 
development leads both to pre-/peri-natal and later-in-life disease risk. These comparisons will 
result in the identification of differential sites of imprinted gene methylation key to elucidating 
the mechanistic underpinnings of in utero origins of health and disease. 
 
 
Figure 3. Overarching goal of dissertation. The overall goal of this research is to address the 
role of imprinted genes in the placenta as a driver of the developmental origins of health and 
disease through three aims: Aim1. Do CpG methylation profiles of imprinted genes in the 
placenta predict intrauterine growth restriction risk?; Aim 2. Is CpG methylation of imprinted 
genes in the placenta associated with childhood growth obesity to 10 years of age?; and Aim 3. 
Do maternal factors, specifically maternal pre-pregnancy BMI, influence CpG methylation of 




1.7 Dissertation Organization 
 This dissertation is organized into five chapters, three comprising original research. The 
first research chapter, Chapter 2, describes the association between CpG DNA methylation of 
imprinted genes in the placenta and intrauterine growth restriction risk. The third chapter 
examines the relationship of CpG DNA methylation of imprinted genes in the placenta and 
childhood growth rate. The final research chapter, Chapter 4, focuses on the maternal 
“environment,” namely maternal pre-pregnancy BMI, as a possible underlying driver of altered 
CpG DNA methylation of imprinted genes in the placenta. The final chapter summarizes the 
studies herein, discusses the novelty of our findings, and highlights future research directions. Of 
particular public health interest, these studies provide a more in depth understanding of how 
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CHAPTER 2: ALTERED METHYLATION PATTERNS OF IMPRINTED GENES 
WITHIN THE PLACENTA AND RISK OF INTRAUTERINE GROWTH 
RESTRICTION 
2.1 Introduction 
Intrauterine Growth Restriction (IUGR) is a pathological decrease in the rate of fetal 
growth, defined in the US as a fetal weight that is below the 10th percentile for gestational age 
and sex [1], and occurs in approximately 7-15% of pregnancies worldwide [2, 3]. The 
pathogenesis of IUGR is not well-defined, though is generally thought to be caused by “placental 
insufficiency” - a physical manifestation of multiple possible problems associated with reduction 
in efficiency of nutrient and waste exchange between mother and fetus [4]. The placenta is 
critical for integrating signals from the mother, her developing child, and the surrounding 
environment [5]; if it is not functioning optimally, the development of the fetus may be at risk. 
An unhealthy placenta can adversely influence fetal growth [6], as well as increase immediate 
perinatal health risks such as hypothermia, increased mortality, hypoglycemia, and immunologic 
deficiencies [7]. Moreover, being born IUGR has been shown to increase risk of later in life 
diseases such as coronary heart disease, hypertension, and type 2 diabetes mellites [8]. Although 
IUGR can occur even when a mother is perfectly healthy, risk factors include smoking, alcohol 
use, preeclampsia, and obesity [3]. Despite these known associations the underlying mechanisms 
remain unclear.   
One possible mechanism underlying IUGR relates to imprinting, to which about 0.1-0.5% 
percent of mammalian genes are susceptible.  When imprinted, a gene is silenced in a parent-of-
origin fashion via CpG methylation, resulting in expression of only one allelic copy. Maternally 
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expressed alleles promote resource conservation in order to preserve the mother’s health 
throughout parturition while paternally expressed alleles encourage prenatal growth [9]. 
Oftentimes imprinted genes are clustered together within the genome, regulated by imprinting 
control regions (ICRs) [10]. A single ICR may control both maternally and paternally-expressed 
genes, and their existence suggests that gene imprinting may also be influenced at a 
chromosomal level [11]. Despite their low prevalence within the genome, imprinted genes play 
an essential role in the development of the fetus and extra-embryonic tissues such as the placenta 
[12] and dysregulation of imprinted genes has been associated with a variety of adverse health 
outcomes, including both immediate perinatal [7] as well as later-in-life risks [13].  
Such associations support a close-knit relationship between the placental epigenome and 
growth restricted birth outcomes. Previous studies examining the relationship between placental 
epigenetics and IUGR have focused on well-established growth-regulating genes like IGF2 and 
H19 [4], but it is also likely that methylation patterns of other imprinted genes may be used as a 
predictor of IUGR risk. In addition to this, several studies have demonstrated a divergence in 
imprinted gene status and expression levels depending on fetal sex [14, 15]. This lends evidence 
to the theory that sexual dimorphism of the intrauterine epigenome is an important factor 
contributing to sex-specific discrepancies in perinatal, postnatal, and later-in-life health outcomes 
[14]. Taking this into consideration, in the present study we explore methylation patterns of 
imprinted genes in the placenta associated with being born IUGR not only at commonly 
examined ICRs, but also in a CpG site-specific manner within imprinted genes. Discriminating 
methylation levels site-by-site gives us powerful insight into sex-specific and intra-genetic 
differences in imprinting status and IUGR risk. Through this, we hope to identify critical 
epigenetic mechanisms by which fetal growth restriction risk occurs. 
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2.2 Materials and Methods 
2.2.1 The Elgan Study 
The Extremely Low Gestational Age Newborn (ELGAN) cohort was established as part 
of an observational study of women delivering prior to 28 weeks gestation, conducted from 
2002-2004. Institutional Review Board approval was granted for enrollment at 14 study sites in 
11 cities across 5 states (Massachusetts, Connecticut, Illinois, Michigan, and North Carolina).  
Of the 1,509 mothers eligible for inclusion, 1249 (83%) who gave birth to 1506 infants provided 
informed consent to enrollment in the study [16].  
2.2.2 Participant characteristics and sociodemographic data 
After delivery, a trained research nurse interviewed each mother using standardized 
questionnaires and data collection procedures. Mothers self-reported their sociodemographic 
characteristics including age, race/ethnicity, marital status, and education. Additionally, the 
research nurse also reviewed the medical charts to further abstract data including anthropometric 
measures. These measures were used to calculate birth weight z-scores, which represent the 
number of standard deviations above or below the median of individuals in referent samples and 
are sex- and age-adjusted. Subjects were classified as being born IUGR if they had a birth weight 
z-score < −2. 
2.2.3 Placental processing  
Placentas collected from subjects enrolled in ELGAN were placed in a sterile exam basin 
and transported to a sampling room, where they were biopsied under sterile conditions as soon as 
possible after delivery (~82% within 1 hr). At the midpoint of the longest distance between the 
cord insertion and the edge of the placental disk, the amnion was pulled back using sterile 
tweezers to expose the chorion. Using a second set of sterile tweezers, traction was applied to the 
chorion and the underlying trophoblast tissue and a piece of tissue was removed by cutting at the 
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base of the section with the second set of scissors. The tissue was placed into a cryo-vial and 
immediately immersed in liquid nitrogen. Specimens were stored at minus 80˚C.  
2.2.4 DNA extraction 
In preparation for DNA isolation, the cryotubes containing the biopsies were placed on 
dry ice and samples of the frozen tissue were obtained using a sterile dermal curette, tissue was 
washed in 1x PBS (Fisher Scientific, Waltham, MA) to reduce any potential blood 
contamination, and then immediately snap frozen in homogenization tubes and placed on dry ice 
to preserve integrity of the tissue sample. Samples were homogenized using RLTplus lysis buffer 
(Qiagen, Germantown, MD) and a sterile stainless-steel bead (Qiagen, Germantown, MD) using 
the Qiagen TissueLyserII instrument. Samples were spun to collect the bead and cellular debris, 
and after clarification, the homogenate was stored at minus 80˚C. Nucleic acids were extracted 
from the banked homogenate on Qiagen’s QIAcube using the AllPrep DNA/RNA/miRNA 
Universal kit (Qiagen, Germantown, MD). This kit allows for simultaneous extraction of DNA 
and RNA molecules 18 nucleotides and greater from a single homogenate aliquot. DNA quantity 
was first assessed using the Nanodrop 1000 spectrophotometer and subsequently quantified and 
normalized using the Quant-iT PicoGreen dsDNA Quantitation Assay (ThermoFisher Scientific, 
Waltham, MA).  
2.2.5 CpG methylation assessment  
Genomic DNA isolated from placental tissue underwent bisulfite conversion using the 
EZ-96 DNA Methylation Kit (Zymo Research, Irvine, CA) and genome-wide DNA methylation 
was assessed using the Illumina EPIC Human Methylation 850K BeadChip array (Illumina, San 
Diego, CA), as per the manufacturers’ protocol. All methylation processing was performed at 
Wayne State’s Applied Genomics Technology Core (ATGC). The EPIC array assesses CpG 
methylation status of approximately 860,000 sites across 20,000 human genes, averaging ~17 
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probes per gene at a single nucleotide resolution. Samples were randomly allocated to different 
plates and chips to minimize confounding. The EPIC arrays were scanned with the Illumina 
iScan and image intensities were extracted.  
2.2.6 Analytic and statistical approaches  
Following an approach previously described [17], DNA methylation data was imported 
into R for preprocessing using the minfi package [18]. We performed functional normalization 
with a preliminary step of normal-exponential out-of-band (noob) correction [19] for background 
subtraction and dye normalization, followed by the typical functional normalization method with 
the top two principal components of the control matrix [20, 21]. Quality control was performed 
on individual probes by computing a detection p-value and probes with non-significant detection 
(p > 0.01) for 5% or more of the samples were excluded. Lastly, we used the ComBat function to 
adjust for batch effects from sample plate [22]. Data was visualized using density distributions at 
all processing steps. Each probe measures the average methylation level at a single CpG site. 
Methylation levels are calculated and expressed as β-values (β = intensity of the methylated 
allele (M)) / (intensity of the unmethylated allele (U) + intensity of the methylated allele (M) + 
100). An imprinted gene list was derived from the publicly available database GeneImprint 
(http://www.geneimprint.com) and was filtered for experimentally validated and computationally 
predicted imprinted genes (n=206) (Appendix 2). The Illumina EPIC annotation file was queried 
for every CpG that is linked to the 206 genes of interest and the associated beta values were 
compiled into a curated data set comprising 1553 CpGs, spanning 162 genes (Appendix 3). 
We investigated the relationship between methylation at each individual CpG (n = 1553) 
or the averaged methylation of all CpGs located within a given imprinting control region (ICR, n 
= 19) with IUGR risk. Separate mixed-effects Poisson regression models were fit to estimate the 
relative risk of IUGR for each CpG or each ICR. A robust error variance procedure was used to 
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relax variance assumptions [23]. The overall model adjusted for fetal sex (male, female), 
maternal age (continuous variable), maternal race (Hispanic/Non-Hispanic White and 
Hispanic/Non-Hispanic Black), intrauterine inflammation (chorioamnionitis, categorical yes/no), 
insurance as a proxy for socioeconomic status (public insurance, categorical yes/no), and 
single/multi gestation (categorical). Covariates were selected for known roles in influencing both 
methylation and in utero growth, and inclusion was determined using a directed acyclic graph 
approach (DAG, appendix 4). In order to investigate sexually dimorphic effects, sex stratified 
models were fit for each sex and adjusted for the same covariates, minus fetal sex. 
While methylation levels (β-values) are calculated as a proportion between 0 and 1, for 
the purposes of this analysis, β–value will be adjusted to β-value*100 in order to examine the 
change in the relative risk (RR) with a 1% increase in methylation. A 1% increase represents a 
reasonable change given the ranges of our data. This transformation does not change the 
underlying distribution of the data or the sensitivity of the model. For all models, we used a post-
hoc adjustment for multiple comparisons via the Benjamini-Hochberg (FDR) procedure and 
controlled for the false discovery rate of 0.05. All statistical analyses were performed in R 
software.  
2.2.7 Functional analysis of biological networks  
To investigate the underlying function of the CpG probes identified in these analyses, 
genes showing differential methylation associated with IUGR risk were analyzed for biological 
functions, canonical pathways, upstream regulatory molecules, and interacting molecular 
networks using Ingenuity Pathway Analysis Software. Statistical significance of network 
enrichment was determined based on a modified Fisher’s exact test. P-values represent the 
probability of differentially methylated genes appearing in the associated biological network at 




2.3.1 Study demographics  
Maternal and birth characteristics of the ELGAN subjects for whom we had a placenta 
specimen (n = 426) as compared to the larger cohort (n = 889) are presented in Table 3. Data are 
presented as the number (%) of subjects in the sample unless otherwise noted. There were no 
significant differences in fetal sex, maternal age, maternal race, intrauterine inflammation, 
insurance as a proxy for socioeconomic status, or single/multi gestation (data not shown).  
2.3.2 Altered methylation of imprinted genes is associated with IUGR risk 
Of the 1553 probes that were assessed, methylation levels at a total of 29 CpG sites, 
spanning the genome and corresponding to 19 unique genes, were identified as being associated 
with IUGR risk (Figure 4). In order to gain insight into the biological role of these genes, 
functional analyses were performed.  The identified CpGs corresponded to genes that encode 
proteins related to lipid metabolism and small molecule biochemistry (p<10-35), and include 
Anoctamin 1 (ANO1) and Mesoderm Specific Transcript (MEST), among others.  
2.3.3 Methylation patterns associated with IUGR risk are altered in a sexually-dimorphic 
manner 
When stratified by infant sex, a sexually dimorphic effect was observed. Specifically, we 
identified 53 imprinted genes associated with IURG risk in placentas derived from a   
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Table 3. Elgan cohort characteristics. Demographics for the subset of the ELGAN-2 cohort for 
whom a placenta specimen is available as compared to the demographics of the subset for whom 
we do not have a placenta specimen. Data are presented as percent, except in column labelled 
“total”, which is the row total. 
 
Yes No Total  




White 62 64 554 
Black 28 24 227 
Other 10 13 98 
Hispanic Yes 9 11 86 
Maternal 
age, years 
< 21 12 14 115 
21-35 68 66 594 
> 35 20 20 180 
Years of 
education 
≤12 (HS) 39 43 355 
>12 to <16 24 23 202 
≥ 16 (College) 37 34 306 
Public 
insurance 




<18.5 8 8 68 
18.5,<25 52 48 429 
25,<30 18 20 166 
>30 21 24 194 
Preeclampsia yes 14 12 115 
Caesarean 
delivery 
yes 66 66 590 
Mycoplasma 
or BV* 
yes 23 21 192 
Child characteristics 
Sex Male 53 49 455 
Multiple 
gestation 
Yes 39 31 313 
Gestational 
age, weeks 
23-24 22 20 187 
25-26 43 47 400 
27 34 33 302 
Birth weight, 
grams 
≤750 37 38 332 
751-1000 45 41 382 
> 1000 19 21 175 
Birth weight 
z-score 
< -2 5 6 53 
≥ -2; < -1 11 16 120 
≥ -1 84 78 716 






Figure 4. CpG methylation of imprinted genes and relative risk of IUGR. Forest plot 
showing association between CpG methylation of imprinted genes within the placenta and 





pregnancy with a male fetus which broadly fall into biological functions such as nervous system 
development & function, organismal injury & abnormalities, and reproductive system disease 
(p<10-14). In placentas derived from a pregnancy resulting in a female fetus, we identified 9 
imprinted genes involved in embryonic development, organismal development, and gene 
expression (p<10-09).  
Only 3 imprinted genes, namely LIM Homeobox Transcription Factor 1 Beta (LMX1B), 
MEST, and Sarcoglycan Epsilon (SGCE), were common among both male and female placentas 
and are involved in nervous system development & function, tissue development, and cellular 
development (p<10-06) (Figure 5).  
 
 
Figure 5. Venn diagram of sex-dependent differentially methylated probes that were 
associated with relative risk of IUGR. Top associated biological processes for each group are 
displayed with corresponding p-value. 
 
2.3.4 Differentially methylated ICRs are associated with IUGR risk 
We identify increased IUGR risk associated with altered methylation at the following 
four known ICRs: (1) Growth Factor Receptor Bound Protein 10 (GRB10), (2) Potassium 




(KCNQ1/KCNQ1OT), (3) MEST/ Intronic Transcript 1, Antisense RNA (MEST/MESTIT1), and 
(4) Nucleosome Assembly Protein 1 Like 5/ HECT and RLD Domain Containing E3 Ubiquitin 
Protein Ligase 3 (NAP1L5/HERC3) (Table 4). 
 




 A well-functioning placenta is paramount in determining the health of a newborn child. 
Placental epigenetic dysregulation can produce serious consequences for an offspring’s health, 
both immediately and later-in-life. The pathology of intrauterine growth restriction (IUGR) 
serves as a prime example of the placenta’s undeniable role in fetal health. IUGR can precipitate 
severe short-term and long-term fetal health outcomes, and the dynamics of its pathogenesis are 
still widely unknown. It is recognized that imprinted genes are factors in this process, and thus it 
is imperative to better understand the mechanisms through which imprinting impacts feto-
placental development and IUGR risk. In the present study, we have analyzed an expansive list 
of novel CpG methylation sites in order to explore the relationship between epigenetic 
imprinting in the placenta and fetal growth restriction outcomes. To accomplish this, we 




differential methylation patterns in the placenta, even within the same gene, may contribute 
uniquely to IUGR risk.  
 Analysis of methylation levels revealed 29 CpG sites, spanning the genome and falling 
within 19 unique genes, were associated with risk of IUGR. Interestingly, these genes broadly 
encode for proteins related to lipid metabolism and small molecule biochemistry.  Fetal 
development requires a substantial amount of lipids throughout gestation [25], which are 
regulated by the placenta through specific enzymes, receptors, and transport proteins. ANO1, 
long believed to act solely as a calcium-activated chloride channel, was more recently discovered 
to belong to the family of phospholipid scramblases. Phospholipid scramblases are a type of lipid 
transporter that lowers the energy required for passive transport of lipids [26, 27]. In vivo studies 
identify Mest as having a putative role in placental lipid accumulation [28], and that 
downregulated Mest expression is associated with a decrease in adipocytes in transgenic mouse 
models [29]. Moreover, previous epidemiological studies have shown that expression levels of 
lipoprotein receptors involved in lipid uptake and metabolism were downregulated in placentas 
from IUGR pregnancies, thus contributing to poor fetal growth [30, 31]. This suggests that 
impaired placental transfer of lipophilic compounds underlies the metabolic dysfunction and 
decreased birth weight seen in IUGR [32, 33]. A study examining 296 neonates found that 
reduced birth weight, as seen in small for gestational age (SGA) births, was associated with both 
lower insulin sensitivity and a dysregulated lipid metabolism in the early postnatal period [34]. 
Taken together with these observations, our findings suggest a potential epigenetic underpinning, 





Methylation of imprinted genes within the placenta was associated with both elevated and 
reduced risk in a parent-of-origin independent manner, surprising as maternally-expressed genes 
tend to be growth restricting while paternally expressed genes tend to promote growth. The 
methylation level of 13 imprinted genes was associated with a higher relative risk of IUGR, 
while methylation of 6 imprinted genes yielded a decreased risk of growth restriction. Within 
these genes, changes in relative risk of IUGR were determined by the specific CpG site 
experiencing methylation. For some genes, such as PPP1R9A, a single CpG (cg04134217) 
showed a RR=11.5 (95% CI 2.8-47.3). This elevated risk is perhaps unsurprising as PPP1R9A is 
important for early development of multiple fetal tissues [35]. In other cases, multiple CpGs 
were associated with IUGR risk for a given gene. For example, methylation at 4 CpGs spanning 
SGCE were associated with different magnitudes of increased risk. These results imply that site-
by-site methylation can direct changes in risk across the same gene, though it is unclear if they 
may have an additive effect.   
When examined in the context of fetal sex, a strong sexually dimorphic response was 
observed. In placentas derived from a pregnancy resulting in a male fetus, 53 imprinted genes 
were found to be associated with IUGR. In comparison, female placentas revealed only 9 IUGR-
associated genes. Of the three imprinted genes overlapping between both groups, namely 
LMX1B, MEST, and SGCE, fetal sex affected risk of IUGR in both CpG-specific and 
dichotomous manners. In the case of MEST, increased methylation was associated with increased 
risk of being born IUGR for both sexes; however, the associated CpGs differed between the male 
and female placentas. We also observed a sex-specific, dichotomous response to increased 
methylation of LMX1B. LMX1B showed increased risk of being born IUGR in the placentas 




being born IUGR in pregnancies resulting in a male fetus, suggesting that sex-specific 
differential methylation of certain CpG sites may also suggest protective mechanisms.  
Several ICRs with known associations to fetal growth and development were also 
associated with increased IUGR risk. Growth Factor Receptor-bound Protein 10 (GRB10), acts to 
fine tune fetal growth during the later stages of pregnancy [36]. Loss of methylation, and 
presumably subsequent overexpression, at the ICR for KCNQ1 Opposite Strand/Antisense 
Transcript 1 (KCNQ1OT1) leads to offspring who tend to experience placental overgrowth and 
are born above average birth weight and length (large for gestational age, LGA), as see in 
Beckwith–Wiedemann syndrome [37, 38]. Decreased methylation of the ICR for MEST has been 
observed in IUGR placentas [39]. 
 Differential methylation events along many of the same genes – such as CDH18 and 
MAGI2 - have been associated with later-in-life diseases, such as endometrial cancer, ovarian 
cancer, and cervical cancer [40-42]. In addition to this, imprinting events along the MEST and 
Paternally Expressed 10 (PEG10) genes have been shown to induce postnatal, sex-specific 
differences in BMI and metabolic function [43, 44]. Studies have also shown that imprinting 
along the SGCE and PEG10 genes may influence adolescent behavior in a sexually dimorphic 
manner, with adverse outcomes including abnormal behavior, anxiety, and depression [45].   
 Previous literature has demonstrated the significant role that placental methylation plays 
in IUGR outcomes. Studies have shown 6 imprinted genes which, when methylated, exhibited a 
decreased risk of IUGR. Notably, five of these genes – BLCAP, RBP5, CDK4, LMX1B and 
MAGI2 - are associated directly or indirectly in pro-apoptotic pathways [46-51]. This pattern is 
worth noting, as previous literature has advocated that premature apoptosis may play an 




methylation (and potential silencing) might interfere with pro-apoptotic expression events, and as 
a result, could contribute to the blunted risk of IUGR pregnancy. However, these relationships 
cannot be assumed from the extent of our dataset alone, and thus we are compelled to further 
explore these relationships going forward.    
 In the present study, we have identified novel epigenomic data which highlights exciting 
new relationships between CpG methylation events and risk of IUGR. It is to be noted that these 
data cannot necessarily inform the mechanistic events underlying these etiologies; transcriptomic 
and proteomic analyses will be required to further interrogate any functional changes. In addition 
to this, our study population was defined by extremely low gestational aged newborns, and 
therefore these findings seek validation within a term cohort to determine generalizability.  
 It is widely understood that imprinted genes play an important role in mediating fetal 
growth, placental size, and embryonic, neonatal, and postnatal morbidity and mortality [9]. Our 
work has confirmed similar methylation events on imprinting control regions, and 
simultaneously discovered novel loci of genetic imprinting associated with increased risks of 
IUGR in a notably site and sex-specific manner. These results provide a more in depth 
understanding of how epigenetic dysregulation of imprinted genes in the placenta result in 
perinatal consequences such as IUGR and may do so in a sexually dimorphic manner. The 
identification of such CpG methylation patterns may serve as preventative therapeutic targets. As 
being born IUGR carries life-long health risks, this research will impact our understanding of the 
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CHAPTER 3: ALTERED METHYLATION PATTERNS OF IMPRINTED GENES 
WITHIN THE PLACENTA AND CHILDHOOD GROWTH TRAJECTORIES 
3.1 Introduction  
Observations from a series of epidemiological studies from the UK first published over 
30 years ago led to David J. Barker’s “fetal origins hypothesis,” theorizing that gestational 
undernutrition is important in early genesis of later in life metabolic disease [1]. While Barker 
suggested these observations were due to adaptive responses of the fetus specifically, this was 
the basis for the current Developmental Origins of Health and Disease Hypothesis (DOHaD). 
This hypothesis has evolved beyond just fetal adaptive response to more broadly examine 
periconceptual, fetal, and early life conditions which pose a lifetime risk for development of 
chronic diseases, with a particular interest in the underlying role genomic imprinting may play in 
regulating these physiological responses [2].  
More recent epidemiological studies suggest that early life growth is associated with risk 
for development of chronic diseases such as obesity and metabolic dysfunction [3-5]. In 2017, 
the prevalence of obesity in the United States among 6–11-year-old children was 18.4%, and 12–
19-year-old children was 20.6% [6]. Of concern, obese children are more likely to develop early 
onset of illnesses traditionally thought of as “adult diseases,” such as non-alcoholic fatty liver 
disease, diabetes, cardiovascular disease, insulin resistance, and some cancers [7, 8]. Moreover, 
childhood obesity has been associated with later in life obesity [9]. Of interest is the “catch-up” 
dilemma, which posits that while rapid early growth may have short-term benefits, such as 
reduced childhood morbidity and mortality, there are also long-term negative consequences [10]. 
Emerging evidence in this field identifies an association between the rate of growth in 
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infancy and obesity [4, 5, 11-16]. Strikingly, infants who gain weight rapidly (defined as weight-
for-age Z score gain greater than 0.67 between birth and 1.5 years) had approximately 3 times 
the odds of being overweight/obese by the age of 7-9 [17]; additionally, rapid weight gain during 
early infancy had five times the odds of being obese by age 20 [12]. 
While obesity is a complex disease involving both genetic and lifestyle choices, it is 
becoming increasing clear that underlying biological factors, such as methylation of imprinted 
genes, play an important role in early life growth and weight gain [18]. Despite their low 
prevalence within the genome, there are currently more than 200 known or putative imprinted 
genes in humans [19], many of which can be found in the placenta. Imprinting defies traditional 
Mendelian genetics, as one copy is turned off in a parent of origin manner and differs from 
typical CpG methylation in that epigenetic reprogramming of imprinted genes does not occur 
during embryogenesis [20]. Moreover, consequences of imprinting errors may influence the life-
long health of the offspring, making the placenta an organ of interest in the growing field of 
DOHaD [21]. Within the context of the developmental origins of health and disease hypothesis, 
dysregulation of the perinatal epigenome has been implicated as an etiologic factor in childhood 
growth, obesity, and other chronic disease [22, 23].  
The present study explores the relationship between CpG site-specific methylation 
patterns of imprinted genes in the placenta with childhood growth to age 10. Additionally, 
because of the established sexual dimorphism in terms of growth [24, 25], we also analyzed 
associations stratified by fetal sex. Through this, we aimed to identify critical epigenetic 
mechanisms underlying childhood “catch-up” growth trajectories which may influence the 




3.2 Materials and Methods 
3.2.1 The Elgan Study 
The Extremely Low Gestational Age Newborn (ELGAN) cohort was established as part 
of an observational study of women delivering prior to 28 weeks gestation, conducted from 
2002-2004. Institutional Review Board approval was granted for enrollment at 14 study sites in 
11 cities across 5 states (Massachusetts, Connecticut, Illinois, Michigan, and North Carolina).  
Of the 1,509 mothers eligible for inclusion, 1249 (83%) who gave birth to 1506 infants provided 
informed consent to enrollment in the study [26].  
3.2.2 Participant characteristics & sociodemographic data 
After delivery, a trained research nurse interviewed each mother using standardized 
questionnaires and data collection procedures. Mothers self-reported their sociodemographic 
characteristics including age, race/ethnicity, marital status, and education. Additionally, the 
research nurse also reviewed the medical charts to further abstract data. Follow up assessments, 
including anthropometric measures, were also obtained at the approximate ages of 2 and 10 
years. These measures were used to calculate BMI z-scores, which represent the number of 
standard deviations above or below the median BMI of individuals in referent samples and are 
sex- and age-adjusted. Of note, the reference population for birth weight z-score include those 
not delivered for preeclampsia or any fetal indications [27, 28]. Covariates were selected for 
known roles in influencing both methylation and growth, and inclusion was determined using a 
directed acyclic graph approach (DAG, Appendix 4). 
3.2.3 Placental processing  
Placentas collected from subjects enrolled in ELGAN were placed in a sterile exam basin 
and transported to a sampling room, where they were biopsied under sterile conditions as soon as 
possible after delivery (~82% within 1 hr). At the midpoint of the longest distance between the 
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cord insertion and the edge of the placental disk, the amnion was pulled back using sterile 
tweezers to expose the chorion. Using a second set of sterile tweezers, traction was applied to the 
chorion and the underlying trophoblast tissue and a piece of tissue was removed by cutting at the 
base of the section with the second set of scissors. The tissue was placed into a cryo-vial and 
immediately immersed in liquid nitrogen. Specimens were stored at minus 80˚C.  
3.2.4 DNA extraction 
In preparation for DNA isolation, the cryotubes containing the biopsies were placed on 
dry ice and samples of the frozen tissue were obtained using a sterile dermal curette, tissue was 
washed in 1x PBS (Fisher Scientific, Waltham, MA) to reduce any potential blood 
contamination, and then immediately snap frozen in homogenization tubes and placed on dry ice 
to preserve integrity of the tissue sample. Samples were homogenized using RLTplus lysis buffer 
(Qiagen, Germantown, MD) and a sterile stainless-steel bead (Qiagen, Germantown, MD) using 
the Qiagen TissueLyserII instrument. Samples were spun to collect the bead and cellular debris, 
and after clarification, the homogenate was stored at minus 80˚C. Nucleic acids were extracted 
from the banked homogenate on Qiagen’s QIAcube using the AllPrep DNA/RNA/miRNA 
Universal kit (Qiagen, Germantown, MD). This kit allows for simultaneous extraction of DNA 
and RNA molecules 18 nucleotides and greater from a single homogenate aliquot. DNA quantity 
was first assessed using the Nanodrop 1000 spectrophotometer and subsequently quantified and 
normalized using the Quant-iT PicoGreen dsDNA Quantitation Assay (ThermoFisher Scientific, 
Waltham, MA).  
3.2.5 CpG methylation assessment  
Genomic DNA isolated from placental tissue underwent bisulfite conversion using the 
EZ-96 DNA Methylation Kit (Zymo Research, Irvine, CA) and genome-wide DNA methylation 
was assessed using the Illumina EPIC Human Methylation 850K BeadChip array (Illumina, San 
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Diego, CA), as per the manufacturers’ protocol. All methylation processing was performed at 
Wayne State’s Applied Genomics Technology Core (ATGC). The EPIC array assesses CpG 
methylation status of approximately 860,000 sites across 20,000 human genes, averaging ~17 
probes per gene at a single nucleotide resolution, including 1553 CpGs spanning 162 imprinted 
genes (Appendix 3). Samples were randomly allocated to different plates and chips to minimize 
confounding. The EPIC arrays were scanned with the Illumina iScan and image intensities were 
extracted.  
3.2.6 Analytic and statistical approaches  
The general model form was as follows: 
𝐵𝑀𝐼 𝑧 − 𝑠𝑐𝑜𝑟𝑒𝑖𝑗 = 𝛼 +  𝑋𝑖0𝛽 +  𝑇𝑖𝑚𝑒 𝑖𝑗 𝛽 +  𝑋𝑖0(𝑇𝑖𝑚𝑒 𝑖𝑗)𝛽 + 𝑍𝑖0𝛽 + 𝜇𝑖0 + 𝑒𝑖𝑗 
where BMI z-scoreij is the measure of the child’s relative weight adjusted for their age and sex 
for the ith child at time j. Xi0 is the average methylation level (β value) for a specific CpG loci 
located within an imprinted candidate gene as measured in placental tissue. Methylation levels 
were first multiplied by 100 so as to estimate the change in BMI z-score associated with a 1% 
increase in methylation. Time is the duration between baseline and each BMI z-score 
measurement (i.e., 1, 2, or 10 years). The β coefficient for Xi0(Timeij) is the expected annual 
change in BMI z-score corresponding to a 1% increase in methylation at the respective CpG loci. 
Zi0 is a matrix of potential confounders, representing maternal age, race, public insurance status 
in addition to the presence of chorioamnionitis, the child’s sex, and whether or not the child was 
a multiple (e.g., a twin or triplet). μi0 is a random intercept for each child used to account for the 
within-subject correlation of the repeated BMI z-score measurements, and eij is the error term. 
All analyses were conducted in Stata/SE version 15 (College Station, TX) and controlled for 
covariates described in section 3.2.2. Additionally, in order to investigate sexually dimorphic 
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effects, sex stratified models were fit for each sex and adjusted for the same covariates, minus 
fetal sex. 
3.2.7 Functional analysis of biological networks  
To investigate the underlying function of the CpG probes identified in these analyses, 
genes showing differential methylation associated with IUGR risk were analyzed for biological 
functions, canonical pathways, upstream regulatory molecules, and interacting molecular 
networks using Ingenuity Pathway Analysis Software. Statistical significance of network 
enrichment was determined based on a modified Fisher’s exact test. P-values represent the 
probability of differentially methylated genes appearing in the associated biological network at 
random. 
3.3 Results 
3.3.1 Study demographics  
Maternal and birth characteristics of the ELGAN subjects for whom we had a placenta 
specimen (n = 426) as compared to the larger cohort (n = 889) are presented in Table 3. Data are 
presented as the number (%) of subjects in the sample unless otherwise noted. There were no 
significant differences in fetal sex, maternal age, maternal race, intrauterine inflammation, 
insurance as a proxy for socioeconomic status, or single/multi gestation (data not shown).  
3.3.2 Altered methylation of imprinted genes is associated with childhood growth 
trajectories  
Methylation levels at a two CpG sites representing two unique genes within the placenta, 
namely ZFP36 Ring Finger Protein Like 2 (ZFP36L2) and LIM Homeobox Transcription Factor 
1 Beta (LMX1B), were identified as being associated with childhood growth rate (Table 5).  
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3.3.3 Altered methylation of imprinted genes associated with childhood growth trajectories 
exhibits a strong sexually dimorphic response 
When stratified by infant sex, a dimorphic effect was observed with 2 CpGs representing 
two genes in placentas of male fetuses and 25 CpGs representing 20 unique genes in placentas of 
female fetuses (Table 5) found to be differentially methylated. Of the 20 imprinted genes 
identified in the females, methylation levels for 8 were positively associated with an annual 
change in BMI z-score, with the remaining 12 showing negative association. None of the 
differentially methylated imprinted genes were common among both males and females.  
The 20 imprinted genes identified as being significantly associated with childhood 
growth rate in the placentas of female fetuses were also analyzed for common pathways and 
underlying biological functions. Pathway analysis revealed an enrichment of genes involved in 
adipogenesis (p= 6.49 × 10-03), and whose biological functions broadly related to growth failure 
(p3.78x10-04) and body size (2.25x10-04). Network analysis revealed an imprinted gene cluster 
that interacts with known drivers of metabolic function such as insulin, glucose, and PPARG 
Coactivator 1 Alpha (PPARGC1A) and is involved in Development and Function, Tissue 




Table 5. Imprinted genes associated with childhood growth trajectories. The model 
coefficients correspond to annual changes in BMI z-scores for every 1-unit increase in baseline 







95% CI q-value 
Overall LMX1B cg25291396 -0.018 -0.025, -0.011 <0.001  
ZFP36L2 cg16720946 0.252 0.137, 0.367 0.01 
Males HOXC9 cg06368141 -0.296 -0.434, -0.158 0.02  
LMX1B cg25291396 -0.025 -0.034, -0.016 0.00 
Females AIM1 cg23962536 -0.034 -0.053, -0.016 0.05  
ATP10A cg25846723 0.009 0.005, 0.014 0.03  
DIRAS3 cg20808078 -0.040 -0.061, -0.019 0.05  
FERMT2 cg15952990 -0.008 -0.013, -0.004 0.05  
FGFRL1 cg06748078 0.140 0.072, 0.208 0.03  
FOXG1 cg26206396 0.003 0.001, 0.004 0.05  
KCNQ1 cg07072281 -0.032 -0.05, -0.014 0.05  
KIAA1530 cg18515449 0.189 0.083, 0.295 0.05  
KLF14 cg06533629 0.037 0.016, 0.059 0.05  
KLF14 cg18645297 0.050 0.021, 0.08 0.05  
MAGEL2 cg01152488 0.078 0.039, 0.116 0.03  
MEST cg14428359 -0.010 -0.016, -0.005 0.05  
OBSCN cg08312035 -0.015 -0.022, -0.007 0.03  
PEG10 cg10466088 0.008 0.003, 0.013 0.05  
PPP1R9A cg21928923 -0.019 -0.031, -0.008 0.05  
PTPN14 cg16488544 -0.021 -0.033, -0.01 0.05  
RB1 cg03460032 -0.009 -0.014, -0.004 0.05  
RB1 cg05026473 -0.013 -0.021, -0.006 0.05  
SLC22A2 cg07601258 -0.012 -0.019, -0.005 0.05  
UBE3A cg00096039 -0.051 -0.08, -0.021 0.05  
UBE3A cg15189393 -0.019 -0.03, -0.008 0.05  
UBE3A cg16141702 -0.007 -0.012, -0.003 0.05  
UBE3A cg19709054 -0.038 -0.061, -0.016 0.05  
ZC3H12C cg26056522 -0.011 -0.018, -0.005 0.05  









In the present study we set out to explore the relationship between site-specific CpG 
methylation patterns of imprinted genes in the placenta and childhood growth to age 10, with the 
goal of identifying critical epigenetic mechanisms underlying childhood growth trajectories 
which may influence the lifetime risk of metabolic and cardiovascular conditions.   
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Childhood growth trajectories were associated with methylation of two genes in our 
unstratified analysis, namely LMX1B and ZFP36L2, and both have been previously implicated in 
growth and obesity [29, 30]. LMX1B is essential for development of limb and renal structures as 
well as serotogenic neurons [31]. Interestingly, serotogenic neurons produce serotonin, which 
plays a fundamental role in appetite regulation [32], and thus it is possible that the increased 
methylation of LMX1B plays a role in dysregulated appetite.  In a meta-analysis of genome-wide 
association studies, (n=35,668 children) LMX1B was identified as a unique locus associated with 
childhood BMI [33]. Additionally, variation of LMX1B increased the odds of medium-to-
medium, lean-to-heavy, and medium-to-heavy body fat trajectories (odds ratios: 1.09, 1.13, 1.14, 
respectively, p value for trend= 0.002) [34]. ZFP36L2 encodes for a putative nuclear 
transcription factor which is believed to play a role in regulating growth factor response and cell 
proliferation [35]. Epigenetic regulation of ZFP36L2 has been previously linked to sex-
dependent differences in placental methylation, and has been implicated obesity development 
[36, 37]. Moreover, in an in vitro study of adipocyte differentiation, knockdown of ZFP36L2 
increased lipid accumulation and glycerol release [38], thus suggesting a potential mechanism in 
which ZFP36L2 modulates childhood obesity pathogenesis.  
When stratified by sex, a striking sexual dimorphism emerges. In placentas derived from 
a pregnancy resulting in a male fetus, two CpG sites representing two unique genes, LMX1B and 
HOXC9, were differentially methylated within the placenta in association with childhood growth 
rate. HOXC9 expression is associated with adipose function and distribution, BMI, and 
alterations of whole-body metabolism [39]. The HOX gene family are important regulators of 
embryogenesis, with a particular role in defining the anterior-posterior axis [40]. 
Epidemiological studies show HOXC9 expression was significantly positively correlated with 
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body fat mass, even after adjustment for age and sex, and the authors proposed that increased 
HOXC9 expression may be linked to adipose tissue dysfunction [39]. In female offspring, 25 
CpG sites across 20 unique imprinted genes were differentially methylated in association with 
childhood growth rate and showed an enrichment for adipogenesis-related genes. FGFRL1 is 
part of the fibroblast growth factor family and plays key roles in energy metabolism and adipose 
tissue function [41], and development of adipose tissue [42]. In vivo studies have found that 
Magel2-null mice exhibit neonatal growth retardation, excessive weight gain after weaning, and 
increased adiposity with altered metabolism in adulthood [43].  KCNQ1, potassium voltage-
gated channel subfamily Q member 1, has been associated with type 2 diabetes, beta cell 
function, and obesity [44, 45], and has previously been found to be differentially methylated with 
respect to change in BMI [46]. Lastly, PEG10, is involved in trophoblast proliferation and 
invasion, which is integral to placental development [47].  In fact, dysregulated PEG10 
expression has been associated with pregnancy complications including fetal death [48, 49], 
IUGR [50] and PE [51], the latter two of which have both also been associated with subsequent 
offspring growth rate [52, 53]. Additionally, PEG10 plays important roles in the early stages of 
adipocyte differentiation [54].  
While we have identified that CpG methylation of imprinted genes within the placenta is 
associated with childhood growth trajectory, exhibiting sexually dimorphic responses, this study 
is not without limitations. Without further investigation, i.e. transcriptomics or proteomics, we 
cannot say if the altered CpG methylation results in functional changes. In addition, the ELGAN 
cohort comprise extremely preterm subjects, thus limiting the generalizability of our results more 
broadly to those infants delivered at term. 
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In conclusion, the present study details key imprinted genes with significantly altered 
methylation in association with childhood growth trajectories. Notably, we demonstrate striking 
sexual dimorphism in this association, with only 2 imprinted genes differentially methylated in 
male offspring but 20 in females. While a wealth of evidence exists linking the intrauterine 
environment to obesity/BMI and growth rate [55-57], our results are among the first that we are 
aware of to discover prominent sexual dimorphism in the epigenetic alterations associated with 
growth rate. Increasingly, the sex-based differences in vulnerability to obesogenic environments, 
the interaction of sex-related hormones with adiposity and body fat distribution, as well as the 
consequences of childhood and adult obesity are being recognized [58-60].  Our results further 








1. Barker, D.J., The origins of the developmental origins theory. J Intern Med, 2007. 261(5): 
p. 412-7. 
2. Cassidy, F.C. and M. Charalambous, Genomic imprinting, growth and maternal-fetal 
interactions. J Exp Biol, 2018. 221(Pt Suppl 1). 
3. Victora, C.G., et al., Maternal and child undernutrition: consequences for adult health 
and human capital. Lancet, 2008. 371(9609): p. 340-57. 
4. Ong, K.K. and R.J. Loos, Rapid infancy weight gain and subsequent obesity: systematic 
reviews and hopeful suggestions. Acta Paediatr, 2006. 95(8): p. 904-8. 
5. Baird, J., et al., Being big or growing fast: systematic review of size and growth in 
infancy and later obesity. BMJ, 2005. 331(7522): p. 929. 
6. Hales, C.M., et al., Prevalence of Obesity Among Adults and Youth: United States, 2015-
2016. NCHS Data Brief, 2017(288): p. 1-8. 
7. (WHO), W.H.O. Facts and figures on childhood obesity [fact sheet]. 2017; Available 
from: www. Who.int/end-childhood-obesity/facts/en. 
8. Güngör, N.K., Overweight and obesity in children and adolescents. Journal of clinical 
research in pediatric endocrinology, 2014. 6(3): p. 129-143. 
9. Guo, S.S. and W.C. Chumlea, Tracking of body mass index in children in relation to 
overweight in adulthood. Am J Clin Nutr, 1999. 70(1): p. 145S-8S. 
10. Victora, C.G. and F.C. Barros, Commentary: The catch-up dilemma--relevance of 
Leitch's 'low-high' pig to child growth in developing countries. Int J Epidemiol, 2001. 
30(2): p. 217-20. 
11. Ong, K.K., et al., Association between postnatal catch-up growth and obesity in 
childhood: prospective cohort study. BMJ, 2000. 320(7240): p. 967-71. 
12. Stettler, N., et al., Rapid weight gain during infancy and obesity in young adulthood in a 
cohort of African Americans. Am J Clin Nutr, 2003. 77(6): p. 1374-8. 
13. Stettler, N., et al., Weight gain in the first week of life and overweight in adulthood: a 
cohort study of European American subjects fed infant formula. Circulation, 2005. 
111(15): p. 1897-903. 
14. Stettler, N., et al., Infant weight gain and childhood overweight status in a multicenter, 
cohort study. Pediatrics, 2002. 109(2): p. 194-9. 
15. Druet, C., et al., Prediction of childhood obesity by infancy weight gain: an individual-
level meta-analysis. Paediatr Perinat Epidemiol, 2012. 26(1): p. 19-26. 
 
60 
16. Monteiro, P.O.A. and C.G. Victora, Rapid growth in infancy and childhood and obesity 
in later life – a systematic review. Obesity Reviews, 2005. 6(2): p. 143-154. 
17. Zhou, J., et al., Rapid Infancy Weight Gain and 7- to 9-year Childhood Obesity Risk: A 
Prospective Cohort Study in Rural Western China. Medicine, 2016. 95(16): p. e3425-
e3425. 
18. Vickers, M.H., Early life nutrition, epigenetics and programming of later life disease. 
Nutrients, 2014. 6(6): p. 2165-78. 
19. Bressan, F.F., et al., Unearthing the roles of imprinted genes in the placenta. Placenta, 
2009. 30(10): p. 823-34. 
20. Koukoura, O., S. Sifakis, and D.A. Spandidos, DNA methylation in the human placenta 
and fetal growth (review). Mol Med Rep, 2012. 5(4): p. 883-9. 
21. Wadhwa, P.D., et al., Developmental origins of health and disease: brief history of the 
approach and current focus on epigenetic mechanisms. Semin Reprod Med, 2009. 27(5): 
p. 358-68. 
22. Kumar, S. and A.S. Kelly, Review of Childhood Obesity: From Epidemiology, Etiology, 
and Comorbidities to Clinical Assessment and Treatment. Mayo Clin Proc, 2017. 92(2): 
p. 251-265. 
23. Monk, D. and G.E. Moore, Intrauterine growth restriction--genetic causes and 
consequences. Semin Fetal Neonatal Med, 2004. 9(5): p. 371-8. 
24. Gasser, T., et al., Sex dimorphism in growth. Ann Hum Biol, 2000. 27(2): p. 187-97. 
25. Greil, H., Patterns of sexual dimorphism from birth to senescence. Coll Antropol, 2006. 
30(3): p. 637-41. 
26. O'Shea, T.M., et al., Neonatal cranial ultrasound lesions and developmental delays at 2 
years of age among extremely low gestational age children. Pediatrics, 2008. 122(3): p. 
e662-e669. 
27. Yudkin, P.L., et al., New birthweight and head circumference centiles for gestational 
ages 24 to 42 weeks. Early Hum Dev, 1987. 15(1): p. 45-52. 
28. Leviton, A., et al., Maternal infection, fetal inflammatory response, and brain damage in 
very low birth weight infants. Developmental Epidemiology Network Investigators. 
Pediatr Res, 1999. 46(5): p. 566-75. 
29. Locke, A.E., et al., Genetic studies of body mass index yield new insights for obesity 
biology. Nature, 2015. 518(7538): p. 197-206. 
30. Bouchard, L., et al., ZFP36: a promising candidate gene for obesity-related metabolic 
complications identified by converging genomics. Obes Surg, 2007. 17(3): p. 372-82. 
 
61 
31. Ding, Y.Q., et al., Lmx1b is essential for the development of serotonergic neurons. Nat 
Neurosci, 2003. 6(9): p. 933-8. 
32. Blundell, J. and J. Halford, Serotonin and Appetite Regulation: Implications for the 
Pharmacological Treatment of Obesity. Vol. 9. 1998. 473-495. 
33. Felix, J.F., et al., Genome-wide association analysis identifies three new susceptibility 
loci for childhood body mass index. Hum Mol Genet, 2016. 25(2): p. 389-403. 
34. Song, M., et al., Associations between genetic variants associated with body mass index 
and trajectories of body fatness across the life course: a longitudinal analysis. 
International Journal of Epidemiology, 2017. 47(2): p. 506-515. 
35. Cotillard, A., et al., Differential effects of macronutrient content in 2 energy-restricted 
diets on cardiovascular risk factors and adipose tissue cell size in moderately obese 
individuals: a randomized controlled trial. The American Journal of Clinical Nutrition, 
2011. 95(1): p. 49-63. 
36. Rosenfeld, C.S., Sex-Specific Placental Responses in Fetal Development. Endocrinology, 
2015. 156(10): p. 3422-34. 
37. Cao, H., J.F. Urban, Jr., and R.A. Anderson, Insulin increases tristetraprolin and 
decreases VEGF gene expression in mouse 3T3-L1 adipocytes. Obesity (Silver Spring), 
2008. 16(6): p. 1208-18. 
38. Ehrlund, A., et al., Transcriptional Dynamics During Human Adipogenesis and Its Link 
to Adipose Morphology and Distribution. Diabetes, 2017. 66(1): p. 218-230. 
39. Brune, J.E., et al., Fat depot-specific expression of HOXC9 and HOXC10 may contribute 
to adverse fat distribution and related metabolic traits. Obesity (Silver Spring), 2016. 
24(1): p. 51-9. 
40. Gehring, W.J., M. Affolter, and T. Burglin, Homeodomain proteins. Annu Rev Biochem, 
1994. 63: p. 487-526. 
41. Nies, V.J.M., et al., Fibroblast Growth Factor Signaling in Metabolic Regulation. 
Frontiers in endocrinology, 2016. 6: p. 193-193. 
42. Kahkonen, T.E., et al., Role of fibroblast growth factor receptors (FGFR) and FGFR 
like-1 (FGFRL1) in mesenchymal stromal cell differentiation to osteoblasts and 
adipocytes. Mol Cell Endocrinol, 2018. 461: p. 194-204. 
43. Bischof, J.M., C.L. Stewart, and R. Wevrick, Inactivation of the mouse Magel2 gene 
results in growth abnormalities similar to Prader-Willi syndrome. Hum Mol Genet, 2007. 
16(22): p. 2713-9. 
44. Yu, W., et al., Association between KCNQ1 genetic variants and obesity in Chinese 
patients with type 2 diabetes. Diabetologia, 2012. 55(10): p. 2655-2659. 
 
62 
45. Unoki, H., et al., SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in 
East Asian and European populations. Nat Genet, 2008. 40(9): p. 1098-102. 
46. Gomez-Uriz, A.M., et al., Obesity and ischemic stroke modulate the methylation levels of 
KCNQ1 in white blood cells. Hum Mol Genet, 2015. 24(5): p. 1432-40. 
47. Chen, H., et al., Silencing of Paternally Expressed Gene 10 Inhibits Trophoblast 
Proliferation and Invasion. PloS one, 2015. 10(12): p. e0144845-e0144845. 
48. Doria, S., et al., Gene expression pattern of IGF2, PHLDA2, PEG10 and CDKN1C 
imprinted genes in spontaneous miscarriages or fetal deaths. Epigenetics, 2010. 5(5): p. 
444-50. 
49. Liang, X.Y., et al., [Genetic imprinted gene PEG10 expression in deciduas from 
inevitable abortion]. Yi Chuan, 2008. 30(6): p. 735-40. 
50. Diplas, A.I., et al., Differential expression of imprinted genes in normal and IUGR 
human placentas. Epigenetics, 2009. 4(4): p. 235-40. 
51. Liang, X.Y., et al., Expression and significance of the imprinted gene PEG10 in placenta 
of patients with preeclampsia. Genet Mol Res, 2014. 13(4): p. 10607-14. 
52. Gunnarsdottir, J., et al., Prenatal exposure to preeclampsia is associated with accelerated 
height gain in early childhood. PLoS One, 2018. 13(2): p. e0192514. 
53. Crume, T.L., et al., The long-term impact of intrauterine growth restriction in a diverse 
U.S. cohort of children: the EPOCH study. Obesity (Silver Spring, Md.), 2014. 22(2): p. 
608-615. 
54. Hishida, T., et al., peg10, an imprinted gene, plays a crucial role in adipocyte 
differentiation. FEBS Letters, 2007. 581(22): p. 4272-4278. 
55. Mühlhäusler, B.S., C.L. Adam, and I.C. McMillen, Maternal nutrition and the 
programming of obesity: The brain. Organogenesis, 2008. 4(3): p. 144-152. 
56. Ross, M.G. and M. Desai, Developmental programming of offspring obesity, 
adipogenesis, and appetite. Clinical obstetrics and gynecology, 2013. 56(3): p. 529-536. 
57. Stout, S.A., et al., Fetal programming of children's obesity risk. 
Psychoneuroendocrinology, 2015. 53: p. 29-39. 
58. Sweeting, H.N., Gendered dimensions of obesity in childhood and adolescence. Nutrition 
journal, 2008. 7: p. 1-1.  
 
63 
59. Burt Solorzano, C.M. and C.R. McCartney, Obesity and the pubertal transition in girls 
and boys. Reproduction (Cambridge, England), 2010. 140(3): p. 399-410. 
60. Tchernof, A. and J.-P. Després, Pathophysiology of Human Visceral Obesity: An Update. 
Physiological Reviews, 2013. 93(1): p. 359-404.
 
64 
CHAPTER 4: THE EFFECT OF MATERNAL PRE-PREGNANCY BMI ON 
IMPRINTED GENES WITHIN THE PLACENTA 
4.1 Introduction 
Obesity is one of the most serious global and national health concerns. 650 million adults 
worldwide are obese [1] and the prevalence of obesity in US adults reached 39.8% in 2015-2016 
[2]. Significant and wide-ranging adverse health outcomes are associated with obesity including 
type-2 diabetes, dyslipidemia, hypertension, asthma and many cancers, as wells as impaired 
quality of life, psychosocial distress, and restricted access to quality health care [3]. It is 
estimated that 280,000 deaths in U.S. adults per year are attributable to obesity [4]. The impact 
of maternal obesity is of particular concern as one in three women of childbearing age in the U.S 
were obese in 2014 [5]. Obese mothers are more likely to develop preeclampsia, gestational 
hypertension, gestational diabetes, or have a miscarriage, stillbirth, or preterm birth [6, 7]. The 
risks also extend to the child who is not only more likely to experience negative neonatal 
outcomes such as birth injury, being admitted to the NICU, or neural tube defects [6], but also 
are at increased risk for obesity [8], cardiovascular disease [9], stroke [10], type 2 diabetes [11], 
asthma [12], and autism [13]. 
The determinants of obesity are complex and involve interaction between biological, 
environmental, and behavioral factors. Food access, eating behaviors, sedentary lifestyles – all 
influenced by culture and policy – are known contributing factors [3]. Biological factors, such as 
being small for gestational age [14] and individual variance in the lipostatic regulation system 
[15], also increase risk. In addition, increasing evidence points to the interaction of genetics and 
environment as a driver of obesity. The DoHAD hypothesis posits that environmental factors 
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early in development, particularly during critical windows, program the risks for onset of adult 
disease later-in-life [16-19]. In fact, research suggests that the intrauterine environment of obese 
mothers can cause metabolic reprogramming toward obesity outcomes in later life for the child 
[6, 20].  
The placenta is the key mediator of the intrauterine environment and plays a critical role 
in growth and development [20, 21]. It functions as the site of gas, nutrient, and waste exchange 
between the mother and fetus, while also protecting the fetus from environmental and maternal 
stressors [22, 23]. To achieve such functions, the placenta carries out a wide range of activities 
(endocrine secretion, immunological protection, active and passive transport, and xenobiotic 
detoxification), which, if impaired, can perturb the normal development process [23]. Maternal 
pre-pregnancy obesity is known to have a negative effect on placental structure and function, 
including alteration of placental vasculature and exacerbation of placental inflammation [24].  
Epigenetic modifications may mediate the effect of maternal obesity on the placenta and 
fetus [20, 25]. CpG DNA methylation, perhaps the most studied epigenetic modification, has 
been shown to modify gene expression in the placenta, and abnormal CpG methylation 
subsequently has been shown to impair placental function [21]. Imprinted genes are of particular 
interest as they play key roles in later life metabolism and regulation of fetal and placental 
growth [26-28]. Altered DNA methylation patterns of imprinted genes have been found in 
placentas of mothers who developed preeclampsia [29-31], gestational diabetes [32, 33], and 
IUGR [34]. While maternal obesity has been linked to altered placental expression of key growth 
genes [35], there is little research combining the two by investigating altered methylation of 
imprinted genes in the placenta. Thus, we set out to explore the effects of maternal pre-
pregnancy BMI on CpG methylation patterns of imprinted genes within the placenta.  
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4.2 Materials and Methods 
4.2.1 The Elgan Study 
The Extremely Low Gestational Age Newborn (ELGAN) cohort was established as part 
of an observational study of women delivering prior to 28 weeks gestation, conducted from 
2002-2004. Institutional Review Board approval was granted for enrollment at 14 study sites in 
11 cities across 5 states (Massachusetts, Connecticut, Illinois, Michigan, and North Carolina).  
Of the 1,509 mothers eligible for inclusion, 1249 (83%) who gave birth to 1506 infants provided 
informed consent to enrollment in the study [36].  
4.2.2 Participant characteristics & sociodemographic data 
After delivery, a trained research nurse interviewed each mother using standardized 
questionnaires and data collection procedures. Mothers self-reported their sociodemographic 
characteristics including age, race/ethnicity, marital status, and education, as well as their pre-
pregnancy weight and their height. These measures were used to calculate maternal pre-
pregnancy BMI, characterized as normal weight (18.5-24.9 kg/m2), overweight (25.0-29.9 
kg/m2), or obese (≥30.0 kg/m2).  
4.2.3 Placental processing  
Placentas collected from subjects enrolled in ELGAN were placed in a sterile exam basin 
and transported to a sampling room, where they were biopsied under sterile conditions as soon as 
possible after delivery (~82% within 1 hr). At the midpoint of the longest distance between the 
cord insertion and the edge of the placental disk, the amnion was pulled back using sterile 
tweezers to expose the chorion. Using a second set of sterile tweezers, traction was applied to the 
chorion and the underlying trophoblast tissue and a piece of tissue was removed by cutting at the 
base of the section with the second set of scissors. The tissue was placed into a cryo-vial and 
immediately immersed in liquid nitrogen. Specimens were stored at minus 80˚C.  
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4.2.4 DNA extraction 
A total of 426 placenta biopsies were selected for CpG methylation analysis as a 
representative sample and were similar in terms of nearly all maternal and child characteristics. 
In preparation for DNA isolation, the cryotubes containing the biopsies were placed on dry ice 
and samples of the frozen tissue were obtained using a sterile dermal curette, tissue was washed 
in 1x PBS (Fisher Scientific, Waltham, MA) to reduce any potential blood contamination, and 
then immediately snap frozen in homogenization tubes and placed on dry ice to preserve 
integrity of the tissue sample. Samples were homogenized using RLTplus lysis buffer (Qiagen, 
Germantown, MD and a sterile stainless-steel bead (Qiagen, Germantown, MD) using the 
Qiagen TissueLyserII instrument. Samples were spun to collect the bead and cellular debris, and 
after clarification, the homogenate was stored at minus 80˚C. Nucleic acids were extracted from 
the banked homogenate on Qiagen’s QIAcube using the AllPrep DNA/RNA/miRNA Universal 
kit (Qiagen, Germantown, MD). This kit allows for simultaneous extraction of DNA and RNA 
molecules 18 nucleotides and greater from a single homogenate aliquot. DNA quantity was first 
assessed using the Nanodrop 1000 spectrophotometer and subsequently quantified and 
normalized using the Quant-iT PicoGreen dsDNA Quantitation Assay (ThermoFisher Scientific, 
Waltham, MA).  
4.2.5 CpG methylation assessment  
Genomic DNA isolated from placental tissue underwent bisulfite conversion using the 
EZ-96 DNA Methylation Kit (Zymo Research, Irvine, CA) and genome-wide DNA methylation 
was assessed using the Illumina EPIC Human Methylation 850K BeadChip array (Illumina, San 
Diego, CA), as per the manufacturers’ protocol. All methylation processing was performed at 
Wayne State’s Applied Genomics Technology Core (ATGC). The EPIC array assesses CpG 
methylation status of approximately 860,000 sites across 20,000 human genes, averaging ~17 
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probes per gene at a single nucleotide resolution, including 1553 CpGs spanning 162 imprinted 
genes (Appendix 3). Samples were randomly allocated to different plates and chips to minimize 
confounding. The EPIC arrays were scanned with the Illumina iScan and image intensities were 
extracted.  
4.2.6 Analytic and statistical approaches  
Following an approach previously described [37], DNA methylation data was imported 
into R for preprocessing using the minfi package [38]. We performed functional normalization 
with a preliminary step of normal-exponential out-of-band (noob) correction [39] for background 
subtraction and dye normalization, followed by the typical functional normalization method with 
the top two principal components of the control matrix [40, 41]. Quality control was performed 
on individual probes by computing a detection p-value and probes with non-significant detection 
(p > 0.01) for 5% or more of the samples were excluded. Lastly, we used the ComBat function to 
adjust for batch effects from sample plate [42]. Data was visualized using density distributions at 
all processing steps. Each probe measures the average methylation level at a single CpG site. 
Methylation levels are calculated and expressed as β-values (β = intensity of the methylated 
allele (M)) / (intensity of the unmethylated allele (U) + intensity of the methylated allele (M) + 
100).  
We investigated the relationship between maternal pre-pregnancy BMI and methylation 
at each individual CpG (n = 1553). Separate mixed-effects Poisson regression models were fit to 
estimate the effect for each CpG. A robust error variance procedure was used to relax variance 
assumptions [43]. The overall model adjusted for fetal sex (male, female), maternal age 
(continuous variable), maternal race (Hispanic/Non-Hispanic White and Hispanic/Non-Hispanic 
Black), intrauterine inflammation (chorioamnionitis, categorical yes/no), insurance as a proxy for 
socioeconomic status (public insurance, categorical yes/no), and single/multi gestation 
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(categorical). In order to investigate sexually dimorphic effects, sex stratified models were fit for 
each sex and adjusted for the same covariates, minus fetal sex. Covariates were selected for 
known roles in influencing both methylation and weight/BMI, and inclusion was determined 
using a directed acyclic graph approach (DAG, Appendix 4). 
While methylation levels (β-values) are calculated as a proportion between 0 and 1, for 
the purposes of this analysis, β–value will be adjusted to β-value*100 in order to examine the 
change associated with a 1% increase in methylation. A 1% increase represents a reasonable 
change given the ranges of our data. This transformation does not change the underlying 
distribution of the data or the sensitivity of the model. For all models, we used a post-hoc 
adjustment for multiple comparisons via the Benjamini-Hochberg (FDR) procedure and 
controlled for the false discovery rate of 0.05. All statistical analyses were performed in R 
software.  
4.2.7 Functional analysis of biological networks  
To investigate the underlying function of the CpG probes identified in these analyses, 
genes showing differential methylation associated with IUGR risk were analyzed for biological 
functions, canonical pathways, upstream regulatory molecules, and interacting molecular 
networks using Ingenuity Pathway Analysis Software. Statistical significance of network 
enrichment was determined based on a modified Fisher’s exact test. P-values represent the 
probability of differentially methylated genes appearing in the associated biological network at 




4.3.1 Study demographics  
Maternal and birth characteristics of the ELGAN subjects for whom we had a placenta 
specimen (n = 426) as compared to the larger cohort (n = 889) are presented in Table 3. Data are 
presented as the number (%) of subjects in the sample unless otherwise noted. There were no 
significant differences in fetal sex, maternal age, maternal race, intrauterine inflammation, 
insurance as a proxy for socioeconomic status, or single/multi gestation (data not shown).  
4.3.2 Maternal pre-pregnancy BMI is associated with altered methylation of imprinted 
genes  
Methylation levels at a total of 41 CpG sites, representing 29 unique imprinted genes, 
were identified as being altered in relation to maternal pre-pregnancy BMI (Table 6). Identified 
CpGs spanned the genome, corresponding broadly to genes that encode proteins related to cell 
cycle regulation, specifically estrogen-mediated S-phase entry (p=4.62x10-4), and included 
imprinted genes Cyclin dependent kinase 4, (CDK4) and E2F Transcription Factor 7 (E2F7). 
Analysis was performed on the 29 unique imprinted genes in order to identify key upstream 
molecules that are predicted to be master regulators. This analysis uncovered that the genes 
identified were predicted to be regulated by the transcription factor Meis homeobox 1 (MEIS1).  
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Table 6. Imprinted genes associated with maternal pre-pregnancy BMI. The model 
coefficients correspond to annual changes in BMI for every 1-unit increase in baseline 
methylation levels at the respective loci. 
Gene 
name 






ANO1 cg15632675 14.94 0.04 Body Island 
ATP10A cg16389285 -3.42 0.01 TSS200 Island 
 cg03307893 -2.43 0.01 TSS1500 Island 
 cg09984339 -2.12 0.02 TSS1500 Island 
BRUNOL4 cg24860812 2.03 <0.01 Body N_Shelf 
C16orf57 cg01719220 -1.83 0.02 TSS200 Island 
C9orf85 cg18627568 -2.82 0.05 TSS1500 Island 
CDK4 cg03829839 1.02 0.02 TSS1500 S_Shore 
CDKN1C cg22865058 -0.74 0.04 Body Island 
DLK1 cg18121862 2.35 0.01 Body S_Shore 
E2F7 cg26276877 -3.04 0.01 TSS200 Island 
FAM59A cg16596493 -2.59 0.03 TSS1500 Island 
GDAP1L1 cg12689285 -0.61 0.03 TSS200 Island 
GNAS cg10748817 -2.69 0.02 3'UTR Island 
 cg04019914 -4.73 0.03 3'UTR N_Shore 
 cg04779428 -3.37 0.03 3'UTR N_Shore 
 cg03821543 -2.19 0.03 3'UTR Island 
 cg22798925 -3.08 0.04 3'UTR Island 
 cg05926269 -4.41 0.04 3'UTR Island 
HES1 cg21428647 -2.16 0.01 TSS1500 Island 
HOXA2 cg06769202 0.98 0.03 TSS200 N_Shore 
HOXA3 cg02627455 2.21 0.02 5'UTR S_Shelf 
INPP5F cg27613076 1.99 0.04 TSS1500 N_Shore 
ISM1 cg19118558 -1.53 0.01 TSS1500 Island 
KCNQ1DN cg09998591 5.09 0.01 Body S_Shore 
 cg10503232 3.24 0.05 Body S_Shore 
LDB1 cg26412532 -1.09 0.02 TSS1500 S_Shore 
LRRTM1 cg01955779 0.75 0.04 TSS1500 S_Shore 
MAGEL2 cg21325760 1.53 0.04 1stExon 
 
MAGI2 cg14446066 -4.54 0.01 Body 
 
 ch.7.1714607F -1.23 0.04 Body 
 
MEG3 cg14121301 3.75 0.03 Body 
 
MESTIT1 cg20826277 -1.26 0.02 Body N_Shore 
 cg14584935 -1.19 0.04 Body N_Shore 




OSBPL5 cg25908390 3.09 0.02 5'UTR 
 
PLAGL1 cg04895233 4.91 0.03 TSS1500 S_Shore 
 cg10254692 2.07 0.05 TSS1500 S_Shore 
PRDM16 cg05656251 1.65 0.01 Body 
 
 ch.1.131529R -0.69 0.03 Body 
 
SGCE cg05531533 -7.49 0.04 TSS200 Island 
 
4.3.3 Maternal pre-pregnancy BMI is associated with altered methylation of imprinted 
genes in a sexually dimorphic manner  
When stratified by fetal sex, a dimorphic effect was observed with 39 CpGs, representing 
32 unique imprinted genes, identified in placentas derived from a pregnancy with a male fetus 
and 51 CpGs representing 38 imprinted genes identified in placentas derived from a pregnancy 
with a female fetus. Of these imprinted genes, 12 were common among both sexes. When 
interrogated for common molecular networks and pathways, sex-specific clustering of both 
canonical pathways and underlying biological functions was observed (Appendix 5). In the 
placentas of male fetuses, myo-inositol biosynthesis and PTEN signaling (p=6.79x10-3, and 
p=1.21x10-2, respectively) were the top canonical pathways, and included genes such as Inositol 
Polyphosphate-5-Phosphatase F (INPP5F). Functionally, the imprinted genes identified were 
broadly responsible placental development and morphology (p<9.02x10-6). In the placentas of 
female fetuses, the top canonical pathway identified was the aryl hydrocarbon receptor (AHR) 
pathway (p=7.42x10-5) and included genes such as Aldehyde Dehydrogenase 1 Family Member 
L1 (ALDH1L1) and RB Transcriptional Corepressor 1 (RB1). Broadly, the identified genes were 





Figure 7. Tissue specific functions of the sexually dimorphic imprinted genes associated 




4.4 Discussion  
In the present study, we set out to examine the association between maternal pre-
pregnancy BMI and CpG methylation of imprinted genes in the placenta. Methylation of 29 
imprinted genes were significantly associated with maternal pre-pregnancy BMI. These 29 genes 
are involved broadly in cell cycle regulation, and estrogen mediated S-phase entry was identified 
as the top statistically enriched pathway. We also uncovered striking sexual dimorphism in the 
association of maternal pre-pregnancy BMI and imprinted gene methylation, with different sets 
of imprinted genes being altered in the placentas derived from male or female pregnancies (32 
and 38 respectively). Notably, these sets are associated with distinctive biological functions: 
placental development and morphology in the males and fetal nervous system development in 
the females.  
In an unstratified analysis of all subjects, estrogen mediated S-phase entry was the most 
highly enriched pathway and included genes with known roles in proliferation and angiogenesis, 
such as CDK4 and E2F7.  A cycle of estrogen activity and adiposity exists in which adipose 
tissue functions as an endocrine organ in a multitude of ways [45]. As well as its role in obesity, 
estrogen also plays a significant role in the development of the placenta and consequently in 
regulating heathy fetal growth throughout development [46]. The placenta is a key endocrine 
organ that produces estrogen in the syncythiotrophoblast cell layer in order to maintain 
pregnancy [47], and also plays an essential role in placental villous blood vessel development 
which is critical for healthy placental functioning [48]. Interestingly, previous studies examining 
human placental samples observed that CDK4 was localized within the nuclei of the 
cytotrophoblast layer, suggesting that it may regulate cell cycle progression in the proliferative 
compartment (i.e., the cytotrophoblast) as well as being involved in the control of placental 
angiogenesis [49]. E2F7 is critical for repressing a E2F targets that control embryonic viability, 
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trophoblast proliferation, and general placental development and vascularization [50]. Upstream 
regulation of the identified genes was predicted to be MEIS1, a transcription factor which is 
known to play a crucial role in normal development [51]. In vivo studies show Meis1 expression 
significantly modulated transcriptional targets of important factors in early embryo-endometrium 
interactions and implantation [52]. In vivo studies also demonstrate Meis1 plays a role in 
regulation of proximodistal limb axis development [53] and that Meis1 null mice result in 
embryonic death between days 11.5 and 14.5 [54]. Taken together, perturbation of the estrogen 
mediated S phase entry pathway, coupled with upstream regulation by MEIS1, suggest a critical 
role in early angiogenesis, implantation, and embryonic development, and that altered 
methylation of imprinted genes may be an underlying factor. 
When stratified by fetal sex, a sexually dimorphic response was observed in associated 
canonical pathways and biological functions. Within the set of imprinted genes differentially 
methylated in association with maternal pre-pregnancy BMI in placentas from male fetuses, 
myo-inositol biosynthesis and PTEN signaling were the most enriched pathways. Myo-inositol is 
involved in regulating insulin, a critical component of obesity pathogenesis [55], as well a 
number of hormones required for many key placental functions, gametogenesis, and embryonic 
development [56]. Also enriched was the PTEN signaling pathway which has been clearly linked 
to placental development, specifically proper trophoblast invasion and decidual regression [57, 
58]. This observation is particularly worrisome because defective trophoblast invasion is linked 
to spontaneous miscarriage [59, 60], intrauterine growth restriction [61, 62] and preeclampsia 
[63], all of which are outcomes that obese mothers are at high risk of developing [64-66]. The set 
of imprinted genes differentially methylated in association with BMI in placentas of female 
fetuses, however, centered around fetal and nervous system development. Here, the most 
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enriched pathway was the AHR pathway which is involved in xenobiotic metabolism [67], and 
included ALDH1L1, a folate metabolic enzyme linked to neural tube defects and 
neurodevelopmental disorders [68]. In terms of biological functions associated with the 
differentially methylated gene set in placentas of female fetuses, all were involved in abnormal 
nervous system development, neurological disease, or morphology of the brain, ear, or head, and 
included several HOX genes, namely HOX2, HOXA3, and HOXB2. The family of HOX genes 
play a fundamental role in embryonic morphogenesis as evidenced by their involvement in 
various congenital syndromes including hand-foot-genital syndrome, Mowat-Wilson Syndrome, 
and Duanes Retraction Syndrome [69]. Mouse studies also support the role of Hox genes in 
vascular development and angiogenesis in the placenta [70]. Interestingly, there is a purported 
link between HOX gene dysregulation in development and susceptibility to autism spectrum 
disorder [71].  
To the best of our knowledge, this is the first study to evaluate the impact of pre-
pregnancy maternal BMI on CpG-specific imprinted gene methylation in the placenta and our 
finding that pre-pregnancy maternal BMI alters the methylation of imprinted genes in a sexually 
dimorphic manner is novel. In line with these findings, previous studies have shown that 
methylation of imprinted genes at birth was associated with early life weight status in a sexually 
dimorphic manner, supporting the theory of a sex-specific effect of altered methylation and 
weight regulation [72]. However, our study is not without limitations. No single CpG loci 
reached false discovery rate adjusted significance, thus we report findings using a cutoff of 
p<0.05. Additionally, our cohort comprises extremely low gestational age infants; while this is 
advantageous in interrogating placental imprinting during early development, our results may not 
reflect growth patterns and regulation representative of full-term infants.  
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 In summary, we found altered methylation of 29 imprinted genes in relation to increases 
in maternal BMI when evaluating all study subjects. When evaluating sex-specific effects a 
notable sexually dimorphic pattern was observed with distinct sets of genes methylated in 
placenta of male (32 imprinted genes) and female (38 imprinted genes) fetuses. Furthermore, 
different biological functions were found to be associated with each sex: placental invasion and 
morphology in males, and fetal and nervous system development in females. These findings are 
particularly interesting in that they highlight the need for further investigation of the placenta’s 
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CHAPTER 5: DISSERTATION DISCUSSION, FUTURE RESEARCH, AND 
CONCLUSION 
Collectively, the studies presented in each of the chapters of this dissertation demonstrate 
that altered methylation of IGs in the placenta is associated with IUGR risk and childhood 
growth rate, and that maternal pre-pregnancy BMI contributes to that perturbation. Specifically, 
in Chapter 2 we identified sites of CpG methylation within imprinted genes in the placenta that 
were associated with intrauterine growth risk. In Chapter 3, we found IG methylation in the 
placenta was associated with childhood growth rate. Chapter 4 identifies CpGs with perturbed 
methylation patterns associated with maternal pre-pregnancy BMI. These data suggest a potential 
mechanistic underpinning, namely altered CpG methylation of imprinted genes within the 
placenta, and provide key insight to the developmental origins of health and disease (DOHaD).  
5.1 Imprinted Genes in the Placenta Play a Critical Role in Pre-/Perinatal, Childhood, and 
Lifelong Health Trajectories of Offspring 
The main focus of Chapter 2 was to identify CpG methylation patterns of imprinted genes 
within the placenta that were associated with risk of being born IUGR (Figure 8), the hypothesis 
being that CpG methylation profiles of imprinted genes in the placenta will differ between IUGR 
and non-growth restricted infants. Chapter 3 focused on determining how placental CpG 
methylation of imprinted genes is associated with childhood growth trajectories, with our 
hypothesis being that methylation profiles will be altered in children experiencing “catch-up” 
growth through 10 years of age (Figure 8). These hypotheses were based on previous studies of 




Figure 8. Venn diagram displaying shared and unique imprinted genes within the placenta 
across all aims.Total number of IGs in each group is noted in parentheses. 
 
[1], coupled with the knowledge that dysregulation of imprinted genes in the placenta is 
associated with a variety of adverse health outcomes, including both immediate perinatal [2] and 
later-in-life risks [3]. In our research, methylation levels of 29 CpG sites, spanning the genome 
and falling within 19 unique genes, were found to be associated with risk of IUGR when looking 
at the unstratified study sample. The identified CpGs corresponded to genes that encode proteins 
related to lipid metabolism and small molecule biochemistry, perhaps unsurprisingly as fetal 
development requires a substantial amount of lipids, which are regulated by the placenta through 
specific enzymes, receptors, and transport proteins throughout gestation [4]. When looking at the 
 
85 
post-natal effects of placental imprinting, methylation of two imprinted genes was associated 
with childhood growth rate in our unstratified analysis, namely LMX1B and ZFP36L2, and both 
have been previously implicated in growth and obesity [5, 6]. Interestingly, in Chapters 2 and 3, 
methylation of imprinted genes within the placenta was associated with both elevated and 
reduced risk in a parent-of-origin independent manner; these results were not necessarily 
expected as maternally-expressed genes tend to be growth restricting while paternally expressed 
genes tend to promote growth. It is worth mentioning that while the current studies examine 
placental imprinting, it is likely that fetal imprinting is also perturbed, as previous studies have 
illustrated correlation of imprinted gene methylation patters between the placenta, fetal tissues, 
and cord blood (Figure 9) [7]. Taken together, data from these chapters detail key imprinted 
genes within the placenta with significantly altered methylation in association with in utero and 
childhood growth trajectories, as well as being associated with lifelong disease risk. 
5.2 Imprinted Genes Within the Placenta are Susceptible to the Endogenous Maternal 
“Environment” 
The research presented in Chapter 4 examined how maternal factors, specifically 
maternal pre-pregnancy BMI, influences placental CpG methylation of imprinted genes (Figure 
9), the hypothesis being that maternal pre-pregnancy BMI would be associated with altered CpG 
methylation patterns of imprinted genes in the placenta. Given that Chapters 2 and 3 identified 
differentially methylated imprinted genes within the placenta related to in utero and childhood 
growth and were associated with many of the same health risks seen in obese individuals, it 




Figure 9. CpG methylation of imprinted genes across various human tissues. Taken from 
Murphy et al., 2012.  
 
genes within the placenta. Here, methylation levels at a total of 41 CpG sites, representing 29 
unique imprinted genes, were identified as being altered in relation to maternal pre-pregnancy 
BMI. Again, identified CpGs spanned the genome, however this time corresponding broadly to 
genes that encode proteins related estrogen-mediated S-phase entry. This finding is of interest as 
both adipose tissue [8] and the placenta [9] function as endocrine organs, with estrogen playing a 
significant role in the development and proper functioning of the placenta [10]. Together, these 
data suggest estrogen dysregulation caused by maternal pre-pregnancy BMI leads to altered 
methylation of imprinted genes within the placenta.  
 
87 
5.3 Perturbations in Placental Imprinting are Sexually Dimorphic 
In all three research chapters, strong sexually dimorphic associations are reported. This is 
not entirely surprising as the placenta is a sexually dimorphic organ [11-14], sharing the sex of 
the fetus. It is notable that such dimorphic responses are well documented in relation to fetal 
growth and development [13, 15], as well as risk for diseases such as Alzheimer’s [16] and other 
neurodevelopmental outcomes [17, 18], cardiovascular disease [19-22], and cancer [23-26], 
among others – all disorders found to be associated with many of the imprinted genes identified 
within this dissertation. Additionally, sexually dimorphic responses in the placenta may also be 
driven by differential response to the maternal environment as animal models show placental 
morphology, epigenetics, and gene expression may be altered in a sex-dependent manner in 
response to both environmental exposures and maternal nutrition [27, 28]. Not only do these 
results highlight the need to examine sex specific differences in health care and disease 
vulnerability [29, 30] but also, within the context of DOHaD, add to the growing body of 
evidence that in utero programming, and genomic imprinting in particular, may in part be 
responsible for the dimorphism seen in the various late-onset outcomes mentioned above. 
5.4 Proposed Biological Functions and Underlying Mechanisms Contributing to Perturbed 
Methylation Patterns Differ among Studies 
The studies detailed herein identify common imprinted genes, namely ATPase 
Phospholipid Transporting 10A (Putative) (ATP10A), MEST, Obscurin, Cytoskeletal Calmodulin 
And Titin-Interacting RhoGEF (OBSCN), PEG10, PR/SET Domain 16 (PRDM16), and RB1, 
which are all broadly related to growth, metabolic function, and body size (Figure 8, Appendix 
7). It is possible that these 6 imprinted genes may serve as epigenetic mediators of the adverse 
health outcomes studied here and warrant further investigation. Interestingly, despite this 
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commonality of genes across aims, our evidence suggests very different biological functions and 
underlying mechanisms are driving these observations (Figure 10). 
5.4.1 The role of lipoproteins and altered lipid transfer in IUGR pathogenesis and risk of 
associated later-in-life diseases 
 
 
Figure 10. Biological underpinnings of associations between CpG methylation of imprinted 
genes within the placenta, peri-/post-natal outcomes (a, b), as well as possible contributing 
factors such as maternal pre-pregnancy BMI (c). Solid lines indicate statistically significant 
associations that are supported by our findings; dashed lines indicate supportive trends that were 
reported but failed to reach statistical significance after false discovery correction.  
 
Chapter 2 identified altered methylation patterns of imprinted genes in the placenta that 
broadly encode for proteins related to lipid metabolism and small molecule biochemistry, and 
identified genes encompassing lipid transporters, and molecules involved in lipid accumulation, 
uptake, and metabolism. As previously mentioned, fetal development requires a substantial 
amount of lipids throughout gestation [4], which are regulated by the placenta. We propose the 
underlying epigenetic mechanism of our observation is twofold: first, altered imprinting may 
inhibit the placenta’s ability to transfer necessary lipophilic compounds, thus contributing to the 
poor fetal growth seen in IUGR [31, 32]. Second, the altered imprinting not only deprives the 
fetus of required nutrients but also caused an adaptive response resulting in metabolic 
reprogramming leading to later-in-life disease [33, 34], directly in line with Barker’s “fetal 
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origins hypothesis.” Our observations are consistent with the idea that the fetal demand 
signaling, via the placenta, can compensate for reduced lipid transport (i.e., nutrient deficiency), 
thus permanently altering the metabolic trajectory of the fetus [35, 36]. While this adaptive 
response may promote short term survival, it facilitates the subsequent development of metabolic 
syndrome, especially when in utero nutrient restriction is followed by sufficient postnatal 
nourishment [37]. 
5.4.2 Hormone signaling as modulators of childhood growth trajectory in females 
In Chapter 3, though the unstratified and male sexually-stratified analyses identified 
minimal associations between CpG methylation and childhood growth trajectories (LMX1B, 
ZFP36L2 and LMX1B, HOXC9, respectively), the imprinted genes identified therein have been 
previously implicated in growth and obesity [5, 6]. The most striking results were for the female 
sex-stratified analysis, where associated genes were part of a network cluster involved in glucose 
and insulin signaling. 
During pregnancy, maternal insulin and maternal–fetal glucose concentrations increase 
throughout gestation to accommodate the increased fetal nutrient demand [38]; disruption of this 
balance may lead to consequences for the fetus, and previous studies have demonstrated a 
sexually dimorphic response from females when this occurs. A strong inverse association 
between gestational weight gain and placental glucose uptake has been reported in placentas of 
female but not male fetuses [39], suggestive of an adaptation to optimize glucose supply and, in 
effect, protect female fetuses from developing severe dyslipidemia [40]. Here, we propose the 
observed sexually dimorphic response of differentially methylated imprinted genes in the 
placenta, interacting with insulin and glucose, modulates childhood growth via the mechanistic 
target of rapamycin (mTOR) pathway, a known regulator of cellular metabolism and growth.  
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Maternal insulin and glucose are positive regulators of mTOR [41, 42], and glucose 
deprivation promotes activation of the mTOR signaling pathway [43].  Pregnancy complications, 
such as obesity, may alter the mTOR pathway and result in dysregulation of placenta nutrient 
transport. Moreover, studies have detailed sex specific differences in mTOR signaling in relation 
to health outcomes, with in vivo models showing proper mTOR signaling confers cardiac 
protection in females [44]. While it is not possible to explore mTOR signaling within this study, 
this finding warrants further investigation.  
5.4.3 Oxidative stress and altered one carbon metabolism, driven by maternal pre-
pregnancy BMI, disrupts proper placental imprinting 
The results from Chapter 4 identify a positive association between maternal pre-
pregnancy BMI and methylation of imprinted genes within the placenta. A possible mechanism 
driving the observed alterations in placental imprinting is obesity-induced oxidative stress.  
While reactive oxygen species (ROS) is a normal byproduct of aerobic metabolism required for 
sustaining life, oxidative stress (OS) results from an imbalance between ROS production and 
defense mechanisms that protect against DNA damage [45]. Overlap is seen in the molecules 
responsible for both methylation and ROS detoxification. Glutathione, which is required for 
proper methylation maintenance, is also critical in protecting against reactive oxygen species 
during fertilization [46]. Moreover, this balance can be complicated by maternal metabolic 
dysfunction, as high levels of glucose increase ROS production by the embryo [47]. 8-
hydroxyguanosine is one of the most prevalent DNA adducts produced in response to oxygen 
radicals, profoundly altering methylation of adjacent cytosines, and thus serves as potential 
source of OS-associated perturbation in methylation profiles [48]. Systemic oxidative stress is 
well documented in the pathogenesis of obesity [49-51]. Positive associations between indices of 
obesity, such as BMI, and both urinary [50] and plasma [51] biomarkers of oxidative stress have 
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been found. Other studies have shown that obesity-induced systemic OS may be in part driven by 
irregular production of certain cytokines found in adipose tissue that play a role in metabolic 
dysregulation [52, 53]. Supporting this, these cytokines have been identified as being 
proinflammatory, and thus could also be responsible for increased OS [54, 55].   
5-hydroxymethylcytosine (5-hmC) is another oxidative product of cytosine that may 
interrupt proper methylation of DNA. The Ten-eleven translocation (TET) proteins are 
responsible for carrying out the process of active demethylation by oxidizing 5-methylcytosine 
(5-mC) to 5-hmC. While it has been well documented that OS alters global DNA methylation, 
studies have also reported it can alter epigenetic machinery through the modulation of the TET 
proteins, compromising the process of active demethylation [56, 57]. Taken together, our 
findings support that maternal-obesity mediated alterations in placental imprinting are likely 
driven by oxidative stress response. 
In addition to maternal endogenous OS, one-carbon metabolism provides a possible 
explanation for how maternal nutrition may influence the altered CpG methylation of imprinted 
genes seen here. An interaction of folate and methionine cycles, one-carbon metabolism involves 
the addition and removal of a methyl group from subsequent species, including S-Adenosyl 
methionine (SAM), a universal methyl donor and substrate for DNA methyltransferase [58-60]. 
Levels of folate and other nutrients involved in one-carbon metabolism may therefore influence 
DNA methylation levels [61] and provide a link between maternal obesity and epigenetic 
perturbation of the fetus and placenta. Specifically, such modifications may mediate the effect of 
maternal obesity on the placenta and fetus [62, 63]. 
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5.5 Public Health Relevance 
Chapters 2 and 3 examine the relationship between CpG methylation of imprinted genes 
in the placenta and two critical public health issues, namely IUGR and childhood growth 
trajectories. IUGR is a pathological decrease in the rate of fetal growth, occurring in 
approximately 7-15% of pregnancies worldwide [64]. While studies have focused primarily on 
low- and middle-income countries, it has been reported that stunting, severe wasting, and IUGR 
combined were responsible for over 2 million deaths and 21% of disability-adjusted life-years 
(DALYs) for children 5 years of age and younger [65]. Moreover, being born IUGR has been 
associated with a variety of adverse perinatal outcomes [2], as well as increased risk of coronary 
heart disease, hypertension, type 2 diabetes, and obesity later-in-life [3]. The data in this 
dissertation suggest that “placental insufficiency” is due in part to altered lipoproteins and altered 
lipid transfer regulated by imprinted genes, identifying new pathway targets for IUGR 
prevention via maternal nutrition and dietary interventions. 
Recent epidemiological studies suggest that the rate of growth in early life is associated 
with risk for development of chronic diseases such as obesity and metabolic dysfunction [66-68]. 
In 2017, the prevalence of obesity in the United States among 6–11-year-old children was 
18.4%, and 12–19-year-old children was 20.6% [69]. Obese children are more likely to develop 
early onset of illnesses traditionally thought of as “adult diseases,” such as non-alcoholic fatty 
liver, diabetes, cardiovascular disease, insulin resistance, and some cancers [70, 71]. Moreover, 
childhood obesity has been associated with later in life obesity [72], thus contributing to 
cumulative lifetime disease burden. Here we detail key imprinted genes with significantly altered 
methylation associated with childhood growth trajectories. Notably, we demonstrate a striking 
sexual dimorphism in this association, underpinning sex-specific vulnerability to obesogenic 
environments as well as the interaction of sex-related hormones with adiposity and body fat 
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distribution. Researchers, clinicians, and policy-makers need to move beyond the “one size fits 
all approach” and develop nutritional, lifestyle, and behavioral interventions which take these 
differences into account.  
Lastly, the in-utero environment is directly impacted by endogenous maternal cues, 
including maternal pre-pregnancy BMI. Offspring of obese mothers are more likely to 
experience negative neonatal outcomes [73], as well as later-in-life risk for obesity [74], 
cardiovascular disease [75], stroke [76], type 2 diabetes [77], asthma [78] and autism [79]. 
Epigenetic modifications may mediate the effect of maternal obesity on the placenta and fetus 
[62, 63], suggesting that the intrauterine environment of obese mothers can cause metabolic 
reprogramming toward obesity outcomes in later life for the child [62, 73]. By examining the 
influence modifiable maternal factors such as pre-pregnancy BMI have on placental imprinting, 
we seek identify practical intervention strategies that could be used to mitigate adverse outcomes 
that contribute to the developmental origins of disease, such as IUGR and altered childhood 
growth trajectories.  
5.6 Future Research  
The role of genomic imprinting in feto-placental growth and development is undisputed, 
and the findings presented in Chapters 2-4 contribute to understanding the epigenomic 
contributions that link imprinting in the placenta to perinatal and later-life disease risk. Early 
cues during developmental periods of vulnerability, whether maternal or environmental in 
nature, can irreversibly interfere with genomic imprinting and, depending on their nature, may 
have detrimental effects that not only reach throughout an individual’s lifetime, but may also 
have multi-generational effects. Despite this, there are still research gaps and our findings 
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provide a basis for future research, including expanded studies within the Elgan cohort.  Three of 
these are detailed as follows: 
5.6.1 Do the methylation signatures identified in these studies result in functional (e.g. 
transcriptomic and proteomic) changes? Do these trends persist over time?  
Results from our studies suggest that perturbations in placental CpG methylation of 
imprinted genes contribute to the pre-/perinatal, childhood, and lifelong health trajectories of 
offspring. What remains unclear, however, is whether or not these differentially methylated sites 
result in functional changes. While epigenetic regulation, including CpG methylation, has 
traditionally been associated with gene silencing [80], evidence is emerging that location of the 
CpG within the gene is what dictates resulting functional changes, if any. Prior studies from our 
research group demonstrate that DNA methylation changes most predictive of functional 
changes were located within the first exon, the 5’ untranslated region, and 200 bp upstream of 
the transcription start site [81]. An association analysis between mRNA expression and DNA 
methylation was run across all subjects for each of the differentially expressed genes and 
differentially methylated probes and only 16 genes, representing <1% of the total differentially 
methylated genes DMGs, were found to be correlated [81]. These findings are supported 
elsewhere in the literature, where methylation inside the gene body was positively correlated to 
expression [82, 83]. In order to assess if functional changes are associated with the observed 
differential methylation of imprinted genes within the placenta, we are in the process of 
obtaining both mRNA-sequencing data and proteomic data from the same placental biopsies 
used for the methylation analyses presented within this dissertation. Moreover, ELGAN is 
currently in its third research phase (Elgan3-ECHO), with study subjects being followed up now 
at approximately 15 years of age with additional anticipated visits at 18 years of age. At both 
follow-up visits, anthropometric measures and biological specimens are being collected and 
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would allow for examination of the stability of methylation trends observed in the placenta 
throughout the lifetime of the offspring.  
5.6.2 How do other genetic, epigenetic, and environmental factors influence imprinting 
within the placenta?   
Population level contributions to interindividual variability influence the epigenome at 
large [84]; that role, if any, remains unclear in respect to IG though at least one study suggests 
imprinting may be more heterogeneous than previously thought [85].  Also understudied is the 
role of single nucleotide polymorphisms (SNPs) in interindividual differences in IG loci, 
although another study showed genetic variation in imprinted genes was associated with disease 
risk [86].  
Moreover, as the mechanistic underpinnings of genomic imprinting in the placenta 
grows, it has become evident that DNA methylation, while the first discovered and most well 
studied, is but only one part of the imprinting regulatory machinery. Imprinted genes may also be 
regulated by histone modifications and long noncoding RNAs (lncRNAs). For instance, mouse 
models have shown some loci undergo “non-canonical” imprinting independent of DNA 
methylation, specifically through histone modifications such as maternal histone 3 lysine 27 
trimethylation (H3K27me3) [87]. Additionally, ICRs may express lncRNAs as a means of 
chromatin structuring, altering the recruitment and activity of chromatin regulatory complexes 
thus either allowing, or preventing, transcription of near-by genes, as is the case of Potassium 
Voltage-Gated Channel Subfamily Q Member 1 (KCNQ1) in the placenta [88]. Taken together, 
these studies suggest multiple epigenetic mechanisms may work together to coordinate, and co-
regulate, imprinted gene expression.  
As previously discussed, imprinted genes are susceptible to a variety of biological, 
nutritional, and environmental influences, and as such underlying mechanisms that may link 
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these influences to adverse health outcomes, warrants more investigation. For example, we have 
previously hypothesized that distinct methylation patterns due to exposure to environmental 
contaminants may represent “environmental footprints” of transcription factor occupancy during 
DNA methylating events, impacting the occupancy and subsequent methylation of the imprinted 
gene loci [89]. This could have major implications for developmental programming and may 
provide further mechanistic links between genomic imprinting and disease.  
Within the context of the ELGAN cohort, we are uniquely positioned to work toward 
integration of all of these contributions to the observed perturbations in imprinted gene 
methylation within the placenta. First, we can integrate genotype data from the study subjects in 
order to investigate the contributions of genetic variation to our outcomes of interest, namely 
IUGR and childhood growth trajectories. Second, mRNA sequencing of the placenta has just 
been completed and protein extraction is underway for high-throughput proteomic analyses. 
These data this will allow for the identification of functional changes in the transcriptome and/or 
proteome in relation to the identified methylation perturbations in imprinted genes within the 
placenta. Third, miRNA sequencing of the placenta has just been completed, allowing us to 
subsequently interrogate other epigenetic mechanisms which may also contribute to imprinted 
gene regulation, either independently or in collaboration with altered methylation patterns, in 
relation to our outcomes of interest. Lastly, we are currently working with the ECHO Children's 
Health Exposure Analysis Resource (CHEAR) to develop methods to assess levels of toxic and 
essential metals within banked umbilical cord samples as a proxy matrix [90], as there is no 
remaining placenta to evaluate for environmental measures. By integrating toxic and essential 
metals measures (i.e., arsenic, cadmium, lead, selenium, magnesium, and zinc, among others) 
into our analyses of altered CpG methylation of imprinted genes within the placenta and our 
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outcomes of interest stated within this dissertation, we can assess the contribution of the 
environment to epigenetic perturbations. 
5.6.3 What is the paternal contribution to genomic imprinting and DOHaD?  
Perhaps the most overlooked aspect of the role of genomic imprinting in the field of 
DOHaD is the contribution of the paternal alleles to the epigenome. It is understandable that 
studies focus primarily on maternal wellbeing and exposures, as the fetal compartment is directly 
dependent upon the mother for the duration of gestation. Still, there is emerging evidence of the 
role of pre- and peri-conceptual paternal exposures contributing to aberrant imprinting and 
subsequent adverse health outcomes [91]. The handful of epidemiological studies exploring the 
sperm epigenome have examined paternal obesity, exercise, chemotherapy, organophosphate 
flame retardant exposure, smoking status, alcohol use, and nutritional supplementation in relation 
to DMRs and, while not confirmed, may suggest that alterations in the paternal epigenome 
contribute to negative developmental and phenotypic outcomes [as summarized in 91]. Future 
studies should seek to include paternal anthropometric, sociodemographic, and behavioral 
information, as well as collection of biological specimens, in order to more fully investigate how 
both parents contribute to pre-/peri-natal and life-long health trajectories of their offspring. 
5.7 Conclusion 
While we continue to fill in the research gaps, it is undeniable that imprinting plays an 
important role in feto-placental development and placental function, and that the maternal 
“environment” is a contributing factor to offspring health. Disruptions in normal epigenetic 
regulation of imprinted genes lead to possible detrimental health consequences for the fetus, both 
in terms of pre-/peri-natal as well as later-in-life disease susceptibility. Because epigenetic marks 
can be reversible, development of early-detection biomarkers and intervention strategies will 
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lead to a better understanding of the wide spectrum of adult-onset diseases originating in utero 
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APPENDIX 2: LIST OF EXPERIMENTALLY VALIDATED AND PREDICTED 
IMPRINTED GENES USED FOR ALL ANAYSES  
Gene Aliases Location Status Expressed Allele 
ABCC9 SUR2, ABC37, 
CMD1O, 
FLJ36852  
12p12.1 AS  Predicted Maternal 
ABCG8 GBD4, STSL, 
MGC142217  
2p21  Predicted Maternal 
ACD PIP1, PTOP, TPP1, 
TINT1  
16q22.1 AS  Predicted Maternal 
ADAMTS16 FLJ16731, 
ADAMTS16s  
5p15  Predicted Maternal 
AIM1 ST4, CRYBG1  6q21  Imprinted Paternal 
ALDH1L1 FTHFD, 
DKFZp781N0997  
3q21.3 AS  Predicted Maternal 
ANO1 DOG1, TAOS2, 
ORAOV2, 
TMEM16A  
11q13.3  Imprinted Maternal 




q21.1 AS  
Predicted Paternal 
ATP10A ATPVA, ATPVC, 
ATP10C, 
KIAA0566  
15q11.2 AS  Imprinted Maternal 
B4GALNT4 FLJ25045  11p15.5  Predicted Maternal 
BLCAP BC10  20q11.2-
q12 AS  
Imprinted Isoform 
Dependent 
BMP8B OP2, BMP8, 
MGC131757  
1p35-p32 AS  Predicted Paternal 
BRP44L CGI-129, 
dJ68L15.3  
6q27 AS  Predicted Paternal 
BRUNOL4 CELF4, BRUNOL-
4  
18q12 AS  Predicted Maternal 
BTNL2 SS2, BTL-II, 
HSBLMHC1  
6p21.3 AS  Predicted Maternal 
C10orf91 bA432J24.4, RP11-
432J24.4  
10q26.3  Predicted Maternal 
C10orf93 bB137A17.3, RP13-
137A17.3  
10q26.3 AS  Predicted Maternal 
C16orf57 HVSL1, FLJ13154  16q21  Predicted Maternal 












20p12.1  Predicted Paternal 




9q34.3 AS  Predicted Paternal 
C9orf85 MGC61599, RP11-
346E17.2  
9q21.13  Predicted Paternal 
CCDC85A KIAA1912  2p16.1  Predicted Paternal 




p15.1 AS  
Predicted Paternal 
CDK4 CMM3, PSK-J3, 
MGC14458  
12q14 AS  Predicted Maternal 
CDKN1C BWS, WBS, p57, 
BWCR, KIP2  
11p15.5 AS  Imprinted Maternal 
CHMP2A BC2, BC-2, VPS2, 
CHMP2, VPS2A  
19q AS  Predicted Maternal 
CHST8 GalNAc4ST, 
GALNAC4ST1  
19q13.1  Predicted Maternal 
COL9A3 IDD, MED, EDM3, 
FLJ90759, 
DJ885L7.4.1  
20q13.3  Predicted Maternal 




7q32  Imprinted Paternal 




5q31.1  Predicted Maternal 
CYP1B1 CP1B, GLC3A, 
P4501B1  
2p21 AS  Predicted Paternal 




22q11.21  Imprinted Random 
DGCR6L 
 
22q11.21 AS  Imprinted Random 
DIRAS3 ARHI, NOEY2  1p31 AS  Imprinted Paternal 
DLGAP2 DAP2, SAPAP2  8p23  Imprinted Paternal 
DLK1 DLK, FA1, ZOG, 
pG2, PREF1, Pref-
1  
14q32  Imprinted Paternal 
DLX5 
 
7q22 AS  Imprinted Maternal 
 
112 
DNMT1 AIM, DNMT, 
MCMT, CXXC9, 
HSN1E, ADCADN  
19p13.2 AS  Imprinted Paternal 
DVL1 DVL, MGC54245  1p36 AS  Predicted Maternal 





9q34.3  Predicted Paternal 
EVX1 
 
7p15-p14  Predicted Paternal 
FAM50B X5L, D6S2654E  6p25.2  Imprinted Paternal 
FAM59A GAREM, Gm944, 
C18orf11  
18q12.1 AS  Predicted Paternal 
FAM70B MGC20579, RP11-
199F6.1  
13q34  Predicted Maternal 
FASTK FAST  7q35 AS  Predicted Maternal 
FBRSL1 KIAA1545  12q24.33  Predicted Maternal 







14q22.1 AS  Predicted Paternal 
FGFRL1 FHFR, FGFR5  4p16  Predicted Maternal 




13q21.1  Predicted Maternal 
FLJ46321 FLJ46321  9q21.32  Predicted Maternal 










FOXG1C, HBF-G2  
14q13  Predicted Paternal 
FUCA1 FUCA  1p34 AS  Predicted Paternal 
 
113 
GATA3 HDR, MGC2346, 
MGC5199, 
MGC5445  
10p15  Predicted Paternal 
GDAP1L1 dJ881L22.1, 
dJ995J12.1.1  
20q12  Imprinted Paternal 
GFI1 GFI-1, ZNF163, 
FLJ94509  
1p22 AS  Predicted Paternal 
GLI3 PHS, ACLS, GCPS, 
PAPA, PAPB, PAP-
A, PAPA1, PPDIV  
7p13 AS  Predicted Maternal 
GLIS3 ZNF515  9p24.2 AS  Imprinted Paternal 
GNAS AHO, GSA, GSP, 






20q13.3  Imprinted Isoform 
Dependent 
GNASAS SANG, NESPAS, 
GNAS1AS, 
NCRNA00075  
20q13.32 AS  Imprinted Paternal 
GPR1 
 
2q33.3 AS  Imprinted Paternal 
GPT AAT1, ALT1, 
GPT1  
8q24.3  Predicted Maternal 




p11.2 AS  
Imprinted Isoform 
Dependent 




11p15.5 AS  Imprinted Maternal 
HES1 HHL, HRY, HES-1, 
bHLHb39, 
FLJ20408  
3q28-q29  Predicted Paternal 
HIST3H2BB 
 
1q42.13  Predicted Maternal 
HOXA11 HOX1, HOX1I  7p15-p14 AS  Predicted Maternal 
HOXA2 HOX1K  7p15-p14 AS  Predicted Maternal 
HOXA3 HOX1, HOX1E, 
MGC10155  
7p15-p14 AS  Predicted Maternal 
HOXA4 HOX1, HOX1D  7p15-p14 AS  Predicted Maternal 
HOXA5 HOX1, HOX1C, 
HOX1.3, 
MGC9376  
7p15-p14 AS  Predicted Maternal 
 
114 
HOXB2 K8, HOX2, 
HOX2H, Hox-2.8  
17q21-q22 AS  Predicted Maternal 
HOXB3 HOX2, HOX2G, 
Hox-2.7  
17q21.3 AS  Predicted Maternal 
HOXC4 HOX3, cp19, 
HOX3E  
12q13.3  Predicted Maternal 
HOXC9 HOX3, HOX3B  12q13.3  Predicted Maternal 
HSPA6 
 
1q23  Predicted Maternal 
HYMAI NCRNA00020  6q24.2 AS  Imprinted Paternal 
IFITM1 9-27, CD225, IFI17, 
LEU13  
11p15.5  Predicted Maternal 




11p15.5 AS  Imprinted Paternal 
IGF2AS PEG8, 
MGC168198  
11p15.5  Imprinted Paternal 







10q26.11  Imprinted Paternal 
INS ILPR, IRDN  11p15.5 AS  Imprinted Paternal 
IRAIN IGF1R-AS  15q26.3 AS  Imprinted Paternal 




20p12.1  Predicted Paternal 
KBTBD3 BKLHD3, 
FLJ30685  
11q22.3 AS  Predicted Paternal 




8q24.3 AS  Imprinted Maternal 







11p15.5  Imprinted Maternal 
KCNQ1DN BWRT, 
HSA404617  
11p15.4  Imprinted Maternal 
 
115 




transcript 1  
11p15  Imprinted Paternal 
KIAA1530 MGC117169  4p16.3  Predicted Maternal 
KIAA1545 KIAA1545  12q24.33  Predicted Maternal 







20q13.12  Imprinted Paternal 
LDB1 NLI, CLIM2  10q24-q25 AS  Predicted Maternal 
LILRB4 HM18, ILT3, LIR5, 
CD85K, LIR-5, 
LILRB5  
19q13.4  Predicted Maternal 
LIN28B CSDD2  6q21  Imprinted Paternal 
LMX1B NPS1, LMX1.2, 
MGC138325, 
MGC142051  
9q34  Predicted Maternal 
LOC100131170 LOC100131170  17q25.3 AS  Predicted Paternal 
LRRTM1 
 
2p12 AS  Imprinted Paternal 
LY6D E48  8q24-qter AS  Predicted Paternal 
MAGEL2 nM15, NDNL1  15q11-q12 AS  Imprinted Paternal 




7q21 AS  Imprinted Maternal 
MCTS2 
 
20q11.21  Imprinted Paternal 





14q32  Imprinted Maternal 
MEG8 Rian  14q32.31  Imprinted Maternal 
MEST PEG1, MGC8703, 
MGC111102, 
DKFZp686L18234  





7q32.2 AS  Imprinted Paternal 
 
116 
MIMT1 MIM1, LINC00067, 
NCRNA00067  
19q13.4  Imprinted Paternal 
MIR296 MIRN296, 
miRNA296  
20q13.32 AS  Imprinted Paternal 
MIR298 MIRN298, hsa-mir-
298  
20q13.32 AS  Imprinted Paternal 
MIR371A C19MC, MIR371, 
MIRN371, hsa-mir-
371, hsa-mir-371a  
19q13.42  Imprinted Paternal 
MKRN3 D15S9, RNF63, 
ZFP127, ZNF127, 
MGC88288  




6q14.2  Predicted Paternal 
MYEOV2 
 
2q37.3 AS  Predicted Paternal 
MZF1 MZF-1, MZF1B, 
ZNF42, Zfp98, 
ZSCAN6  
19q13.4 AS  Predicted Maternal 
NAA60 HAT4, NAT15  16p13.3  Imprinted Maternal 
NAP1L5 DRLM  4q22.1 AS  Imprinted Paternal 
NDN HsT16328  15q11.2-
q12 AS  
Imprinted Paternal 
NDUFA4P1 NDUFA4  1p13.3  Predicted Paternal 
NKAIN3 FAM77D, 
FLJ39630  
8q12.3  Predicted Paternal 
NKX6-2 GTX, NKX6B, 
NKX6.2, 
MGC126684  
10q26 AS  Predicted Maternal 
NLRP2 NBS1, PAN1, 
NALP2, PYPAF2, 
CLR19.9  
19q13.42  Imprinted Maternal 
NNAT Peg5  20q11.2-q12  Imprinted Paternal 
NPAP1 C15orf2  15q11-q13  Imprinted Unknown 
NTM HNT, NTRI, 
IGLON2  
11q25  Imprinted Maternal 














1q44 AS  Predicted Paternal 
OSBPL5 ORP5, OBPH1, 
FLJ42929  
11p15.4 AS  Imprinted Maternal 
OTX1 FLJ38361, 
MGC15736  
2p13  Predicted Maternal 
PAOX PAO, MGC45464, 
DKFZp434J245  
10q26.3  Predicted Maternal 
PEG10 EDR, HB-1, Mar2, 
MEF3L, Mart2, 
RGAG3  
7q21  Imprinted Paternal 
PEG13 
 
8q24.22  Imprinted Paternal 
PEG3 PW1, ZNF904, 
ZSCAN24  
19q13.4 AS  Imprinted Paternal 
PEX10 NALD, RNF69, 
MGC1998  
1p36.32 AS  Predicted Maternal 
PHLDA2 IPL, BRW1C, 
BWR1C, HLDA2, 
TSSC3  
11p15.5 AS  Imprinted Maternal 





9q34.3  Predicted Maternal 
PKP3 
 
11p15  Predicted Maternal 




6q24-q25 AS  Imprinted Paternal 
PPAP2C LPP2, PAP-2c, 
PAP2-g  
19p13 AS  Predicted Maternal 




7q21.3  Imprinted Maternal 
PRDM16 MEL1, PFM13, 
KIAA1675, 
MGC166915  
1p36.23-p33  Predicted Paternal 
PSIMCT-1 
 
20q11.2  Imprinted Paternal 
PTPN14 PEZ, PTP36, 
MGC126803  
1q32.2 AS  Predicted Maternal 
PURG PURG-A, PURG-B, 
MGC119274  
8p11 AS  Predicted Paternal 
PWCR1 PET1, non-coding 
RNA in the Prader-
Willi critical region  





17q11  Predicted Paternal 
RAB1B 
 
11q12  Predicted Maternal 
RB1 RB, pRb, OSRC, 
pp110, p105-Rb  
13q14.2  Imprinted Maternal 
RBP5 CRBP3, CRBPIII, 
CRBP-III  
12p13.31 AS  Imprinted Maternal 
RNU5D-1 U5DL, U5DS, 
RNU5D  
1p34.1 AS  Imprinted Paternal 
RPL22 EAP, HBP15, 
HBP15/L22  
1p36.3-
p36.2 AS  
Predicted Paternal 
RTL1 MART1, PEG11, 
LOC388015  
14q32.31 AS  Imprinted Paternal 
SALL1 TBS, HSAL1, 
ZNF794  
16q12.1 AS  Predicted Maternal 
SANG SANG, Nespas  20q13.32  Imprinted Paternal 
SGCE ESG, DYT11  7q21-q22 AS  Imprinted Paternal 
SGK2 H-SGK2, 
dJ138B7.2  
20q13.2  Imprinted Paternal 
SIM2 SIM, bHLHe15, 
MGC119447  
21q22.2  Predicted Paternal 







11p15.5  Imprinted Maternal 
SLC22A2* OCT2, MGC32628  6q26 AS  Imprinted Maternal 
SLC22A3* EMT, EMTH, 
OCT3  
6q26-q27  Imprinted Maternal 
SLC26A10 
 
12q13  Predicted Maternal 
SLC4A2 AE2, HKB3, 
BND3L, NBND3, 
EPB3L1  
7q35-q36  Predicted Maternal 
SNORD107 HBII-436, HBII-
436 C/D box 
snoRNA  
15q11.2  Imprinted Paternal 
SNORD108 HBII-437, HBII-
437 C/D box 
snoRNA  
15q11.2  Imprinted Paternal 
SNORD109A HBII-438A  15q11.2  Imprinted Paternal 
SNORD109B HBII-438B, HBII-
438B C/D box 
snoRNA  
15q11.2  Imprinted Paternal 
 
119 
SNORD115@ HBII-52  15q11.2  Imprinted Paternal 
SNORD115-48 HBII-52-48  15q11.2  Imprinted Paternal 
SNORD116@ PET1, PWCR1, 
HBII-85  
15q11.2  Imprinted Paternal 
SNORD64 HBII-13, HBII-13 
snoRNA  
15q12  Imprinted Paternal 












15q11.2  Imprinted Paternal 
SNURF 
 
15q12  Imprinted Paternal 
SOX8 MGC24837  16p13.3  Predicted Paternal 
SPON2 DIL1, DIL-1, 
Mindin, M-spondin  
4p16.3 AS  Predicted Paternal 
TCEB3C HsT829, TCEB3L2, 
Elongin A3  
18q21.1 AS  Imprinted Maternal 
TFPI2 PP5, REF1, TFPI-2, 
FLJ21164  
7q22 AS  Imprinted Maternal 
TIGD1 EEYORE  2q37.1 AS  Predicted Paternal 
TMEM52 
 
1p36.33 AS  Predicted Paternal 
TMEM60 DC32, C7orf35, 
MGC74482  
7q11.23 AS  Predicted Paternal 
TMEM88 FLJ20025, 
MGC71744  
17p13.1  Predicted Maternal 
TNDM DMTN, TNDM1  6  Imprinted 
 
TP53 P53, BCC7, LFS1, 
TRP53  
17p13.1 AS  Imprinted 
 
TP73 P73  1p36.3  Imprinted Maternal 
TSHZ3 TSH3, ZNF537, 
FLJ54422, 
KIAA1474  
19q12 AS  Predicted Paternal 




15q11-q13 AS  Imprinted Maternal 
VAX2 DRES93  2p13  Predicted Maternal 
 
120 




10q26.3  Predicted Maternal 
VTRNA2-1 CBL3, CBL-3, hvg-





5q31.1 AS  Imprinted Paternal 
WDR8 FLJ20430, 
MGC99569  
1p36.3 AS  Predicted Maternal 




11p13 AS  Imprinted Paternal 
WT1-AS WIT1, WIT-1, 
WT1AS, WT1-AS1  
11p13  Imprinted Paternal 
ZC3H12C MCPIP3  11q22.3  Imprinted Paternal 
ZDBF2 
 
2q33.3  Imprinted Paternal 
ZFAT AITD3, ZFAT1, 
ZNF406  




8q24.22  Imprinted Paternal 




p21 AS  
Predicted Maternal 
ZIC1 ZIC, ZNF201  3q24  Predicted Maternal 
ZIM2 ZNF656  19q13.4 AS  Imprinted Paternal 
ZNF225 MGC119735  19q13.2  Predicted Paternal 
ZNF229 FLJ34222  19q13.31 AS  Predicted Maternal 
ZNF597 
 





APPENDIX 3: ILLUMINA EPIC MANIFEST PROBE IDS AND ASSOCIATED 
GENOMIC INFORMATION COMPRISING THE CURRATED IMPRINTED GENE 
DATASET 




CPG ISLAND RELATION 
TO CPG 
ISLAND 
ABCC9 cg01909678 NM_020297 Body 
  
 
cg16361596 NM_005691 TSS200 
  
ABCG8 cg13486675 NM_022437 TSS200 
  
 
cg25029903 NM_022437 3'UTR 
  
ADAMTS16 cg00127167 NM_139056 TSS1500 chr5:5139441-5140941 Island 
 
cg03209854 NM_139056 TSS1500 chr5:5139441-5140941 Island 
 
cg07370650 NM_139056 Body 
  
 
cg08164500 NM_139056 Body 
  
 
cg08641951 NM_139056 Body 
  
 
cg12858370 NM_139056 Body 
  
 
cg14521614 NM_139056 Body 
  
 
cg15131616 NM_139056 Body 
  
 
cg18825212 NM_139056 Body 
  
 
cg19094166 NM_139056 Body 
  
 
cg22562853 NM_139056 Body 
  
 
cg23434203 NM_139056 Body 
  
 
cg26868514 NM_139056 Body 
  
 
cg26908818 NM_139056 Body 
  
AIM1 cg23962536 NM_001624 Body 
  
 
cg25263140 NM_001624 TSS200 chr6:106959764-106960985 N_Shore 
ALDH1L1 cg02569236 NM_012190 TSS1500 chr3:125898662-125899568 S_Shore 
 
cg07330230 NM_012190 TSS1500 chr3:125898662-125899568 S_Shore 
 
cg11952434 NR_072979 Body 
  
 
cg16312163 NM_012190 5'UTR chr3:125898662-125899568 Island 
 
cg16975831 NR_072979 Body 
  
 
cg20988073 NM_012190 TSS1500 chr3:125898662-125899568 S_Shore 
 
cg25308173 NM_001270365 TSS1500 chr3:125898662-125899568 S_Shore 
ANO1 cg00260235 NM_018043 Body chr11:69933919-69934209 N_Shelf 
 
cg00837444 NM_018043 Body 
  
 
cg02179492 NM_018043 Body 
  
 
cg02371301 NM_018043 Body chr11:70023057-70023304 Island 
 
cg02513946 NM_018043 Body 
  
 
cg06393558 NM_018043 Body 
  
 
cg07204975 NM_018043 Body 
  
 
cg07642499 NM_018043 Body 
  
 
cg07776163 NM_018043 TSS200 chr11:69924338-69925197 N_Shore 
 
cg09538651 NM_018043 Body chr11:70001753-70001988 Island 
 
cg10370850 NM_018043 Body chr11:70023057-70023304 S_Shelf 
 
cg10759809 NM_018043 Body chr11:70001753-70001988 S_Shore 
 
cg15269503 NM_018043 TSS200 chr11:69924338-69925197 Island 
 
cg15632675 NM_018043 Body chr11:69933919-69934209 Island 
 




cg16763508 NM_018043 Body 
  
 
cg23696210 NM_018043 Body chr11:69924338-69925197 S_Shelf 
 
cg24276624 NM_018043 Body 
  
 
cg24832721 NM_018043 Body chr11:70023057-70023304 Island 
 
cg26382029 NM_018043 3'UTR 
  
 
cg26507725 NM_018043 Body 
  
 
cg27347247 NM_018043 Body 
  
APBA1 cg02763189 NM_001163 3'UTR 
  
 
cg06752313 NM_001163 ExonBnd 
  
 
cg06847149 NM_001163 Body 
  
 
cg11169227 NM_001163 3'UTR 
  
 
cg13580827 NM_001163 Body 
  
 
cg23074224 NM_001163 5'UTR chr9:72286804-72288081 N_Shore 
 
cg25353069 NM_001163 5'UTR 
  
ATP10A cg00288824 NM_024490 TSS1500 chr15:26107503-26108818 Island 
 
cg00291006 NM_024490 Body 
  
 
cg01364202 NM_024490 Body 
  
 
cg03307893 NM_024490 TSS1500 chr15:26107503-26108818 Island 
 
cg03419058 NM_024490 TSS200 chr15:26107503-26108818 Island 
 
cg06509153 NM_024490 Body 
  
 
cg08867031 NM_024490 Body 
  
 
cg09984339 NM_024490 TSS1500 chr15:26107503-26108818 Island 
 
cg10341806 NM_024490 Body 
  
 
cg12582965 NM_024490 Body 
  
 
cg13417268 NM_024490 TSS1500 chr15:26107503-26108818 Island 
 
cg15523238 NM_024490 TSS1500 chr15:26107503-26108818 Island 
 
cg16243571 NM_024490 Body chr15:25981176-25981392 S_Shore 
 
cg16389285 NM_024490 TSS200 chr15:26107503-26108818 Island 
 
cg16514981 NM_024490 Body 
  
 
cg17354368 NM_024490 Body chr15:25981176-25981392 N_Shore 
 
cg18083248 NM_024490 TSS1500 chr15:26107503-26108818 S_Shore 
 
cg19326876 NM_024490 Body chr15:26107503-26108818 Island 
 
cg19657603 NM_024490 Body 
  
 
cg20124450 NM_024490 TSS200 chr15:26107503-26108818 Island 
 
cg20457261 NM_024490 Body chr15:25981176-25981392 S_Shore 
 
cg22113930 NM_024490 TSS200 chr15:26107503-26108818 Island 
 
cg22797991 NM_024490 TSS1500 chr15:26107503-26108818 Island 
 
cg23438437 NM_024490 Body chr15:25981176-25981392 S_Shelf 
 
cg23652959 NM_024490 Body chr15:25958877-25959240 N_Shore 
 
cg25846723 NM_024490 TSS1500 chr15:26107503-26108818 S_Shore 
 
cg26230285 NM_024490 TSS200 chr15:26107503-26108818 Island 
 
ch.15.89498F NM_024490 Body chr15:25981176-25981392 N_Shore 
B4GALNT4 cg10321339 NM_178537 1stExon 
  
 
cg10798664 NM_178537 TSS1500 
  
 
cg10828456 NM_178537 TSS1500 
  
 
cg12811157 NM_178537 TSS1500 
  
 
cg16004226 NM_178537 1stExon 
  
 
cg18113332 NM_178537 TSS1500 
  
 




cg19787465 NM_178537 TSS1500 
  
 
cg21606329 NM_178537 TSS1500 
  
 
cg25020933 NM_178537 TSS1500 
  
BLCAP cg01082601 NM_001167820 TSS1500 chr20:36156022-36156669 S_Shore 
 
cg04810287 NM_001167821 5'UTR chr20:36148603-36150136 Island 
 
cg07199827 NM_001167821 5'UTR chr20:36156022-36156669 Island 
 
cg11399589 NM_001167823 Body chr20:36148603-36150136 N_Shore 
 
cg12152206 NM_006698 1stExon chr20:36156022-36156669 Island 
 
cg12862537 NM_001167821 5'UTR chr20:36148603-36150136 Island 
 
cg13668823 NM_001167821 5'UTR chr20:36148603-36150136 S_Shore 
 
cg13790727 NM_001167821 5'UTR chr20:36148603-36150136 Island 
 
cg17271585 NM_001167821 5'UTR chr20:36156022-36156669 N_Shelf 
 
cg17705814 NM_001167823 5'UTR chr20:36148603-36150136 Island 
 
cg17971649 NM_001167821 5'UTR chr20:36150920-36151240 S_Shore 
 
cg19782411 NM_001167821 5'UTR chr20:36148603-36150136 N_Shore 
 
cg20479660 NM_001167821 5'UTR chr20:36148603-36150136 Island 
 
cg20703564 NM_001167820 TSS1500 chr20:36156022-36156669 S_Shore 
 
cg21588305 NM_001167821 5'UTR chr20:36148603-36150136 Island 
 
cg21863334 NM_001167820 TSS1500 chr20:36156022-36156669 S_Shore 
 
cg22582721 NM_001167821 5'UTR chr20:36148603-36150136 S_Shore 
 
cg23605670 NM_001167821 5'UTR chr20:36148603-36150136 Island 
 
cg23757721 NM_001167821 5'UTR chr20:36148603-36150136 Island 
 
cg24564503 NM_001167821 5'UTR chr20:36148603-36150136 N_Shore 
 
cg24675557 NM_001167821 5'UTR chr20:36148603-36150136 Island 
 
cg25962605 NM_001167821 5'UTR chr20:36148603-36150136 Island 
BMP8B cg03401114 NM_001720 TSS1500 chr1:40253683-40255172 S_Shore 
 
cg06616202 NM_001720 TSS1500 chr1:40253683-40255172 S_Shore 
 
cg11201606 NM_001720 TSS200 chr1:40253683-40255172 Island 
 
cg13501185 NM_001720 Body chr1:40235767-40237190 N_Shelf 
 
cg18108008 NM_001720 5'UTR chr1:40253683-40255172 Island 
BRP44L cg08583435 NM_016098 TSS1500 chr6:166795368-166797301 Island 
 
cg08849330 NM_016098 TSS1500 chr6:166795368-166797301 Island 
 
cg09735773 NM_016098 TSS1500 chr6:166795368-166797301 Island 
 
cg14375779 NM_016098 TSS1500 chr6:166795368-166797301 Island 
 
cg16434372 NM_016098 TSS1500 chr6:166795368-166797301 S_Shore 
 
cg16866653 NM_016098 TSS1500 chr6:166795368-166797301 Island 
 
cg18578343 NM_016098 TSS1500 chr6:166795368-166797301 Island 
 
cg20176875 NM_016098 TSS1500 chr6:166795368-166797301 Island 
 
cg23587717 NM_016098 TSS1500 chr6:166795368-166797301 Island 
 
cg24554059 NM_016098 TSS1500 chr6:166795368-166797301 Island 
BRUNOL4 cg05729577 NM_001025089 3'UTR chr18:34823798-34824017 S_Shore 
 
cg06248560 NM_001025088 Body chr18:35104533-35104942 Island 
 
cg06547959 NM_001025088 Body chr18:34973989-34974464 Island 
 
cg07374808 NM_001025088 Body chr18:34973989-34974464 Island 
 
cg10407177 NM_001025088 Body chr18:34916712-34916915 Island 
 
cg11154070 NM_001025087 1stExon chr18:35144907-35147628 Island 
 
cg11950360 NM_001025088 Body chr18:34833554-34834606 S_Shore 
 
cg12161122 NM_001025088 TSS200 chr18:35144907-35147628 Island 
 




cg13382322 NM_001025089 TSS1500 chr18:35144907-35147628 Island 
 
cg13511195 NM_001025088 Body chr18:35104533-35104942 N_Shore 
 
cg14423557 NM_001025088 TSS200 chr18:35144907-35147628 Island 
 
cg14631706 NM_001025088 Body chr18:35104533-35104942 Island 
 
cg16345171 NM_001025088 Body chr18:35065039-35065548 S_Shore 
 
cg17227156 NM_001025088 TSS200 chr18:35144907-35147628 Island 
 
cg17319486 NM_001025089 TSS1500 chr18:35144907-35147628 Island 
 
cg17973164 NM_001025089 TSS1500 chr18:35144907-35147628 Island 
 
cg18161374 NM_001025088 TSS200 chr18:35144907-35147628 Island 
 
cg19237294 NM_001025088 Body chr18:35065039-35065548 Island 
 
cg21484749 NM_001025088 TSS200 chr18:35144907-35147628 Island 
 
cg22666828 NM_001025088 Body chr18:34833554-34834606 Island 
 
cg24507502 NM_001025089 3'UTR chr18:34823798-34824017 S_Shelf 
 
cg24860812 NM_001025088 Body chr18:35144907-35147628 N_Shelf 
 
cg25216403 NM_001025089 TSS1500 chr18:35144907-35147628 Island 
 
cg25842602 NM_001025088 TSS200 chr18:35144907-35147628 Island 
BTNL2 cg06871764 NM_019602 TSS1500 
  
 
cg09514561 NM_019602 Body 
  
 
cg26657086 NM_019602 Body 
  
C10ORF91 cg12978253 NM_173541 TSS200 
  
 
cg22045288 NM_173541 TSS1500 
  
C10ORF93 cg01757745 NM_173572 Body chr10:134755663-134756852 N_Shore 
 
cg07371029 NM_173572 Body chr10:134740801-134741033 S_Shore 
 
cg23563927 NM_173572 Body chr10:134755663-134756852 Island 
 
cg26450740 NM_173572 TSS200 chr10:134755663-134756852 Island 
C16ORF57 cg01719220 NM_024598 TSS200 chr16:58033947-58035548 Island 
 
cg03278960 NM_024598 TSS200 chr16:58033947-58035548 Island 
 
cg06649282 NM_024598 3'UTR chr16:58058712-58058928 N_Shelf 
C20ORF20 cg06060853 NM_018270 TSS1500 chr20:61426696-61427099 Island 
C9ORF85 cg11635143 NM_182505 TSS1500 chr9:74525249-74526679 Island 
 
cg13747066 NM_182505 TSS1500 chr9:74525249-74526679 N_Shore 
 
cg14490763 NM_182505 Body 
  
 
cg18627568 NM_182505 TSS1500 chr9:74525249-74526679 Island 
CCDC85A cg20338300 NM_001080433 1stExon chr2:56410865-56412539 Island 
CDH18 cg00606396 NM_001167667 Body 
  
 
cg01115010 NM_004934 Body 
  
 
cg01561389 NM_001291956 TSS1500 
  
 
cg02662003 NM_001167667 5'UTR 
  
 
cg05883445 NM_001291956 TSS1500 
  
 
cg06076122 NM_004934 1stExon 
  
 
cg06700166 NM_004934 3'UTR 
  
 
cg06756125 NM_001291956 5'UTR 
  
 
cg08954776 NM_001167667 5'UTR 
  
 
cg13319364 NM_001291956 5'UTR 
  
 
cg15050865 NM_001167667 5'UTR 
  
 
cg21496319 NM_004934 TSS1500 
  
 
cg25250374 NM_001291956 5'UTR chr5:20305562-20305936 Island 
CDK4 cg03829839 NM_000075 TSS1500 chr12:58145853-58146360 S_Shore 
 




cg09096528 NM_000075 TSS200 chr12:58145853-58146360 Island 
 
cg13521951 NM_000075 TSS200 chr12:58145853-58146360 Island 
 
cg15857731 NM_000075 TSS200 chr12:58145853-58146360 Island 
 
cg16716518 NM_000075 5'UTR chr12:58145853-58146360 Island 
 
cg16807911 NM_000075 5'UTR chr12:58145853-58146360 Island 
 
cg22870189 NM_000075 Body chr12:58145853-58146360 N_Shore 
 
cg27479817 NM_000075 TSS200 chr12:58145853-58146360 Island 
CDKN1C cg00374747 NM_000076 TSS1500 chr11:2905023-2907024 S_Shore 
 
cg01730944 NM_000076 TSS200 chr11:2907308-2907675 N_Shore 
 
cg02953912 NM_001122630 3'UTR chr11:2905023-2907024 N_Shore 
 
cg04402633 NM_000076 TSS200 chr11:2907308-2907675 N_Shore 
 
cg04548378 NM_001122630 Body chr11:2905023-2907024 Island 
 
cg05383783 NM_000076 TSS1500 chr11:2905023-2907024 S_Shore 
 
cg06662685 NM_000076 TSS200 chr11:2907308-2907675 N_Shore 
 
cg08206623 NM_000076 TSS1500 chr11:2907308-2907675 Island 
 
cg11944284 NM_001122630 3'UTR chr11:2905023-2907024 N_Shore 
 
cg17434043 NM_000076 TSS200 chr11:2907308-2907675 N_Shore 
 
cg17738133 NM_000076 TSS200 chr11:2907308-2907675 N_Shore 
 
cg20492951 NM_000076 TSS200 chr11:2907308-2907675 N_Shore 
 
cg22865058 NM_001122630 Body chr11:2905023-2907024 Island 
 
cg23225147 NM_000076 TSS1500 chr11:2905023-2907024 S_Shore 
 
cg23239078 NM_000076 TSS1500 chr11:2907308-2907675 Island 
 
cg23419490 NM_001122630 3'UTR chr11:2905023-2907024 N_Shore 
 
cg23904595 NM_000076 TSS1500 chr11:2905023-2907024 S_Shore 
 
cg25215340 NM_000076 TSS200 chr11:2907308-2907675 N_Shore 
 
cg26718354 NM_000076 TSS200 chr11:2907308-2907675 N_Shore 
 
cg26932552 NM_000076 TSS200 chr11:2907308-2907675 N_Shore 
 
cg27002185 NM_000076 TSS200 chr11:2907308-2907675 N_Shore 
CHMP2A cg03552658 NM_198426 TSS1500 chr19:59066151-59066662 Island 
 
cg04247135 NM_198426 Body chr19:59066151-59066662 N_Shore 
 
cg12553198 NM_198426 1stExon chr19:59066151-59066662 Island 
 
cg14042128 NM_198426 1stExon chr19:59066151-59066662 Island 
CHST8 cg00521703 NM_001127895 TSS1500 chr19:34112279-34114353 N_Shore 
 
cg03125498 NM_001127895 TSS1500 chr19:34112279-34114353 N_Shore 
 
cg08989375 NM_001127895 5'UTR 
  
 
cg12209275 NM_001127896 Body 
  
 
cg13393398 NM_001127895 5'UTR 
  
 
cg13816968 NM_001127896 Body 
  
 
cg13954131 NM_001127895 5'UTR chr19:34175344-34175768 N_Shore 
 
cg15688551 NM_001127895 5'UTR chr19:34175344-34175768 N_Shore 
 
cg16190732 NM_001127895 1stExon chr19:34112279-34114353 Island 
 
cg16609432 NM_001127895 3'UTR chr19:34262943-34263906 S_Shore 
 
cg17171722 NM_001127895 5'UTR chr19:34112279-34114353 S_Shore 
 
cg19257089 NM_001127895 3'UTR chr19:34262943-34263906 S_Shore 
 
cg19594305 NM_001127895 1stExon chr19:34112279-34114353 Island 
 
cg20148881 NM_001127895 TSS1500 chr19:34112279-34114353 N_Shore 
 
cg20439889 NM_022467 5'UTR chr19:34175344-34175768 Island 
COL9A3 cg06497752 NM_001853 Body chr20:61447685-61448891 Island 
 




cg13900920 NM_001853 TSS1500 chr20:61447685-61448891 Island 
 
cg15457981 NM_001853 TSS1500 chr20:61447685-61448891 N_Shore 
 
cg15505615 NM_001853 TSS1500 chr20:61447685-61448891 N_Shore 
 
cg20331689 NM_001853 TSS1500 chr20:61447685-61448891 Island 
 
cg22564949 NM_001853 Body chr20:61456339-61456565 Island 
 
cg27564579 NM_001853 Body chr20:61456339-61456565 Island 
CPA4 cg19690404 NM_016352 Body 
  
CSF2 cg20704330 NM_000758 3'UTR 
  
CYP1B1 cg01410359 NM_000104 Body chr2:38301276-38304518 Island 
 
cg01936270 NM_000104 TSS1500 chr2:38301276-38304518 Island 
 
cg02162897 NM_000104 Body chr2:38301276-38304518 N_Shore 
 
cg07057636 NM_000104 TSS200 chr2:38301276-38304518 Island 
 
cg08761102 NM_000104 TSS1500 chr2:38301276-38304518 Island 
 
cg14957547 NM_000104 TSS200 chr2:38301276-38304518 Island 
 
cg16060486 NM_000104 TSS200 chr2:38301276-38304518 Island 
 
cg16439198 NM_000104 5'UTR chr2:38301276-38304518 Island 
 
cg21715189 NM_000104 TSS1500 chr2:38301276-38304518 S_Shore 
 
cg22488859 NM_000104 TSS1500 chr2:38301276-38304518 Island 
 
cg23151000 NM_000104 5'UTR chr2:38301276-38304518 Island 
 
cg26036993 NM_000104 TSS1500 chr2:38301276-38304518 Island 
 
cg26144569 NM_000104 TSS1500 chr2:38301276-38304518 S_Shore 
DDC cg03721064 NM_000790 Body chr7:50535740-50535953 Island 
 
cg08241694 NM_001082971 TSS1500 
  
 
cg10335743 NM_001082971 TSS1500 
  
 
cg12715421 NM_001082971 5'UTR 
  
 
cg12908660 NM_000790 Body chr7:50535740-50535953 S_Shore 
 
cg15001032 NM_001082971 5'UTR 
  
 
cg16846532 NM_001082971 TSS1500 
  
 
cg23532924 NM_001082971 TSS1500 
  
 
cg26932364 NM_000790 Body 
  
 
cg27528351 NM_001082971 5'UTR 
  
DGCR6 cg01305127 NM_005675 TSS1500 chr22:18893251-18894291 Island 
 
cg02986806 NM_005675 TSS1500 chr22:18893251-18894291 Island 
 
cg05658793 NM_005675 TSS1500 chr22:18893251-18894291 Island 
 
cg11430719 NM_005675 TSS200 chr22:18893251-18894291 Island 
 
cg19262968 NM_005675 TSS1500 chr22:18893251-18894291 Island 
 
cg20975546 NM_005675 TSS200 chr22:18893251-18894291 Island 
 
cg22300727 NM_005675 TSS200 chr22:18893251-18894291 Island 
DGCR6L cg08688798 NM_033257 TSS1500 chr22:20307109-20308026 Island 
DIRAS3 cg03641225 NM_004675 Body chr1:68512643-68513005 N_Shore 
 
cg05949203 NM_004675 1stExon chr1:68516236-68516473 Island 
 
cg20808078 NM_004675 5'UTR chr1:68516236-68516473 N_Shore 
 
cg21808053 NM_004675 5'UTR chr1:68512643-68513005 S_Shore 
DLGAP2 cg00598912 NM_004745 5'UTR 
  
 
cg00777402 NM_004745 5'UTR 
  
 
cg04058153 NM_004745 5'UTR chr8:1496731-1497884 N_Shore 
 
cg07346177 NM_004745 Body chr8:1579038-1579241 S_Shore 
 
cg08038402 NM_004745 5'UTR chr8:1496731-1497884 N_Shore 
 





cg22763586 NM_004745 3'UTR chr8:1649439-1649759 S_Shore 
 
cg27043838 NM_004745 Body chr8:1509850-1511735 N_Shore 
DLK1 cg01242498 NM_003836 Body chr14:101200617-101200929 Island 
 
cg07445547 NM_003836 TSS200 chr14:101192851-101193499 Island 
 
cg17412258 NM_003836 TSS1500 chr14:101192851-101193499 Island 
 
cg18121862 NM_003836 Body chr14:101192851-101193499 S_Shore 
 
cg21575295 NM_003836 1stExon chr14:101192851-101193499 Island 
DLX5 cg01448276 NM_005221 TSS1500 chr7:96653467-96654199 S_Shore 
 
cg02101486 NM_005221 Body chr7:96651963-96652246 Island 
 
cg10243939 NM_005221 TSS1500 chr7:96653467-96654199 S_Shore 
 
cg11500797 NM_005221 Body chr7:96651963-96652246 Island 
 
cg11891395 NM_005221 Body chr7:96651963-96652246 Island 
 
cg13286614 NM_005221 TSS1500 chr7:96653467-96654199 S_Shore 
 
cg15732768 NM_005221 Body chr7:96650221-96651551 Island 
 
cg16876790 NM_005221 TSS1500 chr7:96653467-96654199 S_Shore 
 
cg19962750 NM_005221 TSS1500 chr7:96653467-96654199 S_Shore 
 
cg20377305 NM_005221 Body chr7:96650221-96651551 Island 
 
cg27016494 NM_005221 Body chr7:96651963-96652246 N_Shore 
DNMT1 cg04522489 NM_001130823 Body 
  
 
cg06128182 NM_001130823 TSS200 chr19:10304966-10305864 Island 
 
cg07627628 NM_001130823 Body chr19:10252705-10252917 S_Shore 
 
cg09692733 NM_001130823 ExonBnd chr19:10252705-10252917 N_Shelf 
 
cg11030227 NM_001130823 TSS1500 chr19:10304966-10305864 S_Shore 
 
cg16732626 NM_001379 TSS1500 chr19:10304966-10305864 S_Shore 
 
cg16926196 NM_001130823 TSS1500 chr19:10304966-10305864 S_Shore 
 
cg21892967 NM_001379 TSS1500 chr19:10304966-10305864 S_Shore 
 
cg22950435 NM_001130823 Body 
  
 
cg24477899 NM_001130823 TSS200 chr19:10304966-10305864 Island 
 
cg25919075 NM_001130823 Body 
  
DVL1 cg05115545 NM_004421 TSS1500 chr1:1283933-1285345 Island 
 
cg07313814 NM_004421 Body chr1:1272377-1272634 Island 
E2F7 cg18120578 NM_203394 TSS200 chr12:77458947-77459942 Island 
 
cg24594830 NM_203394 5'UTR chr12:77458947-77459942 Island 
 
cg26276877 NM_203394 TSS200 chr12:77458947-77459942 Island 
 
cg26687049 NM_203394 TSS200 chr12:77458947-77459942 Island 
EGFL7 cg05936059 NM_201446 5'UTR chr9:139559804-139561005 Island 
 
cg08529852 NM_201446 5'UTR chr9:139559804-139561005 N_Shore 
 
cg14353956 NM_201446 5'UTR chr9:139559804-139561005 Island 
 
cg15667409 NM_201446 TSS200 chr9:139559804-139561005 Island 
EVX1 cg01790002 NM_001989 Body chr7:27283408-27283614 Island 
 
cg02194223 NM_001989 Body chr7:27284639-27286237 Island 
 
cg20801476 NM_001989 TSS1500 chr7:27282086-27283136 N_Shore 
FAM50B cg01905633 NM_012135 TSS1500 chr6:3849271-3851048 Island 
 
cg04447621 NM_012135 TSS200 chr6:3849271-3851048 Island 
 
cg05811173 NM_012135 Body chr6:3849271-3851048 Island 
 
cg12840312 NM_012135 TSS1500 chr6:3849271-3851048 Island 
 
cg14275511 NM_012135 Body chr6:3849271-3851048 Island 
 
cg14414415 NM_012135 TSS1500 chr6:3849271-3851048 N_Shore 
 




cg18197332 NM_012135 TSS200 chr6:3849271-3851048 Island 
FAM59A cg00232952 NM_022751 Body chr18:30050115-30051345 N_Shelf 
 
cg00576121 NM_022751 TSS1500 chr18:30050115-30051345 Island 
 
cg05503968 NM_022751 TSS1500 chr18:30050115-30051345 Island 
 
cg13559259 NM_022751 1stExon chr18:30050115-30051345 Island 
 
cg16458671 NM_022751 TSS1500 chr18:30050115-30051345 Island 
 
cg16596493 NM_022751 TSS1500 chr18:30050115-30051345 Island 
 
cg17880256 NM_022751 TSS1500 chr18:30050115-30051345 Island 
 
cg18515624 NM_022751 Body chr18:30050115-30051345 N_Shore 
 
cg26427436 NM_022751 TSS1500 chr18:30050115-30051345 Island 
FASTK cg03930004 NM_033015 TSS1500 chr7:150777607-150780879 Island 
 
cg06807926 NM_006712 3'UTR chr7:150777607-150780879 N_Shelf 
 
cg09369688 NM_006712 Body chr7:150777607-150780879 N_Shore 
 
cg12633680 NM_033015 TSS1500 chr7:150777607-150780879 Island 
 
cg15922246 NM_033015 TSS1500 chr7:150777607-150780879 Island 
 
cg18443486 NM_033015 Body chr7:150777607-150780879 N_Shelf 
FBRSL1 cg00370303 NM_001142641 TSS1500 chr12:133065843-133066393 Island 
 
cg00638090 NM_001142641 TSS1500 chr12:133067072-133067735 N_Shore 
 
cg01845583 NM_001142641 TSS1500 chr12:133067072-133067735 N_Shore 
 
cg05617413 NM_001142641 TSS1500 chr12:133065843-133066393 Island 
 
cg05767299 NM_001142641 Body chr12:133102168-133102604 N_Shore 
 
cg06004166 NM_001142641 Body chr12:133102168-133102604 N_Shore 
 
cg06791426 NM_001142641 Body chr12:133135293-133135722 Island 
 
cg06874943 NM_001142641 Body chr12:133067072-133067735 Island 
 
cg07688604 NM_001142641 TSS1500 chr12:133065843-133066393 Island 
 
cg08082792 NM_001142641 Body chr12:133146517-133148261 Island 
 
cg08163785 NM_001142641 1stExon chr12:133067072-133067735 Island 
 
cg08818195 NM_001142641 TSS1500 chr12:133067072-133067735 N_Shore 
 
cg09125882 NM_001142641 TSS1500 chr12:133067072-133067735 N_Shore 
 
cg09676630 NM_001142641 Body chr12:133102168-133102604 N_Shore 
 
cg10304922 NM_001142641 TSS1500 chr12:133065843-133066393 Island 
 
cg11709225 NM_001142641 TSS1500 chr12:133067072-133067735 N_Shore 
 
cg12967384 NM_001142641 Body chr12:133102168-133102604 Island 
 
cg14034782 NM_001142641 Body chr12:133125659-133126011 N_Shelf 
 
cg15282907 NM_001142641 TSS1500 chr12:133067072-133067735 N_Shore 
 
cg16088107 NM_001142641 TSS1500 chr12:133067072-133067735 N_Shore 
 
cg16435185 NM_001142641 Body chr12:133146517-133148261 Island 
 
cg17152423 NM_001142641 TSS1500 chr12:133065843-133066393 N_Shore 
 
cg18450555 NM_001142641 TSS1500 chr12:133065843-133066393 Island 
 
cg19183325 NM_001142641 TSS1500 chr12:133067072-133067735 N_Shore 
 
cg19510970 NM_001142641 TSS1500 chr12:133067072-133067735 N_Shore 
 
cg19595750 NM_001142641 TSS1500 chr12:133065843-133066393 Island 
 
cg19705626 NM_001142641 TSS1500 chr12:133067072-133067735 N_Shore 
 
cg20214067 NM_001142641 TSS1500 chr12:133065843-133066393 N_Shore 
 
cg20664313 NM_001142641 Body chr12:133073397-133073632 N_Shelf 
 
cg20750930 NM_001142641 Body chr12:133159225-133160576 Island 
 
cg23097155 NM_001142641 TSS1500 chr12:133065843-133066393 Island 
 
cg23890800 NM_001142641 TSS1500 chr12:133065843-133066393 Island 
 




cg24800655 NM_001142641 TSS1500 chr12:133065843-133066393 Island 
 
cg25350087 NM_001142641 TSS1500 chr12:133067072-133067735 N_Shore 
 
cg25694349 NM_001142641 TSS1500 chr12:133065843-133066393 Island 
 
cg26860182 NM_001142641 TSS1500 chr12:133065843-133066393 Island 
FERMT2 cg00871698 NM_001134999 TSS200 chr14:53417108-53418339 Island 
 
cg02955219 NM_001134999 TSS1500 chr14:53417108-53418339 Island 
 
cg10334927 NM_001134999 TSS1500 chr14:53417108-53418339 Island 
 
cg15952990 NM_006832 Body 
  
 
cg17460095 NM_001134999 TSS1500 chr14:53417108-53418339 Island 
 
cg23760656 NM_001134999 Body 
  
 
cg24658874 NM_001134999 Body 
  
 
cg25108743 NM_001134999 TSS1500 chr14:53417108-53418339 Island 
FGFRL1 cg01443390 NM_001004358 Body chr4:1017524-1018938 Island 
 
cg01947949 NM_001004358 TSS1500 chr4:1003106-1005455 Island 
 
cg02827336 NM_001004358 TSS1500 chr4:1003106-1005455 Island 
 
cg02891664 NM_001004358 TSS1500 chr4:1003106-1005455 Island 
 
cg06748078 NM_001004358 TSS1500 chr4:1003106-1005455 Island 
 
cg07106881 NM_001004358 TSS1500 chr4:1003106-1005455 Island 
 
cg07809452 NM_001004358 TSS1500 chr4:1003106-1005455 Island 
 
cg10221240 NM_001004358 TSS1500 chr4:1003106-1005455 Island 
 
cg16660345 NM_001004358 TSS1500 chr4:1003106-1005455 Island 
 
cg17814457 NM_001004358 TSS1500 chr4:1003106-1005455 Island 
 
cg21039597 NM_001004358 TSS1500 chr4:1003106-1005455 Island 
 
cg25932599 NM_001004358 TSS1500 chr4:1003106-1005455 Island 
FOXG1 cg05872306 NM_005249 1stExon chr14:29236835-29237832 N_Shore 
 
cg07150445 NM_005249 TSS1500 chr14:29234889-29235908 Island 
 
cg07974473 NM_005249 TSS1500 chr14:29234889-29235908 Island 
 
cg10300684 NM_005249 1stExon chr14:29236835-29237832 N_Shore 
 
cg10828337 NM_005249 1stExon chr14:29236835-29237832 N_Shore 
 
cg10912240 NM_005249 TSS1500 chr14:29234889-29235908 Island 
 
cg12150366 NM_005249 1stExon chr14:29236835-29237832 S_Shore 
 
cg16582779 NM_005249 1stExon chr14:29236835-29237832 Island 
 
cg16804284 NM_005249 1stExon chr14:29236835-29237832 Island 
 
cg17525102 NM_005249 TSS200 chr14:29236835-29237832 N_Shore 
 
cg18299578 NM_005249 TSS1500 chr14:29236835-29237832 N_Shore 
 
cg19714132 NM_005249 TSS1500 chr14:29236835-29237832 N_Shore 
 
cg19786627 NM_005249 TSS1500 chr14:29234889-29235908 Island 
 
cg21923619 NM_005249 TSS1500 chr14:29234889-29235908 Island 
 
cg23191956 NM_005249 TSS1500 chr14:29234889-29235908 Island 
 
cg26206396 NM_005249 TSS1500 chr14:29234889-29235908 Island 
FUCA1 cg10051214 NM_000147 TSS200 chr1:24194254-24194990 S_Shore 
 
cg15692032 NM_000147 TSS1500 chr1:24194254-24194990 S_Shore 
 
cg17085844 NM_000147 3'UTR 
  
 
cg19367136 NM_000147 TSS1500 chr1:24194254-24194990 S_Shore 
 
cg20382810 NM_000147 Body 
  
 
cg20694461 NM_000147 1stExon chr1:24194254-24194990 Island 
GATA3 cg01255894 NM_001002295 Body chr10:8100384-8100768 N_Shore 
 
cg04213746 NM_001002295 Body 
  
 




cg22892607 NM_001002295 Body chr10:8100384-8100768 S_Shore 
GDAP1L1 cg04448487 NM_024034 TSS200 chr20:42875764-42876184 Island 
 
cg07003360 NM_024034 TSS200 chr20:42875764-42876184 N_Shore 
 
cg07503286 NM_024034 TSS1500 chr20:42875764-42876184 N_Shore 
 
cg09994356 NM_024034 TSS200 chr20:42875764-42876184 Island 
 
cg12689285 NM_024034 TSS200 chr20:42875764-42876184 Island 
 
cg13688260 NR_046353 Body 
  
 
cg21432128 NM_001256738 5'UTR 
  
 
cg25799864 NM_024034 TSS200 chr20:42875764-42876184 N_Shore 
GFI1 cg00791905 NM_001127216 5'UTR chr1:92945907-92952609 Island 
 
cg06338710 NM_001127215 Body chr1:92945907-92952609 Island 
 
cg07011357 NM_001127216 5'UTR chr1:92945907-92952609 Island 
 
cg07805029 NM_005263 TSS1500 chr1:92945907-92952609 S_Shore 
 
cg09662411 NM_001127215 Body chr1:92945907-92952609 Island 
 
cg09674502 NM_005263 TSS1500 chr1:92945907-92952609 S_Shore 
 
cg10832495 NM_001127216 TSS1500 chr1:92945907-92952609 Island 
 
cg11412935 NM_001127216 5'UTR chr1:92945907-92952609 Island 
 
cg11785652 NM_001127216 5'UTR chr1:92945907-92952609 Island 
 
cg14475915 NM_001127216 TSS1500 chr1:92945907-92952609 Island 
 
cg16372625 NM_001127216 5'UTR chr1:92945907-92952609 Island 
 
cg16707062 NM_001127216 5'UTR chr1:92945907-92952609 Island 
 
cg20244474 NM_001127216 5'UTR chr1:92945907-92952609 Island 
 
cg22488998 NM_001127216 TSS200 chr1:92945907-92952609 Island 
 
cg23624705 NM_001127216 TSS1500 chr1:92945907-92952609 S_Shore 
 
cg24683414 NM_001127216 TSS1500 chr1:92945907-92952609 Island 
 
cg25232660 NM_001127216 TSS1500 chr1:92945907-92952609 Island 
 
cg25402655 NM_005263 5'UTR chr1:92945907-92952609 Island 
GLI3 cg02901002 NM_000168 3'UTR chr7:42005067-42006121 N_Shelf 
 
cg04131524 NM_000168 5'UTR chr7:42276003-42277850 N_Shore 
 
cg04682916 NM_000168 TSS1500 chr7:42276003-42277850 Island 
 
cg05541910 NM_000168 Body 
  
 
cg05774127 NM_000168 5'UTR chr7:42267546-42267823 N_Shore 
 
cg07104748 NM_000168 TSS1500 chr7:42276003-42277850 Island 
 
cg07124417 NM_000168 Body 
  
 
cg07413609 NM_000168 TSS200 chr7:42276003-42277850 Island 
 
cg09008589 NM_000168 Body 
  
 
cg10573198 NM_000168 Body 
  
 
cg11364256 NM_000168 Body chr7:42005067-42006121 Island 
 
cg11878113 NM_000168 Body 
  
 
cg14176234 NM_000168 Body 
  
 
cg18723978 NM_000168 TSS200 chr7:42276003-42277850 Island 
 
cg18749153 NM_000168 TSS200 chr7:42276003-42277850 Island 
 
cg18872946 NM_000168 Body 
  
 
cg19935531 NM_000168 Body chr7:42005067-42006121 S_Shelf 
 
cg23367392 NM_000168 5'UTR chr7:42267546-42267823 N_Shore 
GLIS3 cg00123225 NM_152629 Body 
  
 
cg08303922 NM_001042413 5'UTR chr9:4297817-4300182 Island 
 
cg09384111 NM_001042413 1stExon chr9:4297817-4300182 Island 
 





cg10836809 NM_001042413 TSS200 chr9:4297817-4300182 S_Shore 
 
cg13749266 NM_001042413 Body 
  
 
cg13802457 NM_001042413 5'UTR chr9:4297817-4300182 Island 
 
cg14066405 NM_152629 Body 
  
 
cg14325112 NM_152629 Body chr9:4117825-4118594 N_Shelf 
 
cg18988395 NM_152629 TSS1500 
  
 
cg20025028 NM_001042413 5'UTR chr9:4297817-4300182 Island 
 
cg21344081 NM_001042413 5'UTR chr9:4297817-4300182 Island 
 
cg21736378 NM_152629 5'UTR 
  
 
cg22329888 NM_001042413 5'UTR chr9:4297817-4300182 N_Shore 
GNAS cg00267746 NM_001077490 3'UTR chr20:57463652-57467739 Island 
 
cg01538522 NM_001077490 3'UTR chr20:57463652-57467739 Island 
 
cg01817393 NM_080425 TSS1500 chr20:57427691-57427995 N_Shore 
 
cg02890368 NM_080425 TSS1500 chr20:57427691-57427995 N_Shore 
 
cg03264550 NM_001077490 3'UTR chr20:57463652-57467739 Island 
 
cg03821543 NM_001077490 3'UTR chr20:57463652-57467739 Island 
 
cg04019914 NM_001077490 3'UTR chr20:57463652-57467739 N_Shore 
 
cg04779428 NM_001077490 3'UTR chr20:57463652-57467739 N_Shore 
 
cg05926269 NM_001077490 3'UTR chr20:57463652-57467739 Island 
 
cg05960039 NM_001077490 3'UTR chr20:57463652-57467739 Island 
 
cg06047881 NM_001077490 3'UTR chr20:57463652-57467739 Island 
 
cg07284407 NM_080425 1stExon chr20:57429024-57431239 Island 
 
cg07909402 NM_001077490 3'UTR chr20:57463652-57467739 Island 
 
cg09049861 NM_001309840 5'UTR chr20:57463652-57467739 S_Shore 
 
cg09604333 NM_001077490 3'UTR chr20:57463652-57467739 Island 
 
cg09885502 NM_001077490 3'UTR chr20:57463652-57467739 Island 
 
cg10468484 NM_001077490 3'UTR chr20:57429024-57431239 S_Shore 
 
cg10748817 NM_001077490 3'UTR chr20:57463652-57467739 Island 
 
cg11244758 NM_001077490 3'UTR chr20:57463652-57467739 Island 
 
cg13510487 NM_016592 3'UTR 
  
 
cg17414107 NM_080425 TSS1500 chr20:57427691-57427995 Island 
 
cg17986444 NM_016592 TSS200 chr20:57414595-57414896 Island 
 
cg18997188 NM_001077490 3'UTR chr20:57463652-57467739 N_Shore 
 
cg19116006 NM_001077490 3'UTR chr20:57463652-57467739 Island 
 
cg20018057 NM_001077490 3'UTR chr20:57463652-57467739 Island 
 
cg20213508 NM_001077490 3'UTR chr20:57463652-57467739 N_Shore 
 
cg21625881 NM_080425 1stExon chr20:57429024-57431239 Island 
 
cg21938532 NM_080425 TSS1500 chr20:57426729-57427047 Island 
 
cg22659862 NM_016592 3'UTR 
  
 
cg22741626 NM_001077490 3'UTR chr20:57463652-57467739 N_Shore 
 
cg22798925 NM_001077490 3'UTR chr20:57463652-57467739 Island 
 
cg22860367 NM_080425 TSS1500 chr20:57426729-57427047 N_Shore 
 
cg25983380 NM_001077490 3'UTR chr20:57463652-57467739 Island 
 
cg26356502 NM_016592 3'UTR 
  
 
cg26506795 NM_001309840 5'UTR chr20:57463652-57467739 Island 
GNASAS cg01355739 NR_002785 Body chr20:57415135-57417153 Island 
 
cg03613625 NR_002785 Body 
  
 
cg10459054 NR_002785 Body chr20:57414595-57414896 N_Shore 
 




cg12054318 NR_002785 Body chr20:57414595-57414896 N_Shore 
 
cg14597908 NR_002785 Body chr20:57415135-57417153 N_Shore 
 
cg21330323 NR_002785 Body chr20:57414595-57414896 Island 
 
cg21779904 NR_002785 Body chr20:57426729-57427047 N_Shore 
 
cg24975842 NR_002785 Body chr20:57415135-57417153 Island 
 
cg25268451 NR_002785 Body chr20:57414595-57414896 N_Shore 
GPR1 cg09929262 NM_001261455 TSS1500 
  
 
cg11130826 NM_001098199 TSS1500 
  
GPT cg13858580 NM_005309 Body chr8:145730390-145732205 Island 
 
cg17465115 NM_005309 Body chr8:145730390-145732205 Island 
 
cg24811740 NM_005309 5'UTR chr8:145730390-145732205 N_Shore 
GRB10 cg00110519 NM_001001555 5'UTR 
  
 
cg01610059 NM_001001550 Body 
  
 
cg04223026 NM_001001549 Body 
  
 
cg06120688 NM_001001555 5'UTR 
  
 
cg10516089 NM_001001555 5'UTR 
  
 
cg12288551 NM_001001555 5'UTR 
  
 
cg16826856 NM_001001555 5'UTR 
  
 
cg19499709 NM_001001549 3'UTR 
  
 
cg19740223 NM_001001555 5'UTR 
  
 
cg21408624 NM_001001555 5'UTR 
  
 
cg23023285 NM_001001555 5'UTR chr7:50849752-50850871 Island 
 
cg23776146 NM_001001555 5'UTR chr7:50861390-50861638 N_Shore 
 
cg24183958 NM_001001555 5'UTR chr7:50861390-50861638 N_Shore 
 
cg24302095 NM_001001555 5'UTR chr7:50861390-50861638 N_Shore 
 
cg25472458 NM_001001555 5'UTR 
  
 
cg25829805 NM_001001549 Body 
  
 
cg26812147 NM_001001555 5'UTR 
  
 
ch.7.1171004F NM_001001550 Body 
  
 
ch.7.1172609R NM_001001550 Body 
  
H19 cg00237904 NR_002196 TSS1500 chr11:2019565-2019863 S_Shore 
 
cg01895612 NR_002196 TSS1500 chr11:2019565-2019863 S_Shore 
 
cg06658831 NR_131224 TSS200 chr11:2019565-2019863 S_Shelf 
 
cg23476401 NR_002196 TSS1500 chr11:2019565-2019863 S_Shore 
 
cg25821896 NR_002196 TSS1500 chr11:2019565-2019863 S_Shore 
 
cg25852472 NR_002196 Body chr11:2017459-2018253 Island 
 
cg26857192 NR_002196 Body chr11:2017459-2018253 Island 
HES1 cg07747635 NM_005524 TSS200 chr3:193854575-193856015 N_Shore 
 
cg07846755 NM_005524 TSS1500 chr3:193852241-193852717 Island 
 
cg10702309 NM_005524 TSS1500 chr3:193854575-193856015 N_Shore 
 
cg12961656 NM_005524 TSS1500 chr3:193854575-193856015 N_Shore 
 
cg13065537 NM_005524 TSS200 chr3:193854575-193856015 N_Shore 
 
cg14475875 NM_005524 3'UTR chr3:193854575-193856015 S_Shore 
 
cg19959647 NM_005524 TSS1500 chr3:193854575-193856015 N_Shore 
 
cg21428647 NM_005524 TSS1500 chr3:193852241-193852717 Island 
HIST3H2BB cg03449175 NM_175055 TSS1500 chr1:228645196-228646434 N_Shore 
 
cg08639523 NM_175055 TSS1500 chr1:228645196-228646434 N_Shore 
HOXA11 cg03744566 NM_005523 Body chr7:27225050-27225629 N_Shore 
 




cg21447117 NM_005523 TSS200 chr7:27225050-27225629 N_Shore 
HOXA2 cg00445443 NM_006735 TSS1500 chr7:27143181-27143479 Island 
 
cg03763508 NM_006735 Body chr7:27143181-27143479 N_Shelf 
 
cg04737131 NM_006735 TSS1500 chr7:27143181-27143479 N_Shore 
 
cg05921905 NM_006735 TSS200 chr7:27143181-27143479 N_Shore 
 
cg06769202 NM_006735 TSS200 chr7:27143181-27143479 N_Shore 
 
cg06786372 NM_006735 Body chr7:27143181-27143479 N_Shore 
 
cg13985518 NM_006735 TSS1500 chr7:27143181-27143479 S_Shore 
 
cg20087093 NM_006735 TSS1500 chr7:27143181-27143479 N_Shore 
 
cg20747380 NM_006735 1stExon chr7:27143181-27143479 N_Shore 
 
cg21464565 NM_006735 Body chr7:27143181-27143479 N_Shelf 
 
cg22943986 NM_006735 TSS1500 chr7:27143181-27143479 N_Shore 
 
cg26069745 NM_006735 1stExon chr7:27143181-27143479 N_Shore 
HOXA3 cg00318947 NM_153631 5'UTR chr7:27154999-27155426 N_Shore 
 
cg00921266 NM_153631 5'UTR chr7:27154999-27155426 N_Shore 
 
cg01027532 NM_153631 5'UTR chr7:27154999-27155426 S_Shore 
 
cg01820751 NM_153631 5'UTR chr7:27163819-27164098 N_Shore 
 
cg02627455 NM_153631 5'UTR chr7:27154999-27155426 S_Shelf 
 
cg03650946 NM_153631 5'UTR chr7:27154999-27155426 N_Shore 
 
cg04778178 NM_153631 5'UTR chr7:27162087-27162426 Island 
 
cg05109569 NM_153631 3'UTR chr7:27146069-27146600 Island 
 
cg07917150 NM_153631 5'UTR chr7:27154999-27155426 N_Shore 
 
cg07942135 NM_153631 5'UTR chr7:27154999-27155426 N_Shore 
 
cg09144964 NM_153631 5'UTR chr7:27150030-27150418 Island 
 
cg10794257 NM_153631 5'UTR chr7:27154999-27155426 N_Shore 
 
cg14072564 NM_153631 5'UTR chr7:27162087-27162426 Island 
 
cg14216068 NM_153631 3'UTR chr7:27146069-27146600 Island 
 
cg15725372 NM_153631 5'UTR chr7:27162087-27162426 Island 
 
cg15982700 NM_153631 5'UTR chr7:27154999-27155426 N_Shore 
 
cg16406967 NM_153631 5'UTR chr7:27154999-27155426 Island 
 
cg16644023 NM_153631 5'UTR chr7:27154999-27155426 N_Shore 
 
cg16748008 NM_153631 5'UTR chr7:27154999-27155426 Island 
 
cg18680977 NM_153631 5'UTR chr7:27154999-27155426 Island 
 
cg22772747 NM_153631 5'UTR chr7:27162087-27162426 S_Shore 
 
cg22798849 NM_153631 5'UTR chr7:27154999-27155426 Island 
 
cg24360871 NM_153631 5'UTR chr7:27163819-27164098 Island 
 
cg24361385 NM_153631 5'UTR chr7:27163819-27164098 S_Shore 
 
cg26297005 NM_153631 5'UTR chr7:27162087-27162426 Island 
HOXA4 cg02022102 NM_002141 3'UTR chr7:27169572-27170638 N_Shore 
 
cg11227540 NM_002141 Body chr7:27169572-27170638 N_Shore 
 
cg14359292 NM_002141 TSS1500 chr7:27169572-27170638 S_Shore 
 
cg17591595 NM_002141 TSS1500 chr7:27169572-27170638 S_Shore 
 
cg20161965 NM_002141 TSS1500 chr7:27169572-27170638 S_Shore 
 
cg22997113 NM_002141 1stExon chr7:27169572-27170638 Island 
 
cg24169822 NM_002141 TSS1500 chr7:27169572-27170638 S_Shore 
 
cg25952581 NM_002141 TSS1500 chr7:27169572-27170638 S_Shore 
HOXA5 cg00969405 NM_019102 TSS1500 chr7:27182613-27185562 Island 
 
cg01748892 NM_019102 TSS1500 chr7:27182613-27185562 Island 
 




cg09207400 NM_019102 TSS200 chr7:27182613-27185562 Island 
 
cg09549073 NM_019102 5'UTR chr7:27182613-27185562 Island 
 
cg13694927 NM_019102 TSS1500 chr7:27182613-27185562 Island 
 
cg14882265 NM_019102 TSS1500 chr7:27182613-27185562 Island 
 
cg17432857 NM_019102 TSS1500 chr7:27182613-27185562 Island 
 
cg19759481 NM_019102 TSS200 chr7:27182613-27185562 Island 
HOXB2 cg03003334 NM_002145 Body chr17:46620367-46621373 S_Shore 
 
cg09313705 NM_002145 TSS200 chr17:46620367-46621373 S_Shore 
 
cg12121660 NM_002145 Body chr17:46620367-46621373 S_Shore 
 
cg12468273 NM_002145 Body chr17:46620367-46621373 Island 
 
cg17573933 NM_002145 TSS1500 chr17:46620367-46621373 S_Shelf 
 
cg22777724 NM_002145 TSS200 chr17:46620367-46621373 S_Shore 
 
cg22807449 NM_002145 TSS200 chr17:46620367-46621373 S_Shore 
 
cg26841048 NM_002145 TSS200 chr17:46620367-46621373 S_Shore 
HOXB3 cg01990102 NM_002146 5'UTR 
  
 
cg02458062 NM_002146 Body chr17:46629553-46629816 Island 
 
cg02836478 NM_002146 TSS1500 chr17:46654053-46654369 N_Shore 
 
cg03019986 NM_002146 Body chr17:46629553-46629816 N_Shore 
 
cg03260240 NM_002146 5'UTR chr17:46631800-46632212 S_Shore 
 
cg04021898 NM_002146 5'UTR chr17:46631800-46632212 S_Shore 
 
cg04117801 NM_002146 TSS200 chr17:46654053-46654369 N_Shelf 
 
cg04800503 NM_002146 5'UTR 
  
 
cg06186155 NM_002146 5'UTR 
  
 
cg06395298 NM_002146 5'UTR chr17:46654053-46654369 N_Shelf 
 
cg07850987 NM_002146 5'UTR chr17:46641534-46642110 S_Shelf 
 
cg12384483 NM_002146 5'UTR chr17:46629553-46629816 S_Shore 
 
cg13114095 NM_002146 TSS1500 chr17:46654053-46654369 N_Shore 
 
cg13280788 NM_002146 TSS1500 chr17:46654053-46654369 N_Shore 
 
cg15065049 NM_002146 Body chr17:46629553-46629816 N_Shore 
 
cg15255390 NM_002146 5'UTR chr17:46631800-46632212 Island 
 
cg16169513 NM_002146 5'UTR chr17:46631800-46632212 S_Shelf 
 
cg21399057 NM_002146 5'UTR chr17:46631800-46632212 Island 
 
cg21474786 NM_002146 5'UTR chr17:46631800-46632212 Island 
 
cg23014425 NM_002146 5'UTR 
  
 
cg23098235 NM_002146 5'UTR chr17:46631800-46632212 S_Shelf 
 
cg24095592 NM_002146 5'UTR chr17:46631800-46632212 S_Shore 
 
cg25618372 NM_002146 5'UTR 
  
HOXC4 cg00040312 NM_014620 5'UTR chr12:54424610-54425173 Island 
 
cg00187380 NM_014620 5'UTR chr12:54427025-54428709 Island 
 
cg00243574 NM_014620 5'UTR chr12:54411709-54412131 N_Shore 
 
cg00506343 NM_014620 5'UTR chr12:54423427-54423712 N_Shelf 
 
cg00567703 NM_014620 5'UTR chr12:54412990-54413346 Island 
 
cg00576279 NM_014620 5'UTR chr12:54427025-54428709 Island 
 
cg01524853 NM_153633 1stExon chr12:54447744-54448091 Island 
 
cg01683044 NM_014620 TSS200 chr12:54411709-54412131 N_Shore 
 
cg02491017 NM_014620 TSS1500 chr12:54411709-54412131 N_Shore 
 
cg03146625 NM_153633 Body chr12:54447744-54448091 S_Shore 
 
cg03416628 NM_014620 5'UTR chr12:54447744-54448091 N_Shore 
 




cg05982757 NM_014620 5'UTR chr12:54427025-54428709 Island 
 
cg05987823 NM_014620 5'UTR chr12:54427025-54428709 Island 
 
cg05992786 NM_014620 5'UTR chr12:54447744-54448091 N_Shore 
 
cg07266404 NM_014620 5'UTR chr12:54447744-54448091 N_Shore 
 
cg09481972 NM_014620 5'UTR chr12:54411709-54412131 N_Shore 
 
cg09720701 NM_014620 5'UTR chr12:54447744-54448091 N_Shore 
 
cg11585893 NM_014620 5'UTR chr12:54447744-54448091 N_Shore 
 
cg15244786 NM_014620 5'UTR chr12:54447744-54448091 N_Shore 
 
cg15611151 NM_014620 5'UTR chr12:54412990-54413346 N_Shore 
 
cg15648389 NM_153633 Body chr12:54447744-54448091 S_Shore 
 
cg15772924 NM_014620 5'UTR chr12:54411709-54412131 S_Shore 
 
cg15894722 NM_014620 5'UTR chr12:54447744-54448091 N_Shore 
 
cg17026220 NM_014620 TSS200 chr12:54411709-54412131 N_Shore 
 
cg17031478 NM_014620 5'UTR chr12:54427025-54428709 Island 
 
cg18040878 NM_014620 TSS1500 chr12:54408426-54408713 S_Shore 
 
cg19058685 NM_014620 5'UTR chr12:54440642-54441543 Island 
 
cg19164987 NM_014620 5'UTR chr12:54412990-54413346 Island 
 
cg19892287 NM_014620 5'UTR chr12:54412990-54413346 N_Shore 
 
cg20381985 NM_014620 5'UTR chr12:54411709-54412131 N_Shore 
 
cg21487207 NM_014620 TSS200 chr12:54411709-54412131 N_Shore 
 
cg21493516 NM_014620 5'UTR chr12:54445876-54446113 Island 
 
cg21582112 NM_014620 5'UTR chr12:54423427-54423712 N_Shelf 
 
cg22370252 NM_014620 5'UTR chr12:54447744-54448091 N_Shore 
 
cg22621272 NM_014620 TSS1500 chr12:54408426-54408713 S_Shore 
 
cg23047434 NM_014620 TSS200 chr12:54411709-54412131 N_Shore 
 
cg23618344 NM_014620 5'UTR chr12:54423427-54423712 Island 
 
cg26035702 NM_014620 5'UTR chr12:54411709-54412131 N_Shore 
 
cg26162108 NM_014620 TSS1500 chr12:54411709-54412131 N_Shore 
 
cg26472714 NM_014620 5'UTR chr12:54427025-54428709 S_Shelf 
 
cg27138204 NM_014620 5'UTR chr12:54445876-54446113 Island 
 
cg27665143 NM_014620 5'UTR chr12:54440642-54441543 N_Shore 
HOXC9 cg03215137 NM_006897 TSS200 chr12:54393374-54394648 Island 
 
cg06368141 NM_006897 TSS200 chr12:54393374-54394648 Island 
 
cg07634179 NM_006897 TSS1500 chr12:54393374-54394648 N_Shore 
 
cg09045007 NM_006897 TSS1500 chr12:54393374-54394648 N_Shore 
 
cg10587913 NM_006897 TSS1500 chr12:54393374-54394648 N_Shore 
 
cg13233407 NM_006897 TSS200 chr12:54393374-54394648 Island 
 
cg15819717 NM_006897 TSS1500 chr12:54393374-54394648 N_Shore 
 
cg23685155 NM_006897 Body chr12:54393374-54394648 S_Shore 
HYMAI cg07077459 NR_002768 Body chr6:144328916-144329847 Island 
 
cg17865602 NR_002768 Body chr6:144328916-144329847 N_Shore 
 
cg22378065 NR_002768 Body chr6:144328916-144329847 Island 
 
cg25350411 NR_002768 Body chr6:144328916-144329847 Island 
 
cg27216384 NR_002768 Body chr6:144328916-144329847 Island 
IFITM1 cg09026253 NM_003641 TSS1500 chr11:310728-311419 S_Shore 
 
cg21433170 NM_003641 TSS1500 chr11:310728-311419 S_Shore 
 
cg22963452 NM_003641 TSS1500 chr11:310728-311419 S_Shore 
 
cg27032101 NM_003641 TSS1500 chr11:310728-311419 S_Shore 
IGF2 cg00164727 NM_001127598 Body chr11:2158951-2162484 N_Shore 
 
136 
IGF2AS cg11005826 NR_028044 Body chr11:2165135-2165672 S_Shore 
 
cg12322132 NR_028044 Body chr11:2165135-2165672 Island 
 
cg16817891 NR_028044 Body chr11:2165135-2165672 S_Shore 
INPP5F cg02857557 NM_014937 Body chr10:121577529-121578385 S_Shore 
 
cg05643988 NM_014937 Body chr10:121577529-121578385 N_Shelf 
 
cg15922976 NM_014937 Body chr10:121485063-121485319 S_Shore 
 
cg17213342 NR_003251 TSS1500 chr10:121485063-121485319 Island 
 
cg17304954 NM_014937 Body 
  
 
cg20365618 NM_014937 Body chr10:121577529-121578385 Island 
 
cg20491103 NM_001243195 Body 
  
 
cg24618244 NM_014937 5'UTR chr10:121485063-121485319 S_Shore 
 
cg26003475 NM_014937 5'UTR chr10:121485063-121485319 S_Shore 
 
cg27613076 NR_003251 TSS1500 chr10:121485063-121485319 N_Shore 
ISM1 cg02885188 NM_080826 Body 
  
 
cg02962406 NM_080826 3'UTR chr20:13279711-13279947 S_Shore 
 
cg04920227 NM_080826 1stExon chr20:13200670-13202616 Island 
 
cg06355010 NM_080826 1stExon chr20:13200670-13202616 Island 
 
cg06567525 NM_080826 TSS1500 chr20:13200670-13202616 Island 
 
cg10378364 NM_080826 1stExon chr20:13200670-13202616 Island 
 
cg13735403 NM_080826 Body 
  
 
cg14269097 NM_080826 Body 
  
 
cg19118558 NM_080826 TSS1500 chr20:13200670-13202616 Island 
 
cg19727767 NM_080826 3'UTR chr20:13279711-13279947 S_Shore 
 
cg23504092 NM_080826 TSS1500 chr20:13200670-13202616 Island 
 
cg24256058 NM_080826 Body 
  
 
cg25384906 NM_080826 TSS1500 chr20:13200670-13202616 Island 
 
cg25787377 NM_080826 Body chr20:13279711-13279947 Island 
KBTBD3 cg04891917 NM_152433 5'UTR chr11:105948097-105948830 N_Shore 
 
cg09590193 NM_152433 5'UTR chr11:105948097-105948830 N_Shore 
 
cg16794596 NM_152433 TSS1500 chr11:105948097-105948830 Island 
 
cg23373072 NM_152433 5'UTR chr11:105948097-105948830 N_Shore 
 
cg24378945 NM_152433 5'UTR chr11:105948097-105948830 N_Shore 
 
cg26356242 NM_152433 3'UTR 
  
KCNK9 cg00111503 NM_016601 Body chr8:140631096-140631332 Island 
 
cg01532168 NM_016601 TSS1500 chr8:140714585-140718259 Island 
 
cg02505749 NM_016601 TSS1500 chr8:140714585-140718259 Island 
 
cg13969265 NM_016601 TSS1500 chr8:140714585-140718259 Island 
 
cg17834752 NM_016601 5'UTR chr8:140714585-140718259 Island 
 
cg18055853 NR_104210 Body 
  
 
cg18534312 NM_016601 Body 
  
 
cg21415530 NM_016601 TSS1500 chr8:140714585-140718259 Island 
 
cg21727779 NR_104210 Body 
  
 
cg25804018 NM_016601 TSS1500 chr8:140714585-140718259 Island 
KCNQ1 cg00266389 NM_000218 Body chr11:2871364-2871940 N_Shelf 
 
cg00283576 NM_000218 TSS1500 chr11:2465171-2465648 Island 
 
cg01616349 NM_000218 Body chr11:2596378-2596607 Island 
 
cg01867031 NM_000218 Body 
  
 
cg02258534 NM_000218 Body chr11:2555405-2555618 Island 
 





cg03155200 NM_000218 Body 
  
 
cg03197835 NM_000218 Body 
  
 
cg03435383 NM_000218 Body chr11:2596378-2596607 S_Shelf 
 
cg04180268 NM_000218 Body 
  
 
cg04759114 NM_000218 Body chr11:2828445-2828884 N_Shore 
 
cg04894537 NM_000218 Body 
  
 
cg04902871 NM_000218 TSS1500 chr11:2465171-2465648 N_Shore 
 
cg05760393 NM_000218 TSS200 chr11:2466247-2466818 N_Shore 
 
cg06533200 NM_000218 TSS200 chr11:2466247-2466818 N_Shore 
 
cg07003739 NM_000218 Body 
  
 
cg07040680 NM_000218 Body 
  
 
cg07072281 NM_000218 Body 
  
 
cg07618453 NM_000218 Body 
  
 
cg08066631 NM_000218 Body 
  
 
cg08419850 NM_000218 Body 
  
 
cg09076315 NM_000218 Body 
  
 
cg09315662 NM_000218 Body 
  
 
cg09927734 NM_000218 Body chr11:2554103-2554331 N_Shore 
 
cg11342234 NM_000218 Body 
  
 
cg11652182 NM_000218 Body 
  
 
cg12141659 NM_000218 Body 
  
 
cg13577072 NM_000218 Body 
  
 
cg13602520 NM_000218 Body 
  
 
cg15501942 NM_181798 TSS1500 
  
 
cg16379391 NM_000218 Body 
  
 
cg17229197 NM_000218 Body 
  
 
cg17667688 NM_000218 Body 
  
 
cg19779211 NM_000218 TSS1500 chr11:2465171-2465648 Island 
 
cg19923326 NM_000218 Body chr11:2828445-2828884 Island 
 
cg20402210 NM_000218 Body 
  
 
cg20533553 NM_000218 TSS1500 chr11:2465171-2465648 N_Shore 
 
cg21752270 NM_000218 Body chr11:2812415-2813396 S_Shore 
 
cg22047766 NM_000218 Body 
  
 
cg23494536 NM_000218 Body 
  
 
cg25513073 NM_181798 TSS1500 
  
 
cg26190483 NM_000218 Body 
  
 
cg26504274 NM_000218 Body 
  
 
cg26639864 NM_000218 Body 
  
KCNQ1DN cg01923099 NR_024627 TSS1500 chr11:2890388-2891337 N_Shore 
 
cg03947814 NR_024627 TSS1500 chr11:2890388-2891337 Island 
 
cg04876474 NR_024627 TSS1500 chr11:2890388-2891337 N_Shore 
 
cg07592963 NR_024627 TSS1500 chr11:2890388-2891337 Island 
 
cg08246619 NR_024627 TSS1500 chr11:2890388-2891337 Island 
 
cg08771706 NR_024627 TSS1500 chr11:2890388-2891337 Island 
 
cg09502866 NR_024627 TSS1500 chr11:2890388-2891337 Island 
 
cg09998591 NR_024627 Body chr11:2890388-2891337 S_Shore 
 
cg10503232 NR_024627 Body chr11:2890388-2891337 S_Shore 
 
cg12198813 NR_024627 TSS200 chr11:2890388-2891337 Island 
 




cg13885561 NR_024627 TSS1500 chr11:2890388-2891337 Island 
 
cg22675922 NR_024627 TSS1500 chr11:2890388-2891337 N_Shore 
 
cg23762359 NR_024627 TSS1500 chr11:2890388-2891337 N_Shore 
 
cg24780501 NR_024627 TSS1500 chr11:2890388-2891337 Island 
KCNQ1OT1 cg04762676 NR_002728 TSS1500 chr11:2720410-2722087 S_Shore 
 
cg08446215 NR_002728 TSS200 chr11:2720410-2722087 Island 
 
cg11272547 NR_002728 TSS1500 chr11:2720410-2722087 S_Shore 
 
cg15282543 NR_002728 Body 
  
 
cg16739686 NR_002728 TSS200 chr11:2720410-2722087 Island 
KIAA1530 cg05410587 NM_020894 Body 
  
 
cg18515449 NM_020894 TSS1500 chr4:1340107-1341471 N_Shore 
 
cg19296501 NM_020894 Body 
  
 
cg24269412 NM_020894 TSS1500 chr4:1340107-1341471 Island 
 
cg25726513 NM_020894 TSS1500 chr4:1340107-1341471 Island 
 
cg25919687 NM_020894 Body 
  
 
cg27240402 NM_020894 Body chr4:1364146-1364349 Island 
KLF14 cg02778245 NM_138693 TSS1500 chr7:130417912-130419378 S_Shore 
 
cg03914913 NM_138693 TSS1500 chr7:130417912-130419378 S_Shore 
 
cg04528819 NM_138693 1stExon chr7:130417912-130419378 Island 
 
cg06038655 NM_138693 TSS1500 chr7:130417912-130419378 S_Shore 
 
cg06533629 NM_138693 TSS1500 chr7:130417912-130419378 Island 
 
cg08719712 NM_138693 TSS1500 chr7:130417912-130419378 S_Shore 
 
cg09529138 NM_138693 TSS1500 chr7:130417912-130419378 S_Shore 
 
cg18645297 NM_138693 TSS1500 chr7:130417912-130419378 S_Shore 
L3MBTL cg01071811 NM_032107 5'UTR chr20:42143210-42143591 N_Shore 
 
cg09289335 NM_032107 Body chr20:42143210-42143591 S_Shore 
 
cg12699433 NM_032107 TSS200 chr20:42143210-42143591 N_Shore 
 
cg17091610 NM_032107 TSS1500 chr20:42143210-42143591 N_Shore 
 
cg22601123 NM_032107 TSS200 chr20:42143210-42143591 N_Shore 
LDB1 cg02696879 NM_001113407 TSS1500 chr10:103879633-103880628 S_Shore 
 
cg07130508 NM_001113407 Body 
  
 
cg08492205 NM_001113407 Body chr10:103879633-103880628 Island 
 
cg10096454 NM_001113407 TSS1500 chr10:103879633-103880628 S_Shore 
 
cg11964982 NM_003893 Body 
  
 
cg24429450 NM_001113407 TSS1500 chr10:103879633-103880628 S_Shore 
 
cg25170591 NM_001113407 TSS1500 chr10:103879633-103880628 S_Shore 
 
cg26412532 NM_001113407 TSS1500 chr10:103879633-103880628 S_Shore 
 
cg26913927 NM_001113407 5'UTR chr10:103879633-103880628 Island 
 
cg27579745 NM_003893 1stExon 
  
LILRB4 cg04680738 NM_006847 TSS1500 
  
 
cg16770759 NM_001278430 5'UTR 
  
LIN28B cg04171392 NM_001004317 TSS200 chr6:105400877-105401149 S_Shelf 
 
cg04560456 NM_001004317 1stExon chr6:105400877-105401149 S_Shelf 
 
cg15317722 NM_001004317 Body 
  
 
cg17728974 NM_001004317 TSS1500 chr6:105400877-105401149 S_Shelf 
LMX1B cg04996334 NM_002316 Body chr9:129372737-129378106 S_Shelf 
 
cg13466694 NM_002316 Body chr9:129372737-129378106 S_Shelf 
 
cg13653144 NM_002316 TSS1500 chr9:129372737-129378106 Island 
 




cg14204784 NM_002316 Body chr9:129386112-129389231 Island 
 
cg14246940 NM_002316 Body chr9:129433766-129433970 S_Shore 
 
cg14537362 NM_002316 TSS1500 chr9:129372737-129378106 Island 
 
cg18115406 NM_002316 TSS200 chr9:129372737-129378106 Island 
 
cg24382823 NM_002316 Body chr9:129386112-129389231 Island 
 
cg25291396 NM_002316 5'UTR chr9:129372737-129378106 Island 
 
cg26670792 NM_002316 TSS200 chr9:129372737-129378106 Island 
LRRTM1 cg01955779 NM_178839 TSS1500 chr2:80531367-80531719 S_Shore 
 
cg07640800 NM_178839 3'UTR chr2:80529677-80530846 N_Shore 
 
cg15478597 NM_178839 TSS1500 chr2:80531367-80531719 S_Shore 
 
cg21248007 NM_178839 TSS1500 chr2:80531367-80531719 S_Shore 
MAGEL2 cg01152488 NM_019066 TSS1500 
  
 
cg04014889 NM_019066 1stExon 
  
 
cg10073842 NM_019066 TSS1500 
  
 
cg18253764 NM_019066 TSS200 
  
 
cg19961998 NM_019066 TSS200 
  
 
cg20747630 NM_019066 1stExon 
  
 
cg21325760 NM_019066 1stExon 
  
 
cg22925508 NM_019066 TSS200 
  
 
cg25135755 NM_019066 TSS1500 
  
MAGI2 cg00110846 NM_012301 Body chr7:77669670-77670057 N_Shore 
 
cg01720235 NM_001301128 Body chr7:77649014-77649543 S_Shore 
 
cg01914455 NM_012301 Body chr7:77648451-77648668 S_Shore 
 
cg02363960 NM_012301 Body chr7:79081565-79081879 N_Shore 
 
cg04085585 NM_012301 3'UTR chr7:77648451-77648668 N_Shore 
 
cg04976780 NM_012301 Body chr7:77649014-77649543 Island 
 
cg05431839 NM_001301128 Body 
  
 
cg06450689 NM_001301128 Body 
  
 
cg06813732 NM_001301128 Body 
  
 
cg07074977 NM_001301128 Body 
  
 
cg11109374 NM_012301 Body chr7:79082174-79082427 Island 
 
cg13263512 NM_012301 Body chr7:77648451-77648668 S_Shelf 
 
cg14388864 NM_012301 Body 
  
 
cg14446066 NM_001301128 Body 
  
 
cg15999067 NM_012301 Body chr7:77669670-77670057 S_Shore 
 
cg16111259 NM_012301 Body 
  
 
cg16678001 NM_001301128 Body 
  
 
cg17596971 NM_001301128 Body 
  
 
cg18018828 NM_012301 Body chr7:79081565-79081879 Island 
 
cg18405299 NM_012301 Body 
  
 
cg18461347 NM_012301 Body 
  
 
cg18858249 NM_012301 3'UTR chr7:77648451-77648668 N_Shore 
 
cg19049305 NM_001301128 Body 
  
 
cg21121803 NM_001301128 Body 
  
 
cg21563078 NM_012301 Body chr7:79081565-79081879 N_Shore 
 
cg21721775 NM_001301128 Body 
  
 
cg21784917 NM_012301 TSS1500 chr7:79082174-79082427 S_Shore 
 
cg23406149 NM_001301128 Body 
  
 





cg26575140 NM_001301128 Body 
  
 
cg27281047 NM_001301128 Body 
  
 
ch.7.1714607F NM_012301 Body 
  
MEG3 cg02144518 NR_003531 Body 
  
 
cg02412314 NR_046473 Body chr14:101292863-101293101 S_Shelf 
 
cg03768174 NR_046473 Body chr14:101292043-101292709 S_Shelf 
 
cg04304932 NR_002766 TSS1500 chr14:101292043-101292709 Island 
 
cg05501535 NR_046473 Body chr14:101293427-101294433 S_Shelf 
 
cg07460524 NR_003531 Body 
  
 
cg09280976 NR_002766 TSS1500 chr14:101292043-101292709 N_Shore 
 
cg09285543 NR_003531 Body chr14:101293427-101294433 S_Shore 
 
cg09291977 NR_046473 Body chr14:101293427-101294433 Island 
 
cg10065153 NR_002766 TSS1500 chr14:101292043-101292709 N_Shore 
 
cg14121301 NR_003531 Body 
  
 
cg14123427 NR_003531 Body chr14:101293427-101294433 Island 
 
cg16872344 NR_046473 Body chr14:101293427-101294433 S_Shore 
 
cg16905008 NR_046473 Body 
  
 
cg17327651 NR_046473 Body chr14:101292863-101293101 S_Shelf 
 
cg17400327 NR_033360 Body 
  
 
cg19643803 NR_002766 TSS1500 chr14:101292043-101292709 N_Shore 
 
cg23482724 NR_033360 Body 
  
 
cg23870378 NR_002766 TSS1500 chr14:101292043-101292709 N_Shore 
 
cg25086685 NR_046473 Body chr14:101293427-101294433 S_Shore 
MEG8 cg05303297 NR_024149 TSS1500 
  
 
cg21316869 NR_024149 Body 
  
MEST cg03588221 NM_177524 5'UTR chr7:130130739-130133111 Island 
 
cg04344875 NM_002402 TSS1500 chr7:130130739-130133111 Island 
 
cg05556276 NM_177524 5'UTR chr7:130130739-130133111 Island 
 
cg07870293 NM_177524 5'UTR chr7:130130739-130133111 Island 
 
cg08077673 NM_177524 5'UTR chr7:130126017-130126801 Island 
 
cg09080913 NM_177524 5'UTR chr7:130130739-130133111 Island 
 
cg14428359 NM_177524 3'UTR 
  
 
cg16823958 NM_177524 5'UTR chr7:130130739-130133111 Island 
 
cg17079325 NM_002402 TSS1500 chr7:130130739-130133111 Island 
 
cg18622506 NM_177524 5'UTR chr7:130130739-130133111 S_Shore 
 
cg20050761 NM_177524 5'UTR chr7:130130739-130133111 Island 
 
cg20148994 NM_177524 TSS1500 chr7:130126017-130126801 N_Shore 
 
cg21667116 NM_002402 TSS1500 chr7:130130739-130133111 Island 
 
cg23156962 NM_002402 TSS1500 chr7:130130739-130133111 Island 
 
cg26708559 NM_002402 TSS1500 chr7:130130739-130133111 Island 
 
cg27338480 NM_177524 5'UTR chr7:130130739-130133111 Island 
MESTIT1 cg02501418 NR_004382 Body chr7:130130739-130133111 Island 
 
cg07224147 NR_004382 Body chr7:130130739-130133111 Island 
 
cg08229366 NR_004382 Body chr7:130130739-130133111 Island 
 
cg09003373 NR_004382 Body chr7:130130739-130133111 Island 
 
cg14584935 NR_004382 Body chr7:130130739-130133111 N_Shore 
 
cg17347253 NR_004382 Body chr7:130130739-130133111 N_Shore 
 
cg20826277 NR_004382 Body chr7:130130739-130133111 N_Shore 
 cg24941047 NR_004382 Body chr7:130130739-130133111 N_Shore 
 
141 
MIMT1 cg14849423 NR_024059 TSS1500 chr19:57351283-57351995 Island 
MIR886 cg18797653 NR_030583 TSS1500 chr5:135415069-135415307 S_Shore 
 
cg25340688 NR_030583 TSS200 chr5:135416204-135416475 Island 
MKRN3 cg07760796 NM_005664 1stExon 
  
MRAP2 cg15734911 NM_138409 TSS200 chr6:84743357-84743948 Island 
 
cg17575960 NM_138409 5'UTR chr6:84743357-84743948 Island 
 
ch.6.1710035F NM_138409 5'UTR 
  
MYEOV2 cg03444566 NM_138336 TSS1500 chr2:241075403-241075916 S_Shore 
 
cg07628769 NM_138336 TSS1500 chr2:241075403-241075916 S_Shore 
 
cg13749477 NM_138336 TSS1500 chr2:241075403-241075916 S_Shore 
 
cg22062537 NM_138336 TSS1500 chr2:241075403-241075916 S_Shore 
 
cg22993878 NM_138336 TSS1500 chr2:241075403-241075916 S_Shore 
 
cg25823214 NM_138336 TSS1500 chr2:241075403-241075916 S_Shore 
 
cg26154534 NM_138336 TSS1500 chr2:241075403-241075916 S_Shore 
MZF1 cg02765403 NM_198055 Body chr19:59073413-59074755 S_Shore 
 
cg11707067 NM_198055 3'UTR chr19:59073413-59074755 Island 
 
cg13923040 NM_003422 TSS1500 chr19:59086697-59087299 N_Shore 
 
cg21308197 NM_198055 5'UTR chr19:59084201-59085059 N_Shore 
NAA60 cg10651617 NM_001083601 5'UTR 
  
NDN cg01989224 NM_002487 TSS1500 chr15:23931559-23932547 S_Shore 
 
cg24137567 NM_002487 3'UTR chr15:23931559-23932547 N_Shore 
NKAIN3 cg00277827 NM_001304533 TSS1500 chr8:63160598-63162064 Island 
 
cg01706844 NR_130764 Body 
  
 
cg02071162 NM_173688 TSS1500 chr8:63160598-63162064 N_Shore 
 
cg08274073 NM_173688 Body 
  
 
cg12300018 NM_173688 3'UTR 
  
 
cg12380909 NM_001304533 TSS1500 chr8:63160598-63162064 Island 
 
cg20602954 NM_173688 Body 
  
 
cg21498772 NM_173688 TSS1500 chr8:63160598-63162064 Island 
NKX6-2 cg00626110 NM_177400 TSS1500 chr10:134597357-134602649 Island 
 
cg03905847 NM_177400 TSS1500 chr10:134597357-134602649 Island 
 
cg04436469 NM_177400 Body chr10:134597357-134602649 Island 
 
cg06648277 NM_177400 TSS1500 chr10:134597357-134602649 Island 
 
cg08441806 NM_177400 1stExon chr10:134597357-134602649 Island 
 
cg16949120 NM_177400 TSS1500 chr10:134597357-134602649 Island 
 
cg17259183 NM_177400 TSS1500 chr10:134597357-134602649 Island 
NLRP2 cg20995778 NM_017852 5'UTR 
  
NNAT cg11174847 NM_181689 5'UTR chr20:36148603-36150136 Island 
 
cg23566503 NM_005386 1stExon chr20:36148603-36150136 Island 
NTM cg01654560 NM_016522 TSS1500 chr11:131780328-131781532 N_Shore 
 
cg01955745 NM_001048209 1stExon 
  
 
cg03104293 NM_001048209 Body 
  
 
cg04414912 NM_001048209 TSS1500 
  
 
cg05014296 NM_001048209 Body 
  
 
cg05806689 NM_016522 TSS1500 chr11:131780328-131781532 N_Shore 
 
cg06951582 NM_001048209 Body 
  
 
cg08506743 NM_016522 TSS1500 chr11:131780328-131781532 N_Shore 
 
cg09294095 NM_001048209 Body 
  
 





cg10696654 NM_001048209 Body 
  
 
cg11163773 NM_001048209 Body 
  
 
cg13724214 NM_001048209 Body 
  
 
cg13908476 NM_001144059 Body 
  
 
cg15277677 NM_001048209 Body 
  
 
cg15617814 NM_016522 TSS1500 chr11:131780328-131781532 Island 
 
cg16763885 NM_001144059 Body 
  
 
cg18009484 NM_001048209 Body 
  
 
cg19073502 NM_001048209 Body 
  
 
cg20161190 NM_001048209 Body 
  
 
cg22074083 NM_001048209 Body 
  
 
cg23165164 NM_001048209 1stExon 
  
 
cg25602520 NM_001048209 Body 
  
 
cg25881591 NM_016522 TSS1500 chr11:131780328-131781532 N_Shore 
 
cg26286307 NM_001048209 Body 
  
 
cg27016549 NM_016522 TSS1500 chr11:131780328-131781532 N_Shore 
OBSCN cg00311303 NM_052843 Body chr1:228399471-228402037 Island 
 
cg01057552 NM_052843 Body 
  
 
cg01195848 NM_052843 Body chr1:228467964-228468497 N_Shore 
 
cg03033447 NM_052843 Body chr1:228473835-228474043 N_Shore 
 
cg04570284 NM_052843 Body 
  
 
cg04850211 NM_052843 Body chr1:228463249-228464488 Island 
 
cg08312035 NM_052843 Body chr1:228403232-228403528 N_Shore 
 
cg09204449 NM_052843 Body chr1:228463249-228464488 S_Shore 
 
cg09853570 NM_052843 Body chr1:228403232-228403528 Island 
 
cg17389050 NM_052843 Body 
  
 
cg17682590 NM_052843 Body 
  
 
cg18157027 NM_052843 Body chr1:228399471-228402037 Island 
 
cg20630560 NM_052843 TSS200 chr1:228399471-228402037 N_Shelf 
 
cg20961257 NM_052843 Body 
  
 
cg21407117 NM_052843 3'UTR chr1:228548077-228548330 S_Shore 
 
cg21772589 NM_052843 Body chr1:228461885-228462139 N_Shelf 
 
cg22862529 NM_052843 Body chr1:228548077-228548330 N_Shelf 
 
cg26303165 NM_052843 Body chr1:228399471-228402037 Island 
 
cg26575914 NM_001098623 5'UTR chr1:228399471-228402037 N_Shore 
OSBPL5 cg06143708 NM_001144063 1stExon chr11:3186131-3186768 Island 
 
cg10495980 NM_020896 5'UTR 
  
 
cg14183540 NM_020896 5'UTR 
  
 
cg16346813 NM_020896 Body 
  
 
cg16815358 NM_145638 Body 
  
 
cg18327423 NM_020896 1stExon chr11:3186131-3186768 Island 
 
cg19068644 NM_020896 Body chr11:3141642-3141877 S_Shore 
 
cg25908390 NM_020896 5'UTR 
  
OTX1 cg00431699 NM_014562 5'UTR chr2:63274475-63279430 Island 
 
cg02606423 NM_014562 Body chr2:63281034-63281347 N_Shore 
 
cg08473330 NM_014562 Body chr2:63282514-63283122 Island 
 
cg10487970 NM_014562 TSS1500 chr2:63274475-63279430 Island 
 
cg11935853 NM_014562 1stExon chr2:63274475-63279430 Island 
 




cg14174204 NM_014562 TSS1500 chr2:63274475-63279430 Island 
 
cg23116322 NM_014562 TSS1500 chr2:63274475-63279430 Island 
 
cg25622366 NM_014562 Body chr2:63281034-63281347 Island 
 
cg27581028 NM_014562 TSS1500 chr2:63274475-63279430 Island 
PAOX cg02251172 NM_152911 TSS1500 chr10:135191594-135193307 Island 
 
cg05295236 NM_152911 TSS1500 chr10:135191594-135193307 Island 
 
cg05296940 NM_207128 Body chr10:135191594-135193307 S_Shore 
 
cg09215664 NM_152911 1stExon chr10:135191594-135193307 Island 
 
cg10732694 NM_207127 3'UTR chr10:135203101-135203316 S_Shore 
 
cg12488207 NM_207128 Body chr10:135191594-135193307 S_Shore 
 
cg13224723 NM_152911 TSS1500 chr10:135191594-135193307 Island 
 
cg13446658 NM_152911 TSS1500 chr10:135191594-135193307 Island 
 
cg14846060 NM_152911 TSS1500 chr10:135191594-135193307 Island 
 
cg16079309 NM_207127 3'UTR chr10:135203101-135203316 N_Shore 
 
cg17465130 NM_152911 TSS1500 chr10:135191594-135193307 Island 
 
cg20533711 NM_152911 TSS1500 chr10:135191594-135193307 Island 
 
cg23639399 NM_152911 TSS1500 chr10:135191594-135193307 Island 
 
cg23645681 NM_152911 1stExon chr10:135191594-135193307 Island 
 
cg23941927 NM_152911 1stExon chr10:135191594-135193307 Island 
PEG10 cg02384501 NM_001040152 Body chr7:94293609-94293864 N_Shore 
 
cg03379322 NM_001040152 Body chr7:94293609-94293864 N_Shore 
 
cg06999014 NM_015068 Body chr7:94293609-94293864 S_Shore 
 
cg10466088 NM_001184961 Body chr7:94293609-94293864 S_Shore 
 
cg10759957 NM_015068 Body chr7:94293609-94293864 S_Shore 
 
cg19107595 NM_015068 5'UTR chr7:94284858-94286527 Island 
 
cg19924104 NM_015068 5'UTR chr7:94284858-94286527 Island 
 
cg21270593 NM_001040152 Body chr7:94293609-94293864 N_Shore 
 
cg27435646 NM_015068 5'UTR chr7:94284858-94286527 Island 
PEG3 cg13946792 NM_001146186 TSS1500 
  
 
cg18668753 NM_001146184 TSS1500 chr19:57351283-57351995 S_Shore 
 
cg22561329 NM_001146184 5'UTR chr19:57349997-57350470 N_Shelf 
 
cg25458871 NM_001146184 TSS1500 chr19:57351283-57351995 S_Shore 
 
cg26917367 NM_001146184 TSS1500 chr19:57351283-57351995 S_Shore 
PEX10 cg12721952 NM_002617 Body chr1:2339876-2340246 N_Shelf 
 
cg23928726 NM_002617 TSS1500 chr1:2345891-2346156 N_Shore 
PHLDA2 cg04746197 NM_003311 TSS1500 chr11:2949788-2951756 Island 
 
cg06001652 NM_003311 TSS1500 chr11:2949788-2951756 Island 
 
cg14608199 NM_003311 3'UTR chr11:2949788-2951756 Island 
 
cg17504306 NM_003311 TSS1500 chr11:2949788-2951756 Island 
PHPT1 cg14245947 NM_014172 TSS1500 chr9:139738276-139744618 Island 
PKP3 cg20268054 NM_007183 TSS1500 chr11:394257-394619 N_Shore 
 
cg20992002 NM_007183 TSS1500 chr11:394257-394619 N_Shore 
PLAGL1 cg00814597 NM_001080955 TSS1500 chr6:144384894-144385888 S_Shore 
 
cg01659632 NM_001080956 3'UTR 
  
 
cg02566775 NM_001080951 5'UTR chr6:144384894-144385888 N_Shore 
 
cg02676881 NM_001080956 5'UTR 
  
 
cg02926622 NM_001080955 TSS1500 chr6:144384894-144385888 S_Shore 
 
cg03562868 NM_006718 TSS1500 chr6:144328916-144329847 S_Shore 
 




cg04895233 NM_001080955 TSS1500 chr6:144384894-144385888 S_Shore 
 
cg06271237 NM_001080952 Body 
  
 
cg09307468 NM_001080955 TSS1500 chr6:144384894-144385888 S_Shore 
 
cg10254692 NM_001080955 TSS1500 chr6:144384894-144385888 S_Shore 
 
cg10289699 NM_001080955 5'UTR 
  
 
cg12419863 NM_001080952 Body 
  
 
cg13285181 NM_001080956 5'UTR 
  
 
cg13607311 NM_001080956 3'UTR 
  
 
cg13765002 NM_001080955 5'UTR chr6:144384894-144385888 Island 
 
cg14161241 NM_006718 TSS1500 chr6:144328916-144329847 S_Shore 
 
cg14701415 NM_001080956 5'UTR 
  
 
cg15361162 NM_001080956 5'UTR 
  
 
cg17870553 NM_001080956 5'UTR 
  
 
cg18593039 NM_006718 TSS1500 chr6:144328916-144329847 S_Shore 
 
cg20443501 NM_006718 TSS1500 chr6:144328916-144329847 S_Shore 
 
cg21416120 NM_006718 TSS1500 chr6:144328916-144329847 S_Shore 
 
cg23521444 NM_001080951 TSS200 chr6:144384894-144385888 S_Shore 
 
cg26261298 NM_001080952 Body 
  
 
cg27577583 NM_001080956 5'UTR 
  
PPAP2C cg02725885 NM_003712 Body chr19:290594-292249 Island 
 
cg03521736 NM_003712 Body chr19:290594-292249 Island 
 
cg09908879 NM_003712 Body chr19:290594-292249 Island 
 
cg16691033 NM_003712 Body chr19:290594-292249 Island 
 
cg25697727 NM_177526 TSS1500 chr19:290594-292249 Island 
PPP1R9A cg03289906 NM_001166161 TSS1500 chr7:94536849-94537477 S_Shore 
 
cg04134217 NM_001166161 TSS1500 chr7:94536849-94537477 S_Shore 
 
cg06445343 NM_001166161 TSS1500 chr7:94536849-94537477 S_Shore 
 
cg07581310 NM_001166160 Body 
  
 
cg09956907 NM_001166161 TSS1500 chr7:94536849-94537477 S_Shore 
 
cg11164400 NM_001166160 TSS200 chr7:94536849-94537477 N_Shore 
 
cg13912023 NM_001166160 Body 
  
 
cg15558930 NM_001166160 TSS1500 chr7:94536849-94537477 N_Shore 
 
cg16801720 NM_001166161 TSS1500 chr7:94536849-94537477 S_Shore 
 
cg17053223 NM_017650 TSS1500 chr7:94536849-94537477 N_Shore 
 
cg19370980 NM_001166161 TSS1500 chr7:94536849-94537477 S_Shore 
 
cg19435621 NM_001166161 TSS1500 chr7:94536849-94537477 S_Shore 
 
cg21928923 NM_017650 Body 
  
 
cg26062037 NM_017650 TSS1500 chr7:94536849-94537477 N_Shore 
PRDM16 cg00087546 NM_022114 Body chr1:3310102-3311035 N_Shore 
 
cg00251678 NM_022114 Body chr1:3307069-3307285 N_Shore 
 
cg01203812 NM_022114 Body chr1:3080934-3081292 Island 
 
cg02587392 NM_199454 3'UTR chr1:3351365-3351632 S_Shelf 
 
cg02769687 NM_022114 Body 
  
 
cg02892384 NM_022114 Body chr1:3111579-3111909 N_Shelf 
 
cg03352346 NM_022114 Body chr1:3342012-3342806 S_Shore 
 
cg03692239 NM_199454 Body chr1:3239915-3240261 S_Shore 
 
cg04316231 NM_022114 Body chr1:3080934-3081292 S_Shelf 
 
cg04499214 NM_022114 Body 
  
 




cg05288547 NM_199454 TSS1500 chr1:2983925-2987962 Island 
 
cg05656251 NM_022114 Body 
  
 
cg06081361 NM_022114 Body chr1:3195376-3196052 N_Shore 
 
cg06354193 NM_022114 Body chr1:3182821-3183216 Island 
 
cg06814194 NM_022114 Body chr1:3071899-3072239 N_Shore 
 
cg07209071 NM_022114 Body chr1:3102540-3103352 N_Shelf 
 
cg07534194 NM_022114 Body chr1:2983925-2987962 Island 
 
cg07797660 NM_022114 Body chr1:3239915-3240261 N_Shore 
 
cg08034916 NM_022114 Body chr1:3184546-3184824 Island 
 
cg08247866 NM_022114 Body 
  
 
cg08541612 NM_022114 TSS200 chr1:2983925-2987962 Island 
 
cg08636115 NM_022114 Body chr1:3182821-3183216 N_Shelf 
 
cg09321238 NM_022114 Body chr1:3071899-3072239 Island 
 
cg09335331 NM_199454 Body chr1:3111579-3111909 Island 
 
cg09509365 NM_022114 Body 
  
 
cg09867208 NM_199454 3'UTR chr1:3351365-3351632 Island 
 
cg10391102 NM_022114 Body chr1:3203765-3204453 S_Shore 
 
cg10484617 NM_022114 Body chr1:3080934-3081292 S_Shore 
 
cg10504805 NM_022114 Body chr1:3321269-3322310 Island 
 
cg11325950 NM_022114 Body chr1:3182821-3183216 N_Shore 
 
cg12559532 NM_199454 Body 
  
 
cg12884780 NM_199454 Body chr1:3080934-3081292 N_Shelf 
 
cg13722084 NM_199454 Body chr1:3321269-3322310 N_Shelf 
 
cg13731483 NM_199454 Body 
  
 
cg15156029 NM_022114 Body 
  
 
cg15386853 NM_022114 Body chr1:3307069-3307285 N_Shore 
 
cg15619820 NM_022114 Body 
  
 
cg15622583 NM_199454 Body chr1:3071899-3072239 S_Shore 
 
cg15641565 NM_022114 Body chr1:3307069-3307285 N_Shelf 
 
cg16051865 NM_199454 Body chr1:3155160-3155361 N_Shore 
 
cg16262201 NM_022114 Body chr1:3157509-3158300 N_Shore 
 
cg16265140 NM_022114 Body chr1:3080934-3081292 N_Shelf 
 
cg17239558 NM_022114 Body chr1:2983925-2987962 Island 
 
cg17511251 NM_022114 Body chr1:3071899-3072239 N_Shore 
 
cg17861161 NM_022114 Body chr1:3184546-3184824 N_Shore 
 
cg18396811 NM_022114 Body chr1:3331040-3331279 S_Shore 
 
cg19190836 NM_199454 Body chr1:3321269-3322310 N_Shelf 
 
cg19478129 NM_199454 TSS1500 chr1:2983925-2987962 Island 
 
cg20798164 NM_022114 Body chr1:3351365-3351632 N_Shelf 
 
cg21467989 NM_199454 TSS1500 chr1:2983925-2987962 Island 
 
cg21475097 NM_022114 Body chr1:3163969-3164643 Island 
 
cg22510139 NM_022114 Body chr1:3059050-3059268 N_Shore 
 
cg22608265 NM_199454 3'UTR chr1:3351365-3351632 N_Shore 
 
cg22851557 NM_022114 Body chr1:3038067-3038343 Island 
 
cg23258188 NM_022114 Body chr1:3071899-3072239 S_Shelf 
 
cg23609682 NM_022114 Body chr1:3071899-3072239 N_Shore 
 
cg23631759 NM_022114 Body 
  
 
cg24155739 NM_022114 Body chr1:3080934-3081292 N_Shelf 
 




cg24499605 NM_022114 Body 
  
 
cg24741666 NM_022114 Body chr1:3038067-3038343 S_Shore 
 
cg25372239 NM_022114 Body 
  
 
cg25987136 NM_199454 Body 
  
 
cg26153353 NM_022114 Body 
  
 
ch.1.131529R NM_022114 Body 
  
PTPN14 cg00163510 NM_005401 5'UTR chr1:214724104-214725056 N_Shore 
 
cg06068545 NM_005401 Body 
  
 
cg06566767 NM_005401 Body 
  
 
cg06826449 NM_005401 Body chr1:214557165-214557442 N_Shelf 
 
cg10009514 NM_005401 Body 
  
 
cg10952190 NM_005401 TSS1500 chr1:214724104-214725056 S_Shore 
 
cg10994693 NM_005401 Body chr1:214557165-214557442 N_Shore 
 
cg11816923 NM_005401 TSS1500 chr1:214725192-214725528 Island 
 
cg12823387 NM_005401 Body 
  
 
cg13584078 NM_005401 5'UTR 
  
 
cg16318728 NM_005401 5'UTR 
  
 
cg16488544 NM_005401 5'UTR 
  
 
cg17778482 NM_005401 Body 
  
 
cg20968551 NM_005401 Body 
  
 
cg25349729 NM_005401 Body chr1:214557165-214557442 S_Shelf 
PURG cg02993340 NM_013357 TSS1500 
  
 
cg04002325 NM_013357 TSS1500 
  
 
cg04756577 NM_001015508 3'UTR 
  
 
cg04833152 NM_013357 TSS1500 
  
 
cg05779300 NM_013357 TSS1500 
  
 
cg07129253 NM_013357 TSS1500 
  
 
cg12672713 NM_001015508 1stExon 
  
 
cg19311679 NM_013357 TSS1500 
  
 
cg20533040 NM_013357 TSS1500 
  
 
cg21604516 NM_013357 TSS200 
  
 
cg25618087 NM_013357 TSS1500 
  
PYY2 cg20947476 NR_003064 Body chr17:26554244-26555018 Island 
RAB1B cg04592747 NM_030981 TSS200 chr11:66035828-66036808 Island 
 
cg05214125 NM_030981 TSS1500 chr11:66035216-66035447 Island 
 
cg07629401 NM_030981 TSS200 chr11:66035828-66036808 Island 
 
cg09978545 NM_030981 TSS1500 chr11:66035828-66036808 Island 
 
cg14538055 NM_030981 TSS1500 chr11:66035828-66036808 Island 
 
cg16309993 NM_030981 TSS200 chr11:66035828-66036808 Island 
 
cg17342184 NM_030981 TSS200 chr11:66035828-66036808 Island 
 
cg19178040 NM_030981 Body chr11:66034751-66035054 S_Shore 
 
cg21531702 NM_030981 TSS1500 chr11:66035828-66036808 N_Shore 
 
cg23490166 NM_030981 TSS200 chr11:66035828-66036808 Island 
 
cg27286967 NM_030981 TSS200 chr11:66035828-66036808 Island 
RB1 cg03460032 NM_000321 Body 
  
 
cg05026473 NM_000321 Body chr13:48877459-48878501 S_Shelf 
 
cg07880715 NM_000321 Body chr13:48892635-48893857 S_Shore 
 
cg09751228 NM_000321 Body 
  
 




cg13485756 NM_000321 TSS200 chr13:48877459-48878501 Island 
 
cg14641315 NM_000321 TSS200 chr13:48877459-48878501 Island 
 
cg16153267 NM_000321 Body chr13:48892635-48893857 S_Shore 
 
cg17055959 NM_000321 Body chr13:48877459-48878501 Island 
 
cg24342013 NM_000321 Body chr13:48890957-48891549 Island 
 
cg24937706 NM_000321 TSS200 chr13:48877459-48878501 Island 
 
cg25676335 NM_000321 Body chr13:48892635-48893857 S_Shore 
 
cg27026713 NM_000321 Body chr13:48892635-48893857 S_Shore 
RBP5 cg00294025 NM_031491 3'UTR 
  
 
cg09201266 NM_031491 Body 
  
 
cg10993460 NM_031491 3'UTR 
  
RPL22 cg04025728 NM_000983 TSS200 chr1:6259178-6259883 Island 
 
cg05895952 NM_000983 TSS200 chr1:6259178-6259883 Island 
 
cg08541953 NM_000983 Body chr1:6259178-6259883 Island 
 
cg08760004 NM_000983 TSS1500 chr1:6259178-6259883 S_Shore 
 
cg13476932 NM_000983 TSS1500 chr1:6259178-6259883 S_Shore 
 
cg15234483 NM_000983 TSS200 chr1:6259178-6259883 Island 
 
cg16178974 NM_000983 TSS200 chr1:6259178-6259883 Island 
 
cg21393421 NM_000983 Body chr1:6259178-6259883 Island 
 
cg22174623 NM_000983 Body chr1:6259178-6259883 N_Shore 
 
cg23394916 NM_000983 3'UTR 
  
 
cg26935168 NM_000983 TSS1500 chr1:6259178-6259883 S_Shore 
 
ch.1.228777R NM_000983 Body 
  
RTL1 cg06999127 NM_001134888 TSS1500 chr14:101348385-101348698 S_Shelf 
SALL1 cg01146232 NM_001127892 TSS1500 chr16:51183699-51188763 Island 
 
cg04550052 NM_002968 Body chr16:51183699-51188763 Island 
 
cg06099646 NM_002968 Body 
  
 
cg08199953 NM_002968 Body chr16:51183699-51188763 N_Shore 
 
cg11035433 NM_001127892 TSS1500 chr16:51183699-51188763 Island 
 
cg14115575 NM_001127892 TSS1500 chr16:51183699-51188763 Island 
 
cg27022663 NM_002968 3'UTR chr16:51168266-51169110 S_Shore 
SGCE cg01566785 NM_001099401 TSS1500 chr7:94284858-94286527 Island 
 
cg02444961 NM_001099400 Body chr7:94284858-94286527 N_Shore 
 
cg05531533 NM_001099401 TSS200 chr7:94284858-94286527 Island 
 
cg06695761 NM_001099401 TSS1500 chr7:94284858-94286527 Island 
 
cg13266630 NM_001099400 1stExon chr7:94284858-94286527 Island 
 
cg16956426 NM_001099400 Body chr7:94284858-94286527 Island 
 
cg17890778 NM_001099400 Body chr7:94284858-94286527 Island 
 
cg18484166 NM_001099400 Body chr7:94284858-94286527 N_Shore 
 
cg21771834 NM_001099401 TSS1500 chr7:94284858-94286527 Island 
 
cg22924867 NM_001099401 TSS1500 chr7:94284858-94286527 S_Shore 
 
cg23096644 NM_001099400 Body chr7:94284858-94286527 N_Shore 
 
cg23616761 NM_001099400 1stExon chr7:94284858-94286527 Island 
 
cg23690528 NM_001099400 Body chr7:94284858-94286527 Island 
 
cg24885794 NM_001099401 TSS1500 chr7:94284858-94286527 Island 
 
cg26283564 NM_001099400 Body chr7:94284858-94286527 N_Shore 
 
cg27001184 NM_001099401 TSS1500 chr7:94284858-94286527 Island 
SGK2 cg03337502 NM_001199264 TSS1500 
  
 





cg14573741 NM_001199264 Body 
  
 
cg14869839 NM_016276 TSS1500 
  
 
cg15370163 NM_170693 TSS1500 
  
SIM2 cg00698204 NM_009586 Body chr21:38079941-38081833 Island 
 
cg00754430 NM_005069 Body chr21:38119793-38120742 N_Shore 
 
cg01090834 NM_009586 Body chr21:38079941-38081833 Island 
 
cg01853561 NM_005069 3'UTR chr21:38119793-38120742 Island 
 
cg03194923 NM_005069 5'UTR chr21:38068193-38073891 Island 
 
cg03241388 NM_005069 TSS1500 chr21:38068193-38073891 Island 
 
cg04648480 NM_009586 Body chr21:38079941-38081833 S_Shore 
 
cg04975856 NM_005069 TSS200 chr21:38068193-38073891 Island 
 
cg06551387 NM_005069 TSS200 chr21:38068193-38073891 Island 
 
cg08297082 NM_009586 Body chr21:38068193-38073891 Island 
 
cg10456990 NM_009586 Body chr21:38076762-38077685 Island 
 
cg10850930 NM_009586 Body chr21:38079941-38081833 N_Shore 
 
cg11088471 NM_009586 Body chr21:38079941-38081833 S_Shelf 
 
cg20755721 NM_005069 TSS1500 chr21:38068193-38073891 Island 
 
cg21689102 NM_005069 TSS1500 chr21:38068193-38073891 Island 
 
cg21697851 NM_009586 Body chr21:38076762-38077685 Island 
 
cg22289831 NM_009586 Body chr21:38076762-38077685 N_Shore 
 
cg22976224 NM_005069 TSS1500 chr21:38068193-38073891 Island 
 
cg23896164 NM_005069 3'UTR chr21:38119793-38120742 Island 
 
cg24080247 NM_009586 Body chr21:38079941-38081833 S_Shore 
 
cg24354581 NM_009586 Body chr21:38079941-38081833 N_Shore 
 
cg26720125 NM_009586 Body chr21:38076762-38077685 Island 
 
cg26938272 NM_005069 TSS1500 chr21:38068193-38073891 Island 
SLC22A18 cg08827700 NM_183233 Body chr11:2923301-2923817 S_Shelf 
 
cg13054642 NM_183233 Body 
  
 
cg22858288 NM_183233 Body chr11:2930289-2931093 Island 
 
cg24724917 NM_183233 Body chr11:2923301-2923817 S_Shore 
SLC22A2 cg02666489 NM_003058 TSS200 chr6:160679377-160679701 S_Shore 
 
cg04294894 NM_003058 TSS200 chr6:160679377-160679701 S_Shore 
 
cg07601258 NM_003058 Body chr6:160679377-160679701 N_Shore 
SLC22A3 cg01739295 NM_021977 Body chr6:160768414-160770308 S_Shelf 
 
cg07883823 NM_021977 TSS1500 chr6:160768414-160770308 Island 
 
cg08303612 NM_021977 Body chr6:160768414-160770308 Island 
 
cg11263679 NM_021977 Body 
  
 
cg11450627 NM_021977 Body 
  
SLC26A10 cg02079831 NM_133489 Body chr12:58014708-58015697 Island 
 
cg05157486 NM_133489 Body chr12:58014708-58015697 S_Shore 
 
cg08820231 NM_133489 TSS200 chr12:58014708-58015697 N_Shore 
 
cg09696411 NM_133489 TSS200 chr12:58013171-58013652 Island 
 
cg10605137 NM_133489 Body chr12:58014708-58015697 S_Shore 
 
cg12615879 NM_133489 TSS1500 chr12:58013171-58013652 Island 
 
cg12883767 NM_133489 TSS1500 chr12:58013171-58013652 N_Shore 
 
cg16577509 NM_133489 TSS200 chr12:58013171-58013652 Island 
 
cg20677436 NM_133489 TSS1500 chr12:58013171-58013652 Island 
 
cg22844229 NM_133489 TSS1500 chr12:58013171-58013652 Island 
 
cg26616640 NM_133489 TSS1500 chr12:58013171-58013652 Island 
 
149 
SLC4A2 cg01177956 NM_003040 TSS200 chr7:150756391-150756659 Island 
 
cg01685739 NM_003040 1stExon chr7:150757031-150757297 N_Shore 
 
cg04326743 NM_003040 Body 
  
 
cg05593194 NM_001199694 TSS1500 chr7:150756391-150756659 S_Shelf 
 
cg10842164 NM_003040 5'UTR chr7:150757031-150757297 S_Shore 
 
cg12199996 NM_001199694 TSS200 chr7:150756391-150756659 S_Shelf 
 
cg17497176 NM_003040 Body 
  
 
cg20040836 NM_001199692 5'UTR chr7:150757031-150757297 S_Shore 
 
cg21804273 NM_003040 TSS200 chr7:150756391-150756659 Island 
 
cg24097436 NM_003040 TSS200 chr7:150756391-150756659 Island 
 
cg27087150 NM_003040 TSS200 chr7:150756391-150756659 Island 
SNRPN cg01614564 NM_003097 5'UTR chr15:25200035-25201054 S_Shore 
 
cg03858387 NM_022805 5'UTR chr15:25200035-25201054 N_Shore 
 
cg08560373 NM_022805 5'UTR chr15:25123357-25123708 Island 
 
cg15825819 NM_022808 TSS1500 
  
 
cg19964320 NM_022808 5'UTR chr15:25093191-25093582 S_Shelf 
 
cg22259765 NM_022805 5'UTR chr15:25123357-25123708 N_Shelf 
 
cg23088318 NM_022808 5'UTR chr15:25093191-25093582 S_Shore 
 
cg26939721 NM_022805 5'UTR 
  
SOX8 cg01964856 NM_014587 Body chr16:1029878-1035327 Island 
 
cg02170784 NM_014587 Body chr16:1029878-1035327 Island 
 
cg05857979 NM_014587 TSS200 chr16:1029878-1035327 Island 
 
cg05933904 NM_014587 1stExon chr16:1029878-1035327 Island 
SPON2 cg06048089 NM_001199021 5'UTR chr4:1188185-1189162 N_Shore 
 
cg20939159 NM_012445 TSS1500 chr4:1164515-1166582 S_Shore 
 
cg26030944 NM_001199021 5'UTR 
  
TFPI2 cg03333330 NM_006528 TSS1500 chr7:93519366-93520184 S_Shore 
 
cg14377593 NM_006528 TSS200 chr7:93519366-93520184 Island 
 
cg18302726 NM_006528 TSS1500 chr7:93519366-93520184 S_Shore 
 
cg19854521 NM_006528 TSS1500 chr7:93519366-93520184 S_Shore 
 
cg22799321 NM_006528 Body chr7:93519366-93520184 Island 
TFPI2 cg27496965 NM_006528 TSS1500 chr7:93519366-93520184 S_Shore 
TIGD1 cg05593479 NM_145702 5'UTR chr2:233415005-233415811 Island 
 
cg15957524 NM_145702 TSS1500 chr2:233415005-233415811 Island 
TMEM52 cg04758387 NM_178545 TSS1500 chr1:1850098-1851391 Island 
 
cg08134829 NM_178545 TSS1500 chr1:1850098-1851391 Island 
 
cg09859491 NM_178545 TSS1500 chr1:1850098-1851391 S_Shore 
 
cg10943191 NM_178545 Body chr1:1850098-1851391 Island 
 
cg22094750 NM_178545 TSS1500 chr1:1850098-1851391 Island 
TP73 cg00589002 NM_001126240 TSS1500 chr1:3607096-3607553 N_Shore 
 
cg04137576 NM_005427 5'UTR 
  
 
cg04493946 NM_005427 Body chr1:3607096-3607553 Island 
 
cg05782471 NM_001126240 Body chr1:3623318-3623521 Island 
 
cg10143426 NM_005427 TSS1500 chr1:3566445-3569636 Island 
 
cg11061452 NM_005427 5'UTR 
  
 
cg16163116 NM_001126240 Body chr1:3607096-3607553 S_Shore 
 
cg17163168 NM_005427 Body 
  
 
cg17727502 NM_001204185 Body 
  
 




cg22383924 NM_005427 5'UTR 
  
 
cg23052055 NM_001126240 TSS1500 chr1:3607096-3607553 N_Shore 
 
cg25406408 NM_001126240 Body chr1:3623318-3623521 Island 
 
cg25731359 NM_005427 TSS1500 chr1:3566445-3569636 Island 
 
cg26055950 NM_005427 Body 
  
 
cg27055894 NM_005427 5'UTR 
  
TSHZ3 cg00136902 NM_020856 Body 
  
 
cg00545804 NM_020856 TSS1500 chr19:31839635-31843049 Island 
 
cg04893733 NM_020856 Body 
  
 
cg06196755 NM_020856 Body chr19:31839635-31843049 Island 
 
cg08458170 NM_020856 Body 
  
 
cg08970226 NM_020856 TSS1500 chr19:31839635-31843049 Island 
 
cg11199770 NM_020856 TSS1500 chr19:31839635-31843049 Island 
 
cg12110750 NM_020856 Body chr19:31839635-31843049 N_Shore 
 
cg12986271 NM_020856 TSS1500 chr19:31839635-31843049 Island 
 
cg15208375 NM_020856 TSS1500 chr19:31839635-31843049 Island 
 
cg15792338 NM_020856 TSS1500 chr19:31839635-31843049 Island 
 
cg18328837 NM_020856 Body 
  
 
cg18843803 NM_020856 Body 
  
 
cg21102737 NM_020856 Body 
  
 
cg22721472 NM_020856 3'UTR 
  
 
cg23091984 NM_020856 Body chr19:31839635-31843049 Island 
 
cg26224223 NM_020856 TSS1500 chr19:31839635-31843049 Island 
 
cg26238835 NM_020856 Body 
  
 
cg27336392 NM_020856 Body 
  
UBE3A cg00096039 NM_000462 Body 
  
 
cg00792740 NM_130839 TSS1500 chr15:25683348-25684415 S_Shore 
 
cg12177023 NM_130839 5'UTR chr15:25683348-25684415 N_Shore 
 
cg15189393 NM_000462 ExonBnd 
  
 
cg16141702 NM_130838 TSS1500 
  
 
cg18766912 NM_130839 1stExon chr15:25683348-25684415 Island 
 
cg19709054 NM_130839 5'UTR 
  
 
cg24998848 NM_130838 Body 
  
 
cg25339913 NM_130838 Body 
  
VAX2 cg01109169 NM_012476 Body chr2:71134585-71134792 Island 
 
cg05603527 NM_012476 Body chr2:71131200-71132256 Island 
 
cg08972756 NM_012476 Body chr2:71134585-71134792 N_Shore 
 
cg19907796 NM_012476 Body chr2:71134585-71134792 Island 
 
cg20699736 NM_012476 TSS1500 chr2:71126720-71129209 Island 
 
cg20782615 NM_012476 Body 
  
 
cg23271234 NM_012476 TSS1500 chr2:71126720-71129209 N_Shore 
VENTX cg02317400 NM_014468 TSS1500 chr10:135048797-135052077 Island 
 
cg02447627 NM_014468 TSS1500 chr10:135048797-135052077 Island 
 
cg03002848 NM_014468 TSS1500 chr10:135048797-135052077 Island 
 
cg03786388 NM_014468 TSS1500 chr10:135048797-135052077 Island 
 
cg04215475 NM_014468 TSS1500 chr10:135048797-135052077 Island 
 
cg04652645 NM_014468 TSS1500 chr10:135048797-135052077 Island 
 
cg18002909 NM_014468 TSS1500 chr10:135048797-135052077 Island 
 




cg26285605 NM_014468 TSS1500 chr10:135048797-135052077 Island 
WDR8 cg02415297 NM_017818 Body chr1:3556963-3557201 N_Shelf 
 
cg04021697 NM_017818 TSS1500 chr1:3566445-3569636 Island 
 
cg05399785 NM_017818 Body chr1:3566445-3569636 N_Shelf 
 
cg08945920 NM_017818 Body 
  
 
cg13460118 NM_017818 Body chr1:3559952-3561009 Island 
 
cg16395997 NM_017818 Body chr1:3559952-3561009 S_Shore 
 
cg16823083 NM_017818 TSS1500 chr1:3566445-3569636 Island 
 
cg19711013 NM_017818 Body chr1:3556963-3557201 N_Shore 
 
cg22614891 NM_017818 TSS1500 chr1:3566445-3569636 Island 
WT1 cg02838895 NM_001198552 TSS1500 chr11:32454874-32457311 N_Shore 
 
cg05222924 NM_024425 Body chr11:32452144-32452708 N_Shore 
 
cg07211140 NM_024425 Body chr11:32454874-32457311 Island 
 
cg07716052 NM_024425 Body chr11:32454874-32457311 N_Shore 
 
cg08575722 NM_024425 Body 
  
 
cg08787968 NM_024425 Body chr11:32452144-32452708 N_Shore 
 
cg09257824 NM_024425 Body chr11:32454874-32457311 Island 
 
cg09695430 NM_024425 Body chr11:32448261-32449744 N_Shore 
 
cg12060848 NM_024424 Body chr11:32454874-32457311 Island 
 
cg15446391 NM_024425 Body chr11:32452144-32452708 Island 
 
cg15518358 NM_001198552 TSS200 chr11:32452144-32452708 Island 
 
cg16501028 NM_024425 Body chr11:32448261-32449744 S_Shore 
 
cg18950778 NM_024425 Body chr11:32454874-32457311 Island 
 
cg19126300 NM_024426 TSS200 chr11:32454874-32457311 Island 
 
cg19570244 NM_024426 TSS200 chr11:32454874-32457311 Island 
 
cg20204986 NM_024425 Body chr11:32448261-32449744 N_Shore 
 
cg21769619 NM_024425 Body chr11:32454874-32457311 N_Shore 
 
cg22533573 NM_024425 Body chr11:32452144-32452708 S_Shore 
WT1-AS cg03669907 NR_023920 TSS200 chr11:32454874-32457311 Island 
 
cg07565441 NR_023920 TSS200 chr11:32454874-32457311 Island 
ZC3H12C cg01195135 NM_033390 Body 
  
 
cg02016838 NM_033390 TSS1500 chr11:109963240-109964677 Island 
 
cg04820195 NM_033390 Body 
  
 
cg05839709 NM_033390 TSS1500 chr11:109963240-109964677 N_Shore 
 
cg17345188 NM_033390 Body chr11:109963240-109964677 Island 
 
cg18330398 NM_033390 Body 
  
 
cg23538648 NM_033390 Body chr11:109963240-109964677 S_Shore 
 
cg26056522 NM_033390 Body 
  
ZDBF2 cg04851476 NM_020923 TSS1500 chr2:207139336-207140031 N_Shore 
 
cg07132386 NM_001285549 TSS1500 chr2:207139336-207140031 N_Shore 
 
cg08578136 NM_020923 TSS200 chr2:207139336-207140031 Island 
 
cg12570310 NM_020923 Body 
  
 
cg13788515 NM_020923 TSS200 chr2:207139336-207140031 Island 
 
cg17764507 NM_020923 TSS1500 chr2:207139336-207140031 N_Shore 
 
cg18807071 NM_020923 TSS200 chr2:207139336-207140031 Island 
ZFAT cg00057272 NM_020863 TSS1500 chr8:135724770-135725552 S_Shore 
 
cg06906961 NM_001029939 5'UTR 
  
 
cg08116775 NM_020863 TSS1500 chr8:135724770-135725552 S_Shore 
 





cg10740375 NM_001029939 5'UTR 
  
 
cg17722832 NR_110323 Body 
  
 
cg19657380 NM_020863 Body chr8:135724770-135725552 Island 
 
cg21733775 NM_001029939 5'UTR 
  
 
cg22171996 NR_110323 Body 
  
 
cg22870483 NR_110323 Body 
  
 
cg26750713 NR_110323 Body 
  
ZFP36L2 cg03771385 NM_006887 TSS1500 chr2:43451445-43454951 Island 
 
cg07119260 NM_006887 TSS1500 chr2:43451445-43454951 Island 
 
cg08193650 NM_006887 Body chr2:43451445-43454951 Island 
 
cg16720946 NM_006887 TSS1500 chr2:43451445-43454951 Island 
 
cg16876647 NM_006887 Body chr2:43451445-43454951 Island 
 
cg22198946 NM_006887 TSS1500 chr2:43451445-43454951 Island 
 
cg23038392 NM_006887 TSS1500 chr2:43451445-43454951 Island 
 
cg23288298 NM_006887 Body chr2:43451445-43454951 Island 
ZIC1 cg00475509 NM_003412 TSS1500 chr3:147126988-147128999 N_Shore 
 
cg01227537 NM_003412 TSS200 chr3:147126988-147128999 Island 
 
cg01825295 NM_003412 3'UTR chr3:147130342-147130577 S_Shore 
 
cg04738965 NM_003412 1stExon chr3:147126988-147128999 Island 
 
cg05371578 NM_003412 1stExon chr3:147126988-147128999 Island 
 
cg07291439 NM_003412 TSS1500 chr3:147126988-147128999 N_Shore 
 
cg08855449 NM_003412 TSS1500 chr3:147126988-147128999 N_Shore 
 
cg12204258 NM_003412 Body chr3:147131066-147131333 Island 
 
cg12965599 NM_003412 TSS1500 chr3:147126988-147128999 N_Shore 
 
cg14456683 NM_003412 TSS200 chr3:147126988-147128999 Island 
 
cg15002294 NM_003412 TSS1500 chr3:147126988-147128999 N_Shore 
 
cg16209664 NM_003412 Body chr3:147131066-147131333 Island 
 
cg23449696 NM_003412 TSS1500 chr3:147126988-147128999 N_Shore 
ZNF225 cg01080410 NM_013362 TSS1500 chr19:44617490-44617831 N_Shore 
 
cg01396855 NM_013362 TSS1500 chr19:44617490-44617831 N_Shore 
 
cg02707280 NM_013362 5'UTR chr19:44617490-44617831 Island 
 
cg04323379 NM_013362 TSS200 chr19:44617490-44617831 N_Shore 
 
cg08230124 NM_013362 5'UTR chr19:44617490-44617831 Island 
 
cg08520228 NM_013362 5'UTR chr19:44617490-44617831 Island 
 
cg08684893 NM_013362 TSS1500 chr19:44617490-44617831 N_Shore 
 
cg16511061 NM_013362 TSS1500 chr19:44617490-44617831 N_Shore 
 
cg19864129 NM_013362 TSS1500 chr19:44617490-44617831 N_Shore 
ZNF229 cg09793279 NM_014518 TSS200 chr19:44952416-44952809 Island 
 
cg13150341 NM_014518 TSS1500 chr19:44952416-44952809 S_Shore 
 
cg19915738 NM_014518 TSS200 chr19:44952416-44952809 Island 
 





APPENDIX 4: DIRECTED ACYCLIC GRAPHS (DAGS) USED TO ASSIST IN 
SELECTING MODEL COVARIATES 
= exposure 
I = outcome 
Green line = causal pathway (not included in model) 
Red line = confounding pathway (included in model) 
Green node/black line = ancestor of exposure (not included in model) 
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Green node/black line = ancestor of exposure (not included in model) 
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I = outcome 
Green line = causal pathway (not included in model) 
Red line = confounding pathway (included in model) 
Green node/black line = ancestor of exposure (not included in model) 
Blue node/black line = ancestor of outcome (included in model) 
 
  






APPENDIX 5: SEX-STRATIFIED BIOLOGIC FUNCTIONS ASSOCIATED WITH 







Upstream Regulator p-value of overlap
MEIS1 8.94E-06 DLK1,HOXA2,HOXA3
Males Diseases or Functions Annotation p-Value Molecules
Organ Morphology
Abnormal morphology of placental 
spongiotrophoblast layer 0.00000902 E2F7,PEG10,ZFAT
Abnormal morphology of small placenta 0.0000133 E2F7,KCNQ1OT1,PEG10
Abnormal morphology of membranous 
labyrinth 0.0000201 DLX5,HES1,KCNQ1
Abnormal morphology of 
spongiotrophoblasts 0.0000375 E2F7,PEG10
Abnormal morphology of placenta 0.0000456 E2F7,KCNQ1OT1,PEG10,ZFAT
Females Diseases or Functions Annotation p-Value Molecules
Neurological Disease & 
Organismal Development Abnormality of peripheral nervous system 1.84E-08 DLX5,GFI1,GNAS,HOXA2,HOXA3,HOXB2,KCNQ1,RB1
Morphology of head 3.13E-08
CYP1B1,DLX5,GFI1,GNAS,HOXA2,HOXA3,HOXB2,KCNQ1,LR
RTM1,PRDM16,RB1,SGCE,SIM2,TP73
Abnormality of ear 6.28E-08 DLX5,GFI1,GNAS,HOXA2,HOXB2,KCNQ1,RB1
Abnormal morphology of head 7.03E-08
CYP1B1,DLX5,GFI1,GNAS,HOXA2,HOXA3,HOXB2,KCNQ1,LR
RTM1,RB1,SGCE,SIM2,TP73
Morphology of nervous system 0.000000168
DLX5,GFI1,GNAS,HOXA2,HOXA3,HOXB2,KCNQ1,LRRTM1,PR
DM16,RB1,SGCE,SIM2,TP73
Abnormal morphology of nervous system 0.0000002
DLX5,GFI1,GNAS,HOXA2,HOXA3,HOXB2,KCNQ1,LRRTM1,RB
1,SGCE,SIM2,TP73
Abnormality of inner ear 0.000000219 DLX5,GFI1,HOXA2,HOXB2,KCNQ1,RB1
Morphology of brain 0.000000226
DLX5,GNAS,HOXA2,HOXB2,LRRTM1,PRDM16,RB1,SGCE,SI
M2,TP73
Cycle regulation/estrogen-mediated S-phase entry
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APPENDIX 7: COMMON IMPRINTED GENES WITHIN THE PLACENTA WITH ALTERED METHYLATION ACROSS 
ALL THREE STUDIES  
 
Gene  Illumina cg all ♀ ♂ all ♀ ♂ all ♀ ♂ Genome location Group Relation 
ANO1 




























































































































































































































































cg13735403   ↓        Body   









KCNK9 cg21727779   ↓      −  Body  
KCNQ1 cg07072281     ↓      Body   
cg09315662        +   Body   
cg11652182         −  Body   
cg15501942        +   TSS1500   







































































MAGEL2 cg01152488     ↑      TSS1500   
cg20747630         +  1stExon   









MAGI2 cg14388864 ↓          Body   
cg14446066       −  −  Body   
cg25832180 ↓          Body   
cg26575140   ↓        Body   
ch.7.1714607F       −    Body  
MEG3 





cg14121301       +    Body   
cg23482724   ↓        Body   















cg14428359     ↓      3'UTR   






















































cg17389050   ↓        Body   
cg17682590       −    Body   




OSBPL5 cg16346813   ↓        Body   
cg25908390   ↓    + +   5'UTR  
PEG10 














PLAGL1 cg01659632         −  3'UTR   































cg21928923     ↓      Body  
PRDM16 










cg05656251       +  +  Body   










cg09509365         −  Body   
cg12559532   ↓        Body   










cg26153353   ↓        Body   
ch.1.131529R       −    Body  
PTPN14 





cg16318728   ↓        5'UTR   
cg16488544     ↓      5'UTR  
PURG cg21604516        +   TSS200   








RB1 cg03460032     ↓      Body   
























































































cg26030944         +  5'UTR  
TP73 





cg17727502   ↓        Body   




TSHZ3 cg00136902   ↓        Body   
cg21102737 ↓        −  Body  
ZC3H12C 





cg26056522     ↓      Body  
ZFAT cg08770998         +  Body   
cg22870483   ↓        Body   
cg26750713         +  Body  
ZFP36L2 









*  ↑ denotes increased RR of IUGR with increased CpG methylation; ↓ denotes decreased RR of IUGR with increased CpG methylation 
#  ↑ denotes accelerated growth with increased CpG methylation; ↓ denotes slower growth with increased CpG methylation 
ⱡ   + denotes positive association between maternal pre-pregnancy weight (matBMI) and CpG methylation; - denotes negative association between matBMI and 
CpG methylation 
